var title_f21_6_21600="Severe SGA";
var content_f21_6_21600=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F53832&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F53832&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Small for gestational age (SGA) infant",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 288px; height: 350px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The infant has the typical shrunken or \"wizened\" appearance of an SGA infant.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of George T Mandy, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_6_21600=[""].join("\n");
var outline_f21_6_21600=null;
var title_f21_6_21601="Onychomatricoma surgery";
var content_f21_6_21601=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F85740&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F85740&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Surgical excision of onychomatricoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 348px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_6_21601=[""].join("\n");
var outline_f21_6_21601=null;
var title_f21_6_21602="Tinea corporis leg";
var content_f21_6_21602=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F53823&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F53823&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Tinea corporis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_6_21602=[""].join("\n");
var outline_f21_6_21602=null;
var title_f21_6_21603="Ambenonium: Drug information";
var content_f21_6_21603=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"11\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Ambenonium: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?15/29/15828?source=see_link\">",
"    see \"Ambenonium: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F132750\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Mytelase&reg; [DSC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F132769\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Cholinergic Agonist",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F132754\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Myasthenia gravis:",
"     </b>",
"     Oral: 5-25 mg 3-4 times/day; administer every 3-4 hours; adjust dose every 1-2 days as needed depending on patient response; dose requirements can vary greatly, with some patients requiring as much as 50-75 mg/dose",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F132755\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F15671486\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15671487\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F132741\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Caplet, oral, as chloride:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mytelase&reg;: 10 mg [DSC] [scored]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F132729\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F13334080\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer 3-4 times/day every 3-4 hours. Medication is usually not required throughout the night.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F132742\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of myasthenia gravis",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F132767\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Anxiety, malaise, vertigo",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal cramps, diarrhea, nausea, salivation, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Urinary urgency",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Fasciculations, muscle cramps",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Lacrimation, miosis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Bronchial secretions increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Diaphoresis increased",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F132744\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to ambenonium or any components of the formulation; concomitant administration with belladonna derivatives, mecamylamine, or other ganglionic-blocking agents",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F132732\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anticholinergic insensitivity: May develop for brief or prolonged periods; reduce or withhold dosages until the patient becomes sensitive again. May require respiratory support.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Belladonna alkaloids: Routine administration of atropine or other belladonna alkaloids with ambenonium is contraindicated because they may suppress the muscarinic symptoms of excessive gastrointestinal stimulation, leaving only the more serious symptoms as signs of overdosage (eg, muscle fasciculations, paralysis).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cholinergic agents: Should not be used with other cholinergic agents except under strict medical supervision. Prior to initiating therapy, other cholinergic should be suspended until the patient is stabilized.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Asthma: Use with caution in patients with asthma.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Intestinal obstruction: Use with caution in patients with intestinal obstruction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Parkinson's disease: Use with caution in patients with Parkinson's disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Urinary tract obstruction: Use with caution in patients with urinary obstruction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: There is a narrow margin between the first appearance of side effects and serious toxic effects; use caution when adjusting dose. Overdose may lead to cholinergic crisis. Temporarily discontinue use if signs of overdose occur (eg, excess gastrointestinal stimulation, excess salivation, miosis, and fasciculations of voluntary muscles). Edrophonium may be used to evaluate the maintenance dose.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298729\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6217813\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors: May enhance the adverse/toxic effect of Cholinergic Agonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers: May enhance the adverse/toxic effect of Cholinergic Agonists. Of particular concern are the potential for cardiac conduction abnormalities and bronchoconstriction. Management: Administer these agents in combination with caution, and monitor for conduction disturbances.  Avoid methacholine with any beta blocker due to the potential for additive bronchoconstriction.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13333201\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Safety in pregnancy has not been established.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F132757\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F13333211\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Observe for cholinergic reactions",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F132746\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Mytelase (FI, HU, PL);",
"     </li>",
"     <li>",
"      Mytelase Chloride (BE, CZ, FR, HN, SE)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F13333207\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Increases acetylcholine concentration at transmission sites in parasympathetic neurons and skeletal muscles by inhibiting acetylcholinesterase",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F13333208\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Absorption: Oral: Poor and unpredictable (Tharasse-Bloch, 1991)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bioavailability Increased when fasting (Ohtsubo, 1992)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Angelini C, \"Diagnosis and Management of Autoimmune Myasthenia Gravis,\"",
"      <i>",
"       Clin Drug Investig",
"      </i>",
"      2011, 31(1):1-14.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/6/21603/abstract-text/21053987/pubmed\" id=\"21053987\" target=\"_blank\">",
"        21053987",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ohtsubo K, Fujii N, Higuchi S, et al, \"Influence of Food on Serum Ambenonium Concentration in Patients With Myasthenia Gravis,\"",
"      <i>",
"       Eur J Clin Pharmacol",
"      </i>",
"      , 1992, 42(4):371-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/6/21603/abstract-text/1516600/pubmed\" id=\"1516600\" target=\"_blank\">",
"        1516600",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tharasse-Bloch C, Chabenat C, Boucly P, et al, \"Pharmacokinetic Studies of Ambenonium Chloride in Patients With Myasthenia Gravis,\"",
"      <i>",
"       Eur J Drug Metab Pharmacokinet",
"      </i>",
"      , 1991, 16(4):299-303.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/6/21603/abstract-text/1823874/pubmed\" id=\"1823874\" target=\"_blank\">",
"        1823874",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8619 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-197.136.42.3-02B1BD5894-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_6_21603=[""].join("\n");
var outline_f21_6_21603=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F132750\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F132769\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F132754\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F132755\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15671486\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15671487\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F132741\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F132729\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13334080\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F132742\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F132767\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F132744\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F132732\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298729\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6217813\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13333201\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F132757\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13333211\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F132746\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13333207\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13333208\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8619\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8619|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?15/29/15828?source=related_link\">",
"      Ambenonium: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_6_21604="Intertrigo";
var content_f21_6_21604=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F65405&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F65405&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Intertrigo",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 473px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Intertrigo before and after skin care. The patient was on antifungal creams for one month with no improvement prior to the top photo. The lower photo shows the effect of simply keeping the skin clean and dry.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Michael J Dixon, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_6_21604=[""].join("\n");
var outline_f21_6_21604=null;
var title_f21_6_21605="APL bone marrow aspirate I";
var content_f21_6_21605=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F82864&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F82864&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Bone marrow aspirate smear from a patient with acute promyelocytic leukemia (APL)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 316px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAE8AhwDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooARSSPmGD6ZzS0UUAFAGM85oooAKKQ5yMfjS0AAFFFFABRRRQAUUUUAFFFFABRSY5zzS0ARrCizPKq4dwAx9cdKkopuW8wjb8uM7s9/SgB1FFFABRQenFC5wM9fagAooooAKKKRs7TtGT2oAWikUkqCwwcciloAKOlGOaaybmU7mG05wDwfrQA6iiigBGUMpVgCp4IPegAAAAcDpUcok8yLYwC7vnBHUY7fjUtAFC506G+SWO/hhljY4UgYbHuawda8GWFy63AmlgWFclFG4ED9a6qaQRRPIxwqgk1Wsrxb+LfEJY9rDIdcZ7/l71tTq1afvQbRSk1qjlrLwnaT3EN1JPcTWsih1V/kx6Aiukh0mytEDWlpGrK29ccc/Wr7orjDgEehps7FIGKgcDjPSieIqVPiY5TcnqQMyyHLfeH8OelRvK0MQ3jc2eNtMEoDZCZLHHTFI03+k+X5bH5cg0rGqiSy3Sq8KMHzKdowM44zzTnyUYx8Ece4pIMhRuBB9DTlULuIycnJqSXZFhWBC8jOKHGVPqOlRRDG49yc80k5m8xNgAi6lu/0pW1M7a6DuMc8/SmIhW4eTd8jAAL6GkyeeRTl4wQMmjYuxOhzTLmNpIyEdkYcgrjOfxpJpDFCzqjSEDOxOpqVeQDgjPakZkb+aUXy9obIyG9O9S0UUhBSMwUEscAdzS0HkUAQSSyhh5UXmJjruxzT4n3KCyFGPBBpyKVUAsTjuRTqAG7F3lto3EYJ71QvtJt7rcVAjkbqyjrV+QsF/dqCcjgnHFOqoycXeLAzdK06HS4iiZeSQ5Z8cn0+gp+r6TYaxbfZ9TtIbqHrtkGcfT0q/QRkU+eXNz31BabHi+u/CaW2ttUl0oxXm/JtbZzsMWT0DV5xfeFdb08CKbT7tT9+ZfLLF8dhivquL5skluuMMMVJXr0M8r01aaUjWNWUdj5JXR9YvLiIWejXm6RAzQJG20/7xPSup0L4Pa7rVxFca1OulWob5oQA0hX2A4BPvX0Z601nAdUwST6dvrV1M/rtWpRUfPdhOtKe5k+FfDel+F9LSw0a3EMK8sxOXc+rN3NbBxnGeaaQ5bqAuO3XNC7/NcsF2cbSOvvmvEnOU5OUndsyHiikBySMHilqQCigHNFABRRRQAUUUUAFFFFACMwUZY4HqaWgjPWigAooJA60UAFFFFABTFjCyM4zluvPH5U+igAoopsjBFLGgAdgqlieBzVZ7+CM/PIqr3ZjgVzut+KIrbzEiIJ5UNjI3CvP9auLi+WATzG4Nwf3iY2+WB2xXfQwMqmstDrp4ZyV5HrNzqhRd8UTOnYjoaqxalOwZnmQD0Cj5a83s9Xk0y4hNnFcT2QG103/lwa6zTdW0y/cNaFkkkOcTLgDHUZ9a1nhPZrVX8xzpcmljoV1Mm42NIECjJyM7qcurMW/dx+auM8cVg6tNa2LpuuliV/m2gZYmuM/4SW9u7nzNItNlsFIkMj8nB5bHaing1VV4rQlUuboew2t1Fcxh42GDU5IHU4ryPTvE8scQlupI5rWViPMX5WXHQYrufD/iK31EpGHVkKja5OMn0PvXPXwc6V2loZVKThudEQGUg9DxSgYAA7UCiuMyCiim7RuDEnI468UAJu3BwQygd/6ilT7g53e/rSOyxoXkbCjue1RzQ+cjjLRsVKhlPIB70AT0jDIIyRkdR2qppltNa2/lT3DXGD8rMOce9XKbsnoDGxpsRV3M20Yy3JP1pse/fIWPy5+UY6U6VS6FQxUnuvUUK6l2QHLL1FIAdVdSjgMCOQe9AKrtXIHYCkYPtOCobPBx2pWVWILAHByPY0AK2ccdaRslTwc9gDSsARg9KSNFjXai7VHagCMRFsGU5xztqOSH5w+M4FTnO/O3OBwc08HimpMpSaKR3YGB+dNVXFwWJJUjAHYVexmlwBVcxXtPIiCts+UAN/tVIQMc9KWmSJ5g2t9327+1QZ3IFaKSZ4o2JePlhjpmpFjI6mh/MSKVkHmPglEOB26Zp1uZGhQzIEkIBZQcgH0zVXZXMx4BHWlooqSSvbmZ2Z5l8sAkKgOcj1PvVikAwSfWloAKKKKACkJAYDuaXvRQAHkcHFFFQ3Urwxl0iaUj+FetC1AmpGUN1oQ5UEjBIziloAKQjnj8aWigBGIAJPSq+F8xmAALdT3qR85wSTmkBVI8kgAdc9qpFISTPG0kcdc0kYaW32Ssd+MMV4qQgbBxSL94YpdA3RLRzTWYh1AUkHqfSjJyeVpEjFOGqWoBncc/hUy9KbKaFooopEhQajciOQOS53YQAZI/+t9akoAKKKQKASQOvJoAWkZd2OSMHPBpaKACignFZt3qaqji0HnyL6dB+NOMXJ2RUYuTsjSzRXMx+IZIwxvYRER90H+P6V0UEyTwpLEwZGGQQaudKVP4ip0pQ3JKKTcMgZGT70Z9OecH2rMzKktxFZC3imeR2mk8tCRuJJyefas3xhfS2Wj3ElsAZlGFyccnvWxO6gohzubO0jqK4r4jyOlpb+UjyoZVEhDYJA7CujCwU6sUzahG80cdKixWwDZMsxzIofcNx5yD61j6lJM07PFHt2rtY7vmI74o1Zvsy3H2OV4xFMtwCW3NlhyKi1W9t3ms5l3IJBuK4+8fSvpacXoz1dkM1adpVWGCVjMx4ROCB6GtjSSHiMpbEYXhAeCR3+tY1sAtxJqcjBHeNtgXk59qnt4/K0yKYSlf76gfMM1U0uXlImaN5cXQspZWkLyvwXY5OB2I/wAKxrXU7rSrt5VCiKZSHIGQ2f5VNrN+09q0VhGYmTAVsA7275FY4nuBHMzLGW2cIvIA7/jVUoXVmib6JF6xCTwqkykiVyTGpyAueMelbOg3kMOvSRgtsc/dzzGy9D9Kw9LlWCOWRY3WVYhz3fPTj1qvouLS4+13Djz95J3HO4E/pVOCkpRZNRXifSemXIvNPguFzh1B5q1WF4LkEnh62cEYbJ4PvUOveMtG0Z5YZrpJbuMZNvEwLD6+n418i6UpVHCCuebytuyOi3DcASMnoKWvO7P4jWF7uuIbVg6p0YcgZ5Ga0bXxtBI0bOItkj7QFJyPY+9avBV1vEp0pLc7PFNdSyMoJUkYBHasvSdes9Tubi2hLJcQEb45BgkHoR6itYVzyi4O0lYhprciBdWjTBcY+ZyalqKeXyUeVgxRFyQoyT+FLBKk8SSxnKOMg1IiTFGBmiigCK5EnlEwgGQcqGOAT6E1HYPcyWkbXsKQ3BHzojbgPxqzTHjV2RiPmQ5Xmn0sA4AgcnNKRkYooJxSAKrzwSO8Rhm8pUJLKFyGzUWkXM91ZCS8iSG4DMrojbgCDxzgdsGrtPVMNhqqyx43bmA+8e9I5wFBUtkgcD9afRSAKKKKAEAAJx3paKO9ABQDmiigAPtUVtCtvHsUuRktljk5JzUtRyybB70b6AlcWSRYwCxxSh1IBzwarg5A35Y0BSyncOPQ1Vi+Usgg0kjrHGzuQqKCxJ7Cq6M7E7sZHQirCnIxSaJasIrb0R0IZWwQfUU4k8bQDzS44pFGBikIWk3DOMjPpSmmhFDlwo3HgnHJoAdQaKYY8zCTe/C7dufl+uPWgCG4m8snqTjpii2fzLcHZtJP3TUzoCQT1phymcYIPaq6F3VrdRZW2oxwx9l602JwzDbyMU0vuk2AEHGdw6CnoiQK7EgD7zMf50bINlqTYpMD0FQ2l5b3cayW0qyxtnDLyDj3qepIIVPNSqOKYq+vSpB0psbYUUUCkIT7w9jSgYAA7UVFHKzzyxmJ1VMYc4w+fT6UAS0UUUAFVdSSJ7ORZ5XijONzIxVhzngirVYvi0qNGkJcKwYFQT94+lVBc0kioR5pJFK81RLi4ZGlCRAZRA2C3vmsDU9bl01vI0/ypw3Lo5xtU+nvWLrMiNF86DEal8xHJFYM7W6CC7Z2miYfMAOEavcpYSK32PWjSjFWNrWNaj1O2tnTdEYGK4J4Y+/vVW11S40fdeWd1JD5iZUF90RPcEGsa5wHlnVkntWTEkCDrj+L61iXusTXERt4h5drGR5MTLg5z612ww8ZR5EtB8iejO/i8XXj3Yvo5llnIH7qRNoB74r0vQdbttVtWeMhbiMDz4u6EivnqfURcqPODo6KGUsMH9K6fwxrkmj+JIr10za3W2G7CnICn7r/AIGubF4CM4XgrNfj5GNahFxutz2x5Vfb8oyp3fN2rkvHJ+2acssZVbVGDGTbkqR/St6Zyjso5AHy/wC1VS/Vb2zeCbC7h1PQH3FeTQtTmpnNTSi7o8ViuY4rqRbuRJIriX5s9XFMvLq2Cny24ifYkKjIYN0HNdBqvhG4sbWe1aOK4ikYyRseGjPrn0rkZFmtbZDbwxxzQygurnl+3ANfTU3Cr70GdyqJlqZgbZ3QRbgOYw2T+XanWjuZkhG9geDKTwGP86qalcCzkJjeKKS4YEuRnGe1OuLeKZUR7vfGPm+Tpn/PeqtpqS3fcS5MkVw+xgRyCw4+bsaqRq10pEUhMsvB29Mj2qos0TsyrGzbGwcng0+1ntxPKIlCMD8iY+6fXNa8rSHfoWTrKW9hbyCOVLqBsEN3+tUrS8uNRnPkKPPaVSEPAIPU/Sqtykt3BOGVPNVtqsOhIra8PWr25jadEXn5pQeh9KbSpxcupE9rHba1rbaf4fg0ezuJrNDHvlkjOC3PIB7Vy80CgPMkTGd4yJ3fnKHvk9TWQt6NQup3aRmEZKYLA5BPX2rRuL66giWF4vMjA2KJHwGU9x61z06PsV7u73BaaJE/h949N0cS3LtN5oYJEOvXr9KkttYuYJoI0s7ccfIhOWOe5x3rlpr24iaAgpPGhwuDgISeAfUVq6gkyxRXXywSv97HBX3xWsqevvdQ5F9o14r6F9UWa4uri21Rl/dFXICsDxz/AENew+BvEJ1CxFrqNzFJqMK7nYfLvX1xXz5cWoiQxSyHzJPm3kZC++fWul8DanHZ61psc0gfOVLEdCOx9jXHjcHGtTbW62OetS0ue86615/Zsh05oxNjdlu47ge9QxapDaiJLm4U4hDOwAxuz047+1UdUuXvrO5aJliEA4fOQpI53D0rzm51W3tQ1xEhkmbBOPuse5ArxcNhPax5Wc/I7WPYIdUspmKx3MRYDJBOMU06naxnZNcRK5Jxz1HrXkFrrRnEcs4UCb5hEG+YCtqytlnuCq3BBZMqjdQDWksujDWTB05LdHo9tqVpdSbLa5hl452uM1crx690prKGVlnEQ34XyucEdse9bmg6/f2dyIZ5DdWiryGPzKfrWdTAe7zUpXJkktj0QABiecmlIqhpOrWeqwtJZSiTacOvQqfQir4rz2mnZkkQhUXJmy24rsxnjH0qQjOKWikACiikBG4jcM9ce1AC0UUc59qACop3lCqYI1kJODubbgetSmgUAIucDOM+1KM96bGXIbzFA+Y4wc8dqdQAVVlOZyPapzGTMJN7YAxtzx9frTJowxB71UXZlRdmNjAz82OegpolV9+xgdpwcdjSSqqBZHUDYeCe1IoManlfmJbNUXvqOUkepPvUgYKNzkKB1JPSosH0wD6U4xLL8siBkwQQ3Q/hSYnYsg5AI6UUyNVijCIu1VGAPaljYugYqyE/wt1FQZgiBN2CTkk8nNOoooAKKCcDoT9KKAGbB5u8kk4wB2FLsU04gHnHIpAAowAAKAEWNVHyilIBGGwQeMHvS0YGRxQAiIqABAFUcADgUtFFABRRRQAUUUUAFFFFACKCAdxzz6YpaKKAA15t491JLzVvsStKkdmN7Og4ZiOR+Ar0S6lEFvLKxwsaFifoK8LXUJ5xHdyKfLuJJJijdMZP869HLqXNNzfQ7MHC7cn0G3t9aR28kNrFK82wFZ17ntxWRMzAgpkMGHmRtyPfHrVy9mNjNLdRbWt/JHy+p9BWGzs8toEUwhpBlXbhB16+le/ThZaHomjdKlncDaVkimBXaDtbPfGeKrx2s2okWc5W2fcfIdiPmHo3pUwsZ9QRxcTxOgm2xhBuxjvT9WtVVrVwEazR9pYZYbgOvtVRaVknqSY1ujXAeKYSf6M5LoU4PsO5Bq3HuhtpmVlP2hs7fvYPpT5POltHmYqrgEo8XIBB7/hSb1jEEscTAFTNj1brlRWqbYPY9ws7mSbS9OaZSLloFZgRjoKfK7kFZOp5welQ2N22o6Rp124IeeBXYehp9wpZlBO4gdxxXy63PPItVii1C1WKRisq/dY8A+1cjd2Cu0lvqNokjKcRySLlifYjqK7toYTY5kYKzHGQOlU7+BriBIYLkCHaVZtuWz2we1bUcRyaLYIq+x55qGlaTdWtrHqdj5TM7IWizuUiubXwpG8k0mmXE32dFLOsny7x6V6Lf+GoZoGiS+uIpCcmTg5OK5bVPDfiCKQrp9xBdQ4GVkJXcPqK9CjjL+6p29TRRlE4eeaK0jnGxgzDYIuw9DWal7GYIUk5dcltowuP/wBdaevahJYzLbavpUkK4OHCng98NWC2o6VI4AZfJUEGPd+tevTTnG7RTqpOzNSKOe7vLcqkiBhjHpnvV/VbqWwthp9ogeUIfNdyMgHvVSW9jstIFzAqFQAERmIZ/eqFvc+c32q4+86/NGecD+7mkve1eyC73NOGwjihkZijWuE8x1GCfb860dRhkAiuSsshiUqhdshI+2BWRLdxyfZBDbqkUec5Y4kP09K2JbmMlC8ixxiMDy2ODt9KmTd02VG+7MBeURmTZ8/7xwDgd8e9TanJc3cCySOZUJ8sbRgBexqxfXcMYkg3D7IgDKeuf/r1BahZJAtu4dZV3NFI20hfWrvpzWNSRrqT+zZCkqx4+VmI3Hjt9KdoMoa+tXRiuH3B2PDMe9VrOZQ01oSgc/6tmHyjHr68Vc8MQrfa1a2/ls0ccomJ3fy9qbsoyb6EVZe60ereLNbX+yrextplhnki3zgpjzCOBk1w+nwpHeLLNJJLuyWjUkjcO1P1hrufXr64IVokj4GcgL6j1qsl7DH5bPKEXBHnBTkk1w0aSpQ5Y9dSKVNKzLcIt2kL20KxMjZHmuSSfar1peOdTM0cj7HjDKnUxsPQ1k/aEgMn2ldhRMrI/wDGO1ZbaxHMEjs90k6vzGiFQ+fU+lV7OUrmzSPVtOnhu2li1KSO3ukXJ28CQHndWBqM9ppqyFpZWMrYKIdxcVx0MhstSE7rcqGbbsf5t2e3NaEsRNxczRiUxpHleMn3yO1Zxw/s3voc7oJs6rQ9fSx1Bbq3kOQMOjvjKjqCK9e0nUbbVLKO6spVkicZ4PQ+h96+ZdQmHm23l26yMyhioHIPqx7Gux+H3iFNFvFVy2x2CyRk4ABPX8K5cfgFVh7WHxGNXD8quj3RCSo3DB9M5paAQRkcg1FNcwQECaaOMt0DsBmvnDlJaTA3ZwM9M0uagErGVshRDgbWz1Pf8KAJ6KB0pOc+1AA4DKVYZUjBFIgCoqqMADAHpTqhkuEQqDklm2jigB3mosixFwZCM4749adGWK5ddp9M5qB5IUzNIyoOm9vlzXN6x4zt7eInTkFw27aGY4Un+da06M6jtBDsdbR1ryu+8d6gsDNLNb2qkffiTeBn0z1NUdO+JeoCMecI5FTIZpYirNjuNtdn9l4i10i1Tkz14qzOwbbs4246++aa8MRjPmqpXqc9K4nSviJaTvHHe27Ru38UJ3j8utdrbXVveRb7eWOVDwdpz+dcdSjUo6TViWpRJYwAox0xxTqBwKKyJGTSxwxtJM6pGvVmOAKfTJESWMrIquh6hhkGn0AFFQ7pTPgxqIh/Hu5P4VKxwBwT9KAFopki7wyvgxlcH1qO0uIJ4/8ARZEkRfl+U5x7UAT0c5ooAwKACijNFABRRRQAUUUUAFFFFABRRRQAUUjH5Tiog5XknNFhpXMnxJced4f1HyiVwjxtuBBPGOK8YjaRl/dqXiChEV+xHFe06rp02pafeWjXDL5iFUKjBGfevF7y0v7CWSK8s5YvKDKVJ5f/AGh9a9vK+XllG+p6OFcVHlT1Mu5ld5BcqCBGpUSIcKT3GKg06JtRsbkStid+Cz9Ao+nes/UNk0cVvYq/lAGRkxghuwxXR6WPLsJbUwqWIBKgfMTjrmvZmlCFzpk9rFWFbrR0aOyeIq6hc4yyA9atXnhy/jsA5umd94DIg4Ib+I1ScywyJOOW+6Vcdaml1+4QGDLSvGDtjX7p+p9al8904fMGm9mQvYS2lp9kuWDo+4qB0B7ZrLv5ZvtenwW0T/aQot1hP8O44rThuZpYDf3OIochgh5JbsAO9db8NvCsn9tjVtYtroXUrGeEspC9Ovt7U6lVUIynU3MqtVQjq9Tu7WE2Fja2RK5giVM+4HNOdyU69Off6USElyWyX6moLhlZRtP1r5xK7uchHc3AZRub5ew/xqLTzIkzE5ZPXsKjcPIwVEYlv1rO1iUW8LQ28hZn4bB6VvGHN7qHFa6E1/4l0a3W4Z7jmI4K45J9q5+bx5ZpKf8AQ7llAzkLwfwrH1O5sobpLUK80p5+4Wx7msZkFy8yW+oRx3BYk5XAA/Gu6GX0re9c6VKVrI6tfHGiX8bQ30RRT/BNHjinaTpnhKVzJY2dgztzkgE15df7I03wzrIzuIxvBIY9yKpvY3Fq8lxA8qCMjeqt0966P7Nik1Tm43Jl3aO/+NujQHw1DqWn26pJauN5jHJjPWvJnvvNhhjMikIAwYcZrvdE8ZedbyaVrQaSKYGPcenPAzXnuvaXL4e1V7eXIt2+aMlc/LXVgITpx9hV3Wq8zKtUWjRrRCO4k82SUvtI2qjY/D61qxkXF27eaGU/Kw79O9cpb3YtXLkHY+AAB19a3tMvkN7lUTLjbmQdPTmuqcWaRmmSSwF4YvLEyw4J3lhx7EVLHFPawwsxTyn4LheT7fStCzt3SSScyJLbqMMh6Z9MVSv7qJImjO1A3zKpPK57CoUnN8pou5NCyzWEjQeWbm3fGT8oNdd4Js/tEjrCGkeSIySSoMbDjoK4KziS5ngjijYXExO+VpMLj6d69c+FtqLe0vZlZTiJxuJwCfxrDGy9lSbuc9aXM0jhrx2t9Qfasm2KRQz54wexp95Gsbw3QnYROSnlgcD3NQawsguJjE48qSTITcWyahkKuiK8jIFI3qhzurS10mjem9C1fXU1rLHE4SSBhuDYGCB6H1qFF+z6juZswTAOG7AelSxCBbWeW9VvKUbYw3zbc+wpluBF5bybHWLDRJ1Uj3BpbKw9yzqF2XuIvLdW+be57Jx2NRfaAIVKtIJZGIYg8kj7v4VE10L2+M0dvhfmbax+XjtUttKY0klEe0Fl27DuGT1+lLlSWw0tR0k000bBMO5YAqRjPPPFSwSPbPcB9rttwNwHy8/riqkk8iRhHYiTPVVwRk9f/r03dNFO0cuyYSYALdOff1pxXR7EVdrH0b4K1WTUfCljdyDzJdvlvsHcHGal1a8tLe6tZp7eF8A5nmIHloeuM854FeXWfjN/CPgmDTrCNLjVyXY5/wBXFk9z/SuDln1a8Z7vUrye4MmGlJ+5z0UD0rwaeVOpOU5O0buxxwot62PdofHOmy3rwWTy3RYkgEYAPoPapbTxbaPvhjtT5UR2squCVPuK8WLahBZPDIq2sk4/dtEcMh/vH2p1jcyWcsbxXQe9J+ckYz7n1zXS8qo2NJYZpXue9afq1ncptic2srvnZMeSPbmtW4uYrfyxI2GkbaigZLH6V5H9rW6tLa6LRqzZBDtjaV681b0TxnFprwC4uhe225iPLbc0Y7kfT0rzquXuzlT18jncH2PUpi5RgjbGGDnbnj2qndz/AGC0eeWZBbDLs0p5UY6D1qM6laf2dFqFosl5BOQVaEb8g9/pXA/EHXzPJBpoCzIY/MdQME57Vy4bDyrTUEVTpuXoZ2u69fa3Osvmpb28ZLQpnbkerVny6jLaqhkgRigYgIepxWJb3W63WFcsAMt8uWHNVtVuAk2I5Hxw7erN2HtX00KKjaEVojp5G0lYq6ndP5srqMwhgdu3Kj1FJLbKJcW0srXBUbV3bRg06NGvboOxkZEUu4XgHHt6VpvDaXEEDWcriQSZmcgcAVvzKNkjoikkZ9ojGXeZjB5X7sk5+/6ium8PapcWl3BJHJJHPGm7532+cuec4rJheGztJ4HUsZGLh8BsP60kDCxitr8TzSxls7doznPIFRVSqxcZIzqQTR7v4f16DV0KgeVcoMvEx/UeorZry1Lxka1vLF/K2uDuZPmC4+6fXNekabeJfWUVxFwrjOD2PpXy2Kw/snzR2Z50o2LVB6UmTux2xS1yEgOBSbvm289M1heLfFmk+FbA3Wr3GzskSDdJIfQLXmn/AAu8zaj5VpoEpt843vMu4++BXVQwNevHmpxuu5Si5bHtBGabHEkefLRUz12jFeb6X8UbTUdUFoyGzI5JmQ7T7Z7V3NlqscxRJwsUj/c+bKv9DUVcNVpaTQOLjuaVIN2TnHtS0VgSVrm1W4Ee5nRkcSAocc/4VZooov0AKrfbrcMytKqspwQ3Bz+NWaQqD1ANAC0Ud6KACikDA4rOvtXhtX2lWchgrFcYGacYuTsioxcnaJpUlZ1lrWn3jBILlDIWK7Dw2fpV1yQabi4u0lYHFrRiu3XBGR1qE5z7UoADFgBk9TUchGOaRcUSxH5v6VheM9IW/t4p0EpuYT8ix9X9q10k2vuFSWh+aUEuWJ3Hccjn09q0hOVOSmug7yhLmR89eIY3s9UuI7nT5beeRASH4O0dCPWqemiaOYyJl8fwnqoP9K+gPFHh608Q6c9vcogm2kRTFclD/hXkujfDbWZr+4guikEMTlDPk/MMcbR3FfR4bMKNWk/aPla/rQ6oYiLjeW5yus3FzdKIRlIIuWIGD+dVtEhuWuZIbFzLOVxtRN7MDwB7V7MPhZpkiBbq+vZUKAMoYKCfXpXXaPoOmaNZpbadZQwxp3C/MT6k9SampnFGELUk2/uRE8Xp7qPOfDPgKy8PQRax4nunaW3xJDbb/ljI5x/tNmtZPH1xK0i/Zoo8p5iDO5gPQjua5Dxh4zTWPE1za2iRfZbNmt/tEmdpPcj8e/tWMnmTTwzvdRxwQ8K33WNRHCyxH73Fbv8AA2hQTXNU1Z6taapp2oSWcKyeVPMpIIHylh2z2PtVhtMulkEflNjd94Dj615QdV2ENvA3HzB5ZxhgeteufDrXJdd0DzbnPnwyNCzH+LHQ/ka5MTQlho+0jqjCvD2eqI7i0mtrSWWOArNt2jf6ex9a4LWbi2t5Xt0V9zR/Kx53MPWvTvE0qKlujybQGL47nArzDX5WGoWFzGSI3ZndWXt0NXgHz+9IdB3RzxebybaH7TtmBJaTHyhj2z61h6tfPBY3BntY5p1chxnDPx1xXWatBbzP5dtcb0SQTR7U5PtmuR8UWwS9ju3jSS5WUF4A38PrXtUXGTVztjsZNr9kubHzFba6AYhbsa0W0S3tP7PZrmR7mYFpcdMds/4VnzTvJetfi28qFMFVI6DPf1rYvNQku7jE20hgMlRwBW01K+j0EldGEunLcSN9pXyXkBEYxjzAOh9q6zRLODxjpDaHrYSG+jX/AEaaQYYMOxNVdbjsbnTbDynZryBiFYnKr3FJ4fkM2rpqBdXmhcbkzneQe3vWVTmqQck7Nf19zMasEldHB6t4evdOkuYbiGVBbyFGdh8pbtg+9R2t4bVBDJbYCDAPJ5r6/ezstfsissFndw7wHTPzIcZwSO4z0riPEPgTwnpcEl3f3TW5kPKE7ufQCsaOd05+5Vi7+Rw+8n7h8/rcPvMkOS5blRn5ia0LbS7u4u4VniKQk5zgFkJ7D1ru3HhjR9acWel3twknyKZpAEbjqPQVf07x9pGmyJN/wjcYljDKi+bliB3wa65YqW9Km39xtKNaS3IPDvw2vp3ivbsw28Sco8y4/ED1qvretOmoSWOntts7U/OR/wAtD3rsZ/ilp2uaPc2VzZ3WnTTQkxu2HGc9OOhrkbjw/FewG50yZZyhG5VPPPXg1xUKtScnLFq3Y5atOpGN1uZWqKDDFdbCsZAOQMgHsaox4uHJgZCzjzJWJ6Y6j613vijwlPpPh2we5cjevlts52MeVBrzLy54mjjjZ2mLFGA5yPXNdNCpGtFuDO2g/cVy3aeU+pyeW8gg2/Omw4HtRr1vapcpbW8n7kgO3OfoKa8dzNtVI5JFA2KwGMY7U6PRbma3S5kxuBOYi2GAHUmt00mm2auSuNtbUpYyTo4Zi5JQ9PQA0n2+KO1jW2Qq4ba+ecGpUcx2zlWaWI/Kq9MH/aqJo9zxxQKXkBJYoPl565NJ26jUiTF1dJKJMqVUc91+pqxYFbnUE80kLtKIAcgv6/lVK4dLZJYoZnlY8zSHoxPQfQVauoXh022O/D7lkdE6j0otdIzldtFjTcyTuIgJQp2hXGQTnuK1THcNJiaz3QONkmDtXg9RVbyYjLZy22xGGSQD80memPepfMubmdYrKd2KnaQ3KrnrknpWLfMze1kRWka3l/dGf7Qtv0VQc5A/hBrXjaxa2mu5m/dQqFMQTJwO2aTTNNvUkCXM4QxgkFCCp/8Ar1zfiPV5LtjbuksaREq2xMBseoFQo+0nyxYr3Yh1eW71LyUgMVmwZ0ROTuPQn04qK4vpIkt5GgltIwSiOEwOeD9aqQWRCpPA4SQYLEcDYfatyz339jd+dcgWypgq4y2e23610PkhK8dh9TqPAesjT5La3LSf2fdExMMkCKQ/xgehrP8AGkuPEcykgw2vBWMEYXFcyrLBJbwASKpw6YJyCOxzWp4mkFxqvnxM4EyqzsvzdB0rkVCMa3OuqElqRpcIZhJJ88CjcNrYA44z3JrHhkaS4mkVftAkJBAODjsa0LK1+0yyvbnam3mQ8Bh7VWhnuFRYo2jVY2xkDqO4rohbWwrWehoR3xtbPcI94C7cqeT6A1PvuIhvujCIXUM/GQnoOKy7qJmZBA/mhgWdVGMDPUVL5zLbzJcRsAvO9Bkse34ZpcmmhVyxcQ2726SN+5Ej5AU5J9T7UlnYzzanpmn+a5tvP3Ky/edP6VHaRR3Bt/Kl2gt8u7Jwe+TXX+G7R7SI3dqkc00r7MSEDy17kemazq1fZxauROZ0eqQNNDMvmNLJDgE7cbcemPat3wDdos91Yec8jgCXa3ROxA/SsOJ545Z3EMfnSLtj3HO7/Gp/Ciz2PiW2S4geKSdWBUDj1yffivHrLnoyi+mpwVLnpAGK4v4q+Mx4L8OrcwRpNqV3J9ns4WOA0hHU+w6muvnaVQvlKrZYA7jjA7mvnX9paeaXxfo9q7OIIbJ5ox23s20n64rjyvDRxOJjCe27+Rmldnl09xqV/qN3earey3l85LTzscg/7KjoB6AVraBbMF+0XTeTDnhlH8Q9aoaVcJpy4kjLKRhQR94+9R6hqUk8m1WMfU4XgCvspty9yKsj0qUVFamxquqNc3O1S+xV28cZFepfCfxauor/AGJq8hkeLH2S57nj7p9x614xO0kq28sbbXb5Wx3+tXNHupNNuFuLW4WG6ikVslsdT0A/pXPiMNDEUuTqKrG9z7E0yZprNGcksMqWIxux3q1WJ4WkdrLEm4swEmW9wK2TwBgcCviKkeWTR5zGymUKfKVWORgE4471JTHJQE4LcjgU+oEBooooADwKarA/X0oc7RnBP0qncyCKYncp3DBBOMU0rlRjzaIi1ST5CRvXAwT6VhSunnpG6ZXGXOOGHrWhb+Z5zytP+7bIKMMgj2NZFy7DEce5VydgbqMdq76MbaHoUo8vumFr9tp9vfRXFuz8gsdr7ShHQiur8I69bappAV7tpLuAETeYuH69cd64rxDvimQbRiUbQGH3Wo0iSLwzN9tuLWS5mjUkLFy3Pp6121qCq0VreS2NK1LnjZbnqMrJEAZZEjDdNxxmmMPm2bgWI3Y9vWvO9S8TzazCZILV4ICMCW4XJX6AVD4f8Tm2VLXUbh5beR/LjnVcbSOgPsa4/qFTl5uvY5vYSUbnpMarICQysB6HOa56XUJ7mZ2t5vs8m791EykMwHWiS4eO3ilOyOV8rwMZHtSWVxPPIst0FLr8q8fMVHcmlTpOPvMxlddDo9NmuZuZRG8G0YkHDbu4Iq/WdbXSW9jNLPlVjBkJPcda8i8S+J7zxPMpikntNOGVS3jba8h7sx+nas6OEniJtR0S6ip0ZVX2PbCwX5i3y4rJ1vVPIsbk2u2Z1XkI4yvvXilvqF7Yapiwu7ryNoXYJCyjHsa2H8Q/Oksli4kSQMJYxtWXjoRXV/ZkoSTvc6oYTld2zy+aCS21WaFZiVMxc8nkE55qy11DNOcI7no6YJ2gVtaw1q99POu03N03mSJg/ux6VbsILfTbQNs8wTL80hGcivonXTim1qdU3ZmNc3UU8MBgSOJIhjJGS3ua9c+B+rQajol9FEnlyRXHzDHB4Az+leJ6mzxSXCxKFibAQNzkGvWv2eYI4/Dt+6Hy5ZbnBHqFHNceaRj9Tb81Y5sX8KOt8WXTR6moP+rEYBPoc5rjtSs/tsEyn51jy4ZTyxrrPFNqrasHRJC+3jngmooNHLW3nTyBXYHJjHArzcPUjSpxZjGSjFWPOL0RXNmNPJNvdvh4mjHIx2PpWFq2m3nmtPEY3CcSuW+YnFes6j4ctiGmMwRniAEw4yD2rz/WtPlsJr5J43ntwA6qeSxx2Neph8RCo/cOqnPmRzF1dx3EYsNji5dFdzjG7HaomgFndLLEwCSfeDHOGxQt5dR263CWTS3ZyAwHEY7VS1SQJZ2s010zyuSuAn3Tmu6MbO3Q3tY043t7OeGeCRJYZ1beWGcPj0+tJoVlH52yIsJ1YEL33E9PpVQtY20rQSLuMURPAxjcOvtW/wCDmWyimvrpMiACVdw5LY4Oe9RUk4wfmZVNUkeh+LvHUXhDTn0+xtYBrEieZhPuJkAbn9WrySfVpbyxlkvvtEtxJu8ws+4yE9/QfhWfqStf30s7yPcm5YvIWPzEk8AegFXLfSnyUj/ciJdxaVcgn04rLDYWlhoX+092QoKGw63t3uLKDdA6LtyVLZLU69hiLRTyRktIhXaxwwFaMl2LQRxh4vN2ZKkZ5PFENvI7RJds7vGeHVeCp/hFa873ZNtLmY1vJNZ280fmkRD5s8E9uKSSa5sXE9vKqGQ4Uo+ShrpLy18+2uY4nCQoVQOxxgnoDWJd6LNY4USxyzqS5wCc/QU4VIz0kZqd9zq4/HjavpH9j63IktyoDJPjaN46K2O9cRbXIt79i6mJomICMvX3qSWFo7eKebyYw3znK/xdOfc1XjvLfUQ8F98l2MiGXs3samlRhTv7NaMdtLI37LVFcMMIbnftKRjrn7v41qXFtCLZZNTRorpwVYg8D0/OuRKJYmGORik6sC4Axk9q3Z7tLuZ0upFWRFEnPAb1qJ0tVKOwJWHw2E0bs0HCt87Q7RyB65qrq1wbS3KwpDE2fmEZ/hPU1PFPqV/lbdRuwIgV5Zl7V12h/Djzp7U6jITbopMm7hmJqJ14Uveqv5Ck2jzGz0m+1TV1sNPilme4dApK8AZ+8T6V13j/AEo+HNeS1CF4ZIBh1Uc9uB7GvddC0fTdGtlh022SFcYzj5j9TXnvxz0wXUelXAWRiC8eV6L0IJ/WuOjmn1nFRha0dTndWSlc8znu4oI7NVuI2njTk7MYJ64PrT9Ojn3xPBIQgcqybv8AWE881jC3nQII4ljC8KrHJb1NaFotwjRvF8rL1TP+sHc16k6fLF2Z6CmpRujb1zXpLWW1siqQ3Eo8x8jAQdOtYy6kLG4aSVkkAOdwHGTTL4i61IxTsCJV+WNuuFHIU/Ws5HeIrHenfGT/AKsjn2z70oU4pJdWVGKRpx3EMkpbywkTg75GP3j2/WtOOaGOxI3wvLK4bLAglvYVhQzxPMAywswIGAec/wAs1LPfjzHwzK0R2B3UcE9qUoXC3VErxT/aWlvAWKPxzlT9PSkSWdLCJpR5cQmfyihBLLVa5uZ1BX5i6gBFPQk9TUkKtLagQsrJFMWIxwM9qe9nIUnYns1nvY1jijfGw7ipxhc9AKiurRrYqsgJtychV4K1v6H5llKkARpmn+ZiD/q1/oKdrkMT20UkZjdmYowI4OP/AK1Zqq1Pltoc/NqYVqzLIsdscFoipY98mkluHguWjJSdlGJNvAA7j61HOiR3XmWsYKFSnznAA9B6moWnMkUixKHcjG49c1qld3NYu5ai1MGUCNdiYOd3U+gpINZv7xRDEqtH1ZicKvpWM9rKWR5NwBwoCn5mNdDo8NzPIYECooGJAQMDHIqpwjFX3K5b7mlpt/rlo08smpkS265VNoKY9q9F8B6k+q6/HMWDbojI4YncDjH8zXnV0lykSpBdqTK43qVzlewz2r0T4T27W2mX1xcEoXyquSM/hXl5goqg5pK70ObERVvdPTD0rwj9pXw/cXNvY63bSCVrLKvbgfMUbv8Aga9fkYarYXtqs5iVo/LEqt8wJHJrGmg8iAXVvPHNcOVt5TPGXBVeoVfXvXj4CrLC11VW66GEIa6s+SYnSWBnmaUxIAVwcio7mSzlwYpXU5/iFe/eL/hFo+rbtQ0m7fSnmBkbAzEPUlf6Vx2o/BVdLhhuZ/EEV3A4JCwxbWOBnPXpX1dLMcHVs+ZpvpZmvtJaK1zzeJ7m4nRLOFy6j5VA3E10/hTTLSPWbOfxMrkiRZEtY+S5HQsf6Vs+FfDlvLOtxbLc22ntujMh4dj6lvT6V3VtZ6f4b0y4mt4WkREDtLcAM27uvr0qa+Kiv3cVqzaNNz+I0bPx1LbyNeHTJIXnlEYErkRhAOx9a6G9+IECrappVnNqM8y7j5SkIv41yGm6s9zBDfRRQX0LAhLaVQNo7lazYCyPdtY3i28lwcIIZNuD/dAPGK8h4OlN3lHbz0/zLlh4Sex3Vr47t7VvNvbIpAWEJkjk3sH7gqe1dYfEGmpJDHNcCKSZdyI45K+v0ryjTbGWzt2m1MRPazP/AMtjluB94e5qrBcw3DrLoepnfIPICynHyjkqCaxqYClNvkdvyMpYVN6HuC3MLqrJIjhjtUq2cmh7lUcqyvke3WvOdAtzpWq6dHYXf2j773Ef8IUjr9Qe9ds2qFDtdEc+qnivMq4dwlaOpyTp8jsXL2fyhjIHrzVc2iSZllTO47iCc/Spr6MFklYLhAQc+9V7S986Von/AHbR4GD/ABA9xWcU+W8S435bxM28g+wSRNDKoadyrRv0I9R71mX94yRzNGItyfM2fmA9xVnXFMutQIshESAknP3T24rCNu0heOYB5onyXXowr0aME0nI76SursrXl1cXrq0ttFNag5LR54/rWbqLb1W6jmkjEbYVSvIHvW7L8qblPlhjneBjPsayNRdwW8yZfIkG1gOcn1rth5G6M+B5osImoBLZydqOvJb0AoukViZHSQxDghxwffFRQqftSg3SOOdhlUcD2rRVoi8oeYTyRocI527vp2rZytK6Fobumfab7RvJvLWSNLc/ITyZUPoe1Tx7oVmknMn2dzsCDkgY4Gad4MtZYtBur2SeRvtOTGkmSIkHYVY1C6SLS/NZuWGF4yFPqa89y99wXc4nq7I5fxrdsdAis7e5IimkAl9gPftXFi6mjWPfH5G1txl6/KPUV1+qWceo+FrpJHjhuUxMAD0IOeB3zXDvqkTyMZU+1FvlcDjZxjmvSwqtBxiup1wtbQ07PVIik32aKKUqv3uzc9RWc2ou98VeeQWwOQHHQj09qrn7O6l7MEKE+eLdxx2A61Xs7mVEjaVT8u5VUpu59q6Y01dtIo19UjM9rKYpVBk6lPvMfastNZeyQ2ty5n4xDx93HHNPtp5LKZZ9++RMSQLJxtz1PpinyXEd1dxy29qiSuxyrAEA92+lOKtpLVBKyMDUxcS4QuWnc72HfP8ACBX0R8GdOXTfAlpEUAlMjvJ3+YnnmuC8JeHtLTWmnuNt1dRIJpJH5VK9l0ExtpcT28SRRPllVRjjPWvLzfFqdJUYrqcGLd7FTxRC72ReHJlU7lx2rnIdUuoNMk8vBcMCpI4x6V3LxJ8zEHJ5zn2rhvE+jT2/+m2xMluwzIGJG33xXnYScJL2c/68jKnJNcrF1XWI76ezi2QtGADIjcZb2Nc/4wtftaSwQsfLeI+WVP3GA9e9VrOGS4MjMYlaJhjngk9DUxiRUXd+8Zc5O7AfHbFenTpRpSXL0NoprY832XNvYQebLL5kY8to1HXmrD6ItzeW3m3MbQs+4McfI3uK3tU0m7tppJrVgkUkgYS9WjPoR3rNW4BvWNxYyuxk3b+gYYx+FepGblrA6FPQyLnT/P1icXM8UsrxlGVBw2OlXfEjJaadb6cheGVcSNtPtwprc8E+EpLy6k8iBlUkyPI/KoM5259a4zWbo3mpXkl2CWWQqgAzjBwBRGaq1eVO/KTCad2ULBHnu40jwsbZJGeWI7A9q6+1tr+WByGghhyqqz9SP4jXOWcBR0cKWCjbluACe9bVy8h0yXyWMUUTEl2+Yn1x7Vda8mrA3qVdYuBHdpZWoSVSC5kjGPlzUN0L6aby/tWxlTKADHP/AOqoxezIjuBGVaMKCqkBV9qgKLJiPzi7geYWB+Y4qoqy1Gol2C+kigBvMKVfawj5LD1Iq8NUfDi8uJsqwYERYKrjgZ71hINspe3VHeZQ43DBI9Knt/NuLgJcSKyk4Iz93jpQ4RaFyIv39xZBpftKCeJsFWGWG7sPbFZn9nidpClxtDAkEDDRZ9K1PszSKkhBjETH5AMr07VlX0m3fKkzRtuCZbAx36ehpRaXwshxutD0zwVpun634VVNWijk1W3YqZv4mHY/lWjbeBtFV3e5zMDj5Xbp7CuO+G+ohL5VdgrsWR8Nwc969JGftCo3LBiB618/i51aNSUYydmXSSktS7ptnY6cC0FpHEykkbOTitmzfzJVY5IPPPGKwMyWzKxLbT361oWjHas8EZRW+8pPP1rzpOUndsc4K2h1EaDygRjPXJrF8YaUNb0iS1iIE6/PGx6BhWkkxkjBH3ivrRYrKI1E7B27tjFZQcqb51ujz7NXbPm2SLyNQkhvpUMcYZGQdye4pLC203yi08c6DB2l34T/APXXp/xP8HyTXkGtaXCzCIbbi3jA+Zf7wHrXm+oR26gwlZUSTglh94dlr62hXjiYKcH6rsdFFprQgutHjwk7pMIw/wAkvmZYHHQVXm02VlYCbLSqWRZRz+NbDx2tu8EbsRNbrlV3Er9DWfLcpNcCQJIA2XJPYg9Poa0jKfQ6Fqrsz5LR5Li1tI7Ux7hl3Cccdwavx6NfxyD7S8RV1LIWxwe+fer1nc/vWmm+VFGSVPPTgY9KzLrULhLifdGBC6gIwOTz1pc82+VDUWyjfiHGZGLKwwNvr2rtfhVZQXFpqE98itaOBHFjgt6k/SuGs7e51m8Fnp4YJkCV8ZAHtXsGmaemnaXBZxLjywMe5rkzGvyU/Zp6sGuZ2OE1hZNC1K4e8kk+zyDCEn5cdgcVj6nexzWcJacxBztSGJemD1/GvUteh0640uUaw8aqVO0vjOewFeNxWc7YYyREKx2lvmOPwrTA1lXhzS0aOaUFTlq9y0krzSxCdlOw4HP6/hToomWeRYQs6v8AcdhgZHWoFtXuG86aA5Xqo+XgfWtCBDeSra2aiXCZCqcHniu5yXQ6ItD0sl3klhvDEho/mBOOp9BSwwyWjMDu3qRJIykfKD3FPlvIYozDOXVrf92wxtz7H1FWP7NuL+D7fKrWlmhXdLINoK/7OetQ24r3y5SWxa0uMalOsUPmeXv2tKwwu3ufajVtedbxrfR5Zk0u0UrujXAkfuc9xWRd6kL2IJBKbLRU+QKTtkn/AA9DUS3ONNEiKUhgz5ZzgH/Go9mr3l9xi4qW51XhLxPOxY6lOZUwv72P5WQ+47iu+g8VQW0ccy3EEsUZJLyOAce3pXiukajHb6kpMgIlA3xYAIz7Vc1G5AhnVo4yHzGAccge4rnrYKFSpZq1zN0V0Pc4NTi1SWxmt2tmE+8kCTcBgfzrz+5sR4m8QjThqi2Vtp2Ypd/DzE88e1cj8NNVgsdblgjl8ozR740PIDA4x+VdVMbe9FtcxhBLLK0k83l5G0H7ornWFeGnKMe2jHDflQzXYbea3trTWNTW3tbe4zbrGm0Oy9OR2qG6tbW5u31XVpphJAQWAz5PTjI71J4jtJbnTdRkeaCytpAPsuF7d+vc1i6YLrVNJGnX9urwldsTF/nOP71dMF7qkn6natDQ0+S2sdMn1Fp/KM75EiDCgHjCj6UkKaR/ZnmQwSSwLMFicsQ2/qee9ZtvZanJPFp00KnTLOUMC6jlsfcFMnSVNVihumfS9hd4LcLlJG7DPY+lXyK+/wDwxLkx0+v3VvI8ji9jilmEZhnh3LEo6EZ7VpQwvfWtq1yWa5t2MsO2DbFnPVse1ZUevXWpRwwXFlczXUkxjke6GAq+w71Yt7hbbxBFb3F9dNE0bIkSjIjx3JpzhZbWYGunitrGT7SkG69YMkp2ZUg9MD0rqtPurGewgm+d3kTc554b04rgM3660ljZQG4mkhLecSAFUdCa63w7peryaPbEC2iwuNu4nv1rkrU6cUnt8zKUYnrl2jPbuq4yR3rCmtnurRPNTkEkEHDD0ro6yr4xwMIsEK4JyO3rXztKTTsjhoyadkchLPcGKcpPEgT7xlPzY9BWOLiG0h+1BohHKCCSSTmtnUpoFW6a0CSFOBEowyn1BNc/Y291LaXcE2xWnAMbueh9q9qns29D1IbXEuL5I4t7eYYX/hXoPzrNkvDLcwxTrEu07gx9O1aNv4fe3lJvZYpQ/KPnjd9KqT+H5dszOySW5GGdWAxj0reMqaHcrTRxea889ws1vvCx/JkD2NVdWi+0IZMq4OFTyxjPtn1rS8u6MKWNqwkXIzgAL9GNdD4d8NahaXL3N/bW7Kq/uolfgH+9inOsqS5pPUznNRRu2KT2Xh+wsYleXNuPmHVSexqrr0q/YzBdReUNoYkEGtG8ufs9vE+6QY3IyqvAOKwNaaS905iwjKx4Ul1+8P8AGvOopuXM+5yR3L3hfSbPUopTNEkogA2Aj5WYjgn/AArnPHnhSa4KXbWSQTqgVXgxtY+jCtjwHqMGn/avPl/dY3OyL8ieldncRprenFNrpBIAyORg5zwcUqleeHxHMth+1lTm77HzBGNsgjmUx3kTEgL1THUH2qSK7luLiZpTHCsgI2L1B9favWfiR4Eil017zT4kF4GHzr8rH0+v415sfD18JUj1U29tCjYmeNvmI7iveo4mlXhzpnTCfNqghtzfuscJkngjhwV4VEP+93q7Fbv5aWWjxwz3IAMzkc/7o9q0VkgYQwaNAjW5Pl4POwY5OPWul0v7FpqSRWjCSURgyNIoG0/Wsp1rdBudnruTeC9E1COdYLi08mBvmkkPVlH8Oa9NswWBcMvl/dRVGMAV5xpvinVV3xhYgEPTHHWtKDxtdxBo7uyi3MSInUkKT2yK8bF0K9aXNZfI4a3NN3O3uoWk2lZXj2nkL0YehqMkQKEPlmJsJHGepPvTdNv4L62V45FMm0bwOCD9DVmSHzIgjOwIx8ynBry3ePus5vJnP6j4QsLpmkgBt3PVV+6T9Kwb/wAF6gSgtrmFkU55JB+gr0IdORimySJHjewG44GT1PoK6KeNrU9EylOS2PM5PCOsy3AjcJgDcJC+V+hFaVh4BDyLJrFz56odwjiyA3sal8VfECy0aSa0t1N1fLxtTkL9f8K4W68ea3Jeee0qqhAVIE4Ge5969OnHG4iN1aKN1GpPR6HqlomYlstOjS0thwRtzx3/ABr5s8V2babruqWlw7eZHOxUj0PT8a9Ci8c3SxLa3hLqTkiH5ZBg561m/FmxtNcS38U6PLuidBHcxKPnDDoT9O9dOAhPC1+WptLr5o2ov3uVHI2kiJA8F6rLHKAyuh+bjtVhFN7pyMoljABKoTkN6VVsJHMTrAqSpjkvySfT2pWke3tJlLcsBsBPAGe38q9aS1stGVb3rMikMzFpFMRhVSDvJA4qCAyyvlWEe/hmBAI9qdBMyo+91kVuQhH3D3zV23tfkchEeGaMsxzyn4etW3ZO5sr3I7W1Iuw0RIlcAKDg8e1EFw0Op+QnkwlFOc/3s+9G5Ir608x9saDhWXnPbn3NPnU3F4Hdo96kY39VPvUddewmjeuPNax3gpuACyKh4B9a4y/dje3IaNnQkMc9/b6V0NjqVxDbToIQSDuYnGCPb1rP1HLwvdXBfyZBtSNOQfrU0rxbTFCDGeEZWGq2yndHvzuUnOcHjB9K93mjVZIZmALKAfcDFfP/AIXnCa1p0uwuhuhAqntnHX2r6ant4VIygLKuM46V5Gc2jUj6GcZWk0UXjWa1bJI43AirdirPEmBv3AZJ70xERkZFJXII3DtVPw7Jc20jR3TMXXPBHBHb868eKunboXUk7HUQQb9hdOUJ2nOMVaaJXQrIqsp5x71HF5xaIvgAqSwHPNTOyouWOAK5pO55kndiRlmB3LswSBznI9a5PxP4Hs9YlW4gf7Ncq2/gZRj7iuvBoqqVadGXNTdmJNrY8R1fwPrVhJJKIIbiJm3Fo2wF98dc1x88V0k5ZbeR5TlBCQVI564r6anhjnjMcyh0yDg+xyK5/V5ElvCdkRK/KCy5PFetSzeo1acbnXRqSm+U+d5rLV5Jo4bbSL95SM4CfIfqfStaHwZ4m1QwrfRJawEjdI7fMg9h717OMjjOOMUjR7nVizcDGO1VLN5vSMUjs5X3Oc0Hw9YaDatFYxAE8sxHJPqfrVxrZ5YlErCN+pIPA5rSeMbs5Cj1JrE1x7maOW204CU+W28rztJ6Z9K4IqVed5PfqOUlTR4z8W/EEl/rjafbzf6NbN8xU9WxXD27mUkLI8fPBVu9Sazpd3Y31xHqSmO4DEuJDyff3qlZ3AR/kAZfQjGa+1pUVQpKMNjgc1OV2bEeq6pCpjW4kMYOSZBuH412ngzx29tOY547WJdpBZY+SfXNedXVx5hZIf3SkfMASSfaq1sjKe5BORx/WlKhCtDlkgm+XY+0PDi6Xf2Fpdi0sS1xGGHAYuw6kA/nXkHxj12TU/EcthEzC205QpiU/IXJ7/Suo/Z2tBceEjdXUksskN04hD9IlxjC+xrzHxtILvxTfyKjRwy3RGAeQR1Y/lXhZdQisZUTd+Tb7xUnzSuYscRvb6MoWfyzuJYfd+la1086xxpcSIwRSFiK8fl61DaXbw2X2iNYxbj5CSRl2z976Zqss/2yVhcThHDbpZFHSvak3J3eyO5WSI49oiLmOMzk7izdcelT3DGS0aVdxWPBA/hzUNzGY5UijkjYtyHJ7dvxpnmRBFhnldDnEm05LH6U2uZ3DcSxuUs7zTrmLHneaGkOM7Qxx/KvWi8elW8UzxM1sSViAbAIPJLe9eN3gSG2uzFKAp+8g+8McjFe36NbDV/BlrcM0flNGrFehkfHc1y41pcspbbHLOXJMz/EWo6XFpNvJqRRpAwaOJTuRPTOKzLa0i8lpZbnAnG9VhGCq9zk1dbRLW2mMccCMWXzXVcsuRzjFZuns032u51a/QOW8lYQoDInpWMYqMfdZvTrKWxgSXl8morp0LXEmltKpQzcSnB5G7+tWPEWor/asbL9oSOFvlDNn94KvwXQvbu8cRHybcACKY7WPP8ADV3xDd206wvPbDyXTjKgc+o9cVvzJVF7vQ0UjnbjVNT1G/gvgi5tm+dkbHXj8RVrT7+6GpwLq8UcUSIxiaMjMmexzWV9rNxC7M8se04U7dodQeMetWLaxub3Uoku4SBckL5zndtUjkY7GtGopO6skNOyJbRr+5kKacXimWXMZMm0yL3X3GK9EsNedbVFae1t3UbWjZsEEVyWh+H7warJHbNLerY5lSMEAr2A5rsI9PusMb+HTbeZjnYyAnHYmuHEypyaWjM3KLd2ev0jKGHzAEUtISAMkgV8meUc5r2l6daWV1feWImVd7FRncfTHvXk9+76o7S3Nw1ud+IoUBBQdvl/rXuOqWiX9hPayAFJVK814lqLQ6NqskWpyrG4+USIdwyOwr2ctnzcyerPTwc+aLu9UVEkaK5ZVldIQQo3k/MfYdqeLiS1udrrIIJBllDZH4VnXV69zGpUgHziysK0vBT6dq+tpaTvLHco27DH5Zfoa9eUeWLnJbI6pNRjc9H8LaUlrYIWQym4Xcz7ccdq0bkhhvgOfJ65PbvUD30K3cNvCpaMnaWU4IqLWftcJjmjb92coyjjjsTXgtSnO8up56956lPUPtEk8xgnk8h1GxG4GfbHNU71THp8H2gqj85MfQfhVXVNQkaeNYpJA5ITdEMjHp/9eqU0zpcnes+6UbQXHOB6V2Qg0kbcjasyCyEn254YiHjcZYsMBh7+9eo6FqEUunxI8sYkjXBAb0ry/Tyw1Fx53l5kDTP2FdXJAmtfZJtPso3tTlXkEuw4Bxn3qMbGNSylp5mVZc0rS2D4ka/FDojW8BMszsFIjP3ffNcM8/mWiRxsjJMcOjJls13V14Rsig5dY0ycBuMHqTVG20qM3Pn2pl8m3Bbz2UKGA7AHqe2aeHqUadO0S4VYQioxOZu4YNA07zHiZLtVyyhTgD0ArIOv2k06CIhpNv7wsCCXPb0o1C/e5vXupLiR4pdzktglF/ugVDa3FrBpyg2JLSJuidk3eYc9T6V6cIWjea1Zr7Pn1Z2a3ljPLa2symzunTOHGQfbI4NXJEjwzbGeTy+NqEbD9K4G1jk0+AxvIfN3iRBOCViz6Gu68OahFd20yXfH2ddzyhuB/tY64rlr03SXMnoc06LT0KpubywEFySyykZY5+6e3Fd/4W1h9StFW62rdqu4hf4h61zSut1BJIhMtuVP7zGQfTArDtL9tPdri2yl4x2qCcfmK5qtNYiFrWkZThoeuMoPJAJry34m+OPst4mkaSDJPGplnnUA+TjgD611epeIMeDrvU7eRRPFCQybekmMY/OvENTjV9MEhTdd3ChZXz8wb1qMrwalN1Kq0TtbzHQgr3ZDbXDS/v3iJuGJwi53PnvWrY2NjdyK8byNcMmMSHiP/wCvWL+9WSGOJlbJ8stnDIQKsRkx30QRn+8MuvO7HY17tRN7Ox0uFzoJrKCCzUyxqXjOXPXNZbRvpe3y43NnOSHU9MHv7VqxaqlwZY76JoNh6AcY7EGqU97YTzTnz1kcH50duq+oHasIc+0kY2cXoc5rlkLLdPpmVtbhMCU8/XAHemW4jSLMy5doAgR+gHrmtq0Ki0MTJusrgny2zkIf/rVQutFu9Ov0t7kKwkT5Ah3LIMcEGuuE0/club3vqRxWOcJImAFydq53U23ZULLcwb5F+YHkAgdMY70lreyRPHGIl84gbnfJBAPQVdNyszmOARxjJJyuMc84onzLc0Uuhm2YjvJS5SaPy1OGkBJznrS+VZowN2hdkO6TyznnsSa1LqSFLJ44I/kc/uyTgg+nvWZuja2e2m/1rLnKjHIPQ0021fYokSO8RoljMcscvAOOVX+gqvdRiwtoFlMS8lTgnfnsT2otGk0+VrhiXbzMndkDGOn4Vl6lbzyvKxkeaWdyylXyAD0AHrVRjeWr0BzUdWb/AMNNEn8QeMEeQKLW1b7RJIDyccBcfWvdJJvtBcIw8xThlDZIrD8D+Hl8HeFI1Kb9RugJbl8c5PQfhU8dobiaf7MGivGAbzYxyRnkZ6Zr5zHVliarkvhWiMaT3m+ppQF977wVwcj/AGq19KaN7gBiC3b1NUkguQ6DLBCOd2Mr/iat6ciw3cTbWbcSqseoJ6157WjFWneLNS/uJrZI2gtZLks4UqjAbQf4ufSreBx7UUVynmhRRRQAnasDUofLuHODtznketb/AN4cH8qr3SISpkDbcYLDnH1q4Ss9TWlPklc58rjqKj2sZFCrlfXPStz+zYzgq52nr2rL1K/ttMcxrlpdwAJXIB9K2glN2hudixMehkeJdXsPDumPd6kQx/giAyzH2FcDefFS4Z3tLPTLaOOUgMwcBvxrjvE15Pq+o6jfy3BnYzukfP3VzjAHtXJXQ8ucG3Rk+YKSa+lwuVUow/easuUedanX6ze6N4kuPO1mGS3nbKicHIzXOap4C1C3h+0aVJHf2mM71b5h7Yq/rYtvslqkEDEqv7xt2V5HWl0u/l09oE0m4eNgwEiONyOO+RXdHmpw/dvTs9jCeG6rc4aVmtrhoJrUwkDJLHBzTUkZ3AcF2GNiqOp9MV67fPoOuzeVcwrHMSA5bgA+xroPCXgbSU1iM2FjJI6srmRz8uD1xTePp04c042f4HLUlUj7rOz+DVrPonw9VL+JbdlDTklgeCM8jtivE/EEkUt/LLb/ALyRnaSV8YBJPpX0l4h0+1/sC+gttkLSAD5DyWHQV4Zr+lJJe3JIHnEAMyjGzI6+9eRlVWM6lSq/tM1oyUWcWVDxNsYhflAjPQVLBCF3JLtO3IOO9TG2R2SFHAPCyOw4454NJPYO80i/vVQjI2t1r2mzs5kQ2dk92xd22tEvmKpGAV7CqMTIbx2MJa4x8pJxs9617YfabhYrdTNs+XYMjHHc+tWU0dZbkFIZWlVeI8EhjRzqLfM7EymlojGhtpr3ZDAqPdXDhRsGSc8Zr6c0LwxDYeCbbTrgBpUh+Z07Me4rl/hb4JnsoGvtShhguzjYoXcU/wDr16oN5dtwATjbg8mvm82zH2s1Cm9InJWleR5Lc6XMJJo7eZMiJvmbrx0yBWHdWMGp6ObOVYrS4DLsuQcbyOQD6V67e6EJmfybp4hITvXaDke3pULeE9Paz8iRd7dpCoz+VKOYwSTb1EqlrHg10WsLtv8AQZlut2wKzbgfVgfSqt3qE6mS1umWV4WWS2l3Ajnqp9K9d1jwvqNtcs9sqXNuylMbBuArk721sLOGO2i04W+EyBNA2GYH+9616lPF06mq1OuNVS1OLZ7e5tJJViEzq2wQb+A55yK1/CWlub2d7q42s6h2cHOAP4cetWYrFLa4V44Y0kZmk5XjGOtaOjQQaq+y/nj05UIDMvys57Y9qurVSi0tjV3aOi0O+EsKQ6UQ15cEtJsTDKo4G49q0PtNkXddRhe4ulba7rgDp0FbvhC2tLC3ZbSGMxE489OS3+96Gtsadal3ZrWDLNnO3Oa+frYiCm42/wAzgqys7FwnjjrSH5h0zUTMCc1MgwK861jG1hjozIwRyrEcHGcH1xXNyeDdPurhp7+NJZi24sFxuPrjsa6iirp1Z09YOxUakofCcTqHw70m4kllhDxyMo2rn5QR3rnLD4ZtF4hsb2NmthA26Rlbhx6CvWaMV1QzHEQTjzbl/WJ8rizkNb8NXUyv9hkiII+VX4I/GuS1TXrCyBj1W+eSeEYMCP0xx834164a+UPEOsQ6jrmpXht/LD3TqwbjeqsRlq7Mu5sS3GeyOjC+9dvodNr3jW5JMWn3dnBDHgkJH+869MnrXLXet6xd3Ehk1KV0A3xgKDtbvx1FZU53zxNI0Kxu33VO7YOxpY7cO1xdM8+cAl1bAkJ9K96GHhCOiO5yS0RDcanqj/uftro45KwAjc3cvWhpfiPWtPjW1tbuZoRIJVAlyox2HoKjSOMyxokbwy4Pmbjt2gjqe5pr6VDZRRSBZDa8gFDnc3pn0rb3JLlklYyfvPU9g8G/EXTtSmSDXJCtxKfvFcIvsSK7/VI7AaRcywMMm2IVoyWVV7kdq+aZrS2t4obuTIIIiRVUgsT611fw/wBfvNMlutLWSWbT787I/NORGSOdvevIxWXRf7yg9uhz1KGvMi5bJpsk9szRtIQWMfnfKCB61laqJ9Nsv7Rs7wGFZTvtT/CrHoPpVONrzS9altpw8kJkCYZtxVfWtW+0OOYNcWIYPG+1lz8rDH3sH0rttyyTk9H9x1x2FsNQa48i1+zkkfvBMz5Zh/dINWryd57lGhd7WUjD4H3wOoI9Kx4NJTTrl7i6ud++IiMqckHs2OorStJHtI7H7SjTT9FkXG1lxz+P1pTjG94bBYiuNQuoYY57Gby403ExKx+77rWinii3kSF7mJXkjUESheGP9361z+tPcvcm4054EvmXAjBBAT/aHrVfSpEjQW1yC9y/7yOQDKgj1HtT9jGUeZ7kygrHe/bvtGh38MbkvdQmVAy9CD/SvP7lpLnyRcyIqQurkjhWI7VvaTqF5Hrc9peBXXYJVIGUx6A+hrMmsbiQXC2xhSUEnk9RnOAKdCKpN+Zz8vK9RjNbpG14UQbhhyjcbu2BSCRYPLWEFjsypU8jPr71j3hEkgjj3IicNuOCx+nrT5X8hGA3kOvykfe4rZ07q7ZstSaeW7mLxLck9PML9ef4Qaa8CW8uG2xFfvswyxP19KozQMrxhdhZk8wkscL/APXq/ZQ+cspebzp3UJuYnj3FW/dWgcpatEuIJHjsZAwRuHHTnnvXVadrKanaxaZLDFDeFj9nuc58vjlq46NJQ6cyBGkKnYcbsCrPkqzxSWwNrcxLgoWyTz2rCpShPcXL2Leo6XNpjJa6mcKeUnIxFIM5JDVLtFyWDRwO7IVi8o43DtnPevQ/BV5YX2iRaL4giS6hlYhElXcFPp7e1Wte+GEFzO1zpV4LeUbRHHNHvjTHpjBrh/tCEJ+zxGjXXozm9qk2pHnFv4Za6sILi51IpIW+4UHy/T3qtdaeyEIXLv8AeH7sDJFemTeAb9oFtmntXgBLhlLKwf1os/h3eNcQLf6hD9kQfOkSnefUAn+dCzGlvKf4DVZJXbPLPsU1xd/vSLiYsFhQtzKx9hXrfgLwFb6UIL3WI431LBZYuqR+/ua6Dw54K0Tw/cvc2Frm6cYM0rb2A9s9PwroiTvxt4x1rzsdmsqy9nS0j+LOepVc35GHrALyb4+VbCk+1MskA3jlW7A1rvbx7T/dA474rOvrC5ktJ44JDHJIpCyAfdNefGata5vCqnFRIJbg2Iaa5aSSMYXCrnmr1lB5twLhiCq/dHTGfX3p1nayrBHHMQ7KoBYjqfWtBECLtWpnNWsjOpUVrIdSKwYZHSlHTmisTnCmyqXidAxUsCNy9R7inUCgCG0gW2to4VJIQYyep96mxSHORjGO9LQAVg+N48eE9YeJB532Z2UqOdwHB+tb1Q3cMdxaywz48qRSrZOOCMVdOfJNS7Madnc+Rmimt9NsY5mEcQiDB9uNzE85Pc0XJtxbwoAkjl8bFbBJrpfHfh+502/msJVldIsyW2R1TPb1rD0yOznmKzPGhxk9iD6n2r7rnU4qrHW/Y9ak1KN0OuPsqWywSIsYVcSpG+4qcZqiYLG3gE0Gp7bo/OsLIefqauXOnJK0t1bPEVkIQBG+Y4HJrnJrSU3bGQSDscckDt+NOnG+0i5Oz0LEmXIaOXL5Dq7cHI68V9G/BjWzr3hwXQVMxnyJCOCGX+hr578m2ITzPmlU/KqfeY9B+pr6T+HOhr4O8C21vKoS6ZTNMM9XPOK83O5Q9go/ab09Dz8SrySRralptvbWuqy2Nur3l0PMZC33nxgH2ryC/TUbeVhelYrgHLFOj8V6O93NJI0jOTuPGTis670+3u7jzZ1ViK8fCYn2F1LZlPCNrc8xuZLG4aMTPEJV+VxEpHFA+wQOi2sTMFOcHJFeljSNNjfetlEG9dtc34x8WaZ4ZiWG2tIZb6ThFVBxXfTxjrSUKcWx/V5RXvMxvls7eS4uQtlG53CRxhmPsKqJ4wtbLdPosD3MzdZ5+ApxycVx2ry3+v3/ANo1O7bap+RDwq/Srtrpc6zShlYMU+UHpXqfVoWTqO77Ci0aN14u8QXEqypqMqDdu/ckrz7j0r0PwJ8QLkaktlqwubp58Heo+SED09a8wGmPJMquZkGPMG3pn61qaQv9nTR3NsWaZJMjDZB/CoxGGo1qbioq4T5Wj6dBBAI5zS1T0e5F5pltOP40BP171cr4xpxbTOMKq3UMN2kkUoWVcYKccf4VZGSvIx7VHHDFG8jxoqtIcuQMFj70k7O41oeLeKtPm8N6gRL5jW7DMBHJOf4c1jW1tJ5oeSYFmQ5GBjHUfjXt/ijSU1jSngYqsikOjsPukV5Fe6Pq8Gpy2zabPIsJ3o8ceUYH1r6XB4tV6dpO0lv5nfSrpx1N74f39xb61BCsiizuFIKZJy3r9a9Xrg/A3hV7S5XU78bZsfu4xkAA+orvK8fMJwnWvA5a8oyl7pmaZPNOzJdxCOZDztOQR61p1DbjEZyQxyecdqmrkk7szm7sKKKKkkKKKKAK13MY4J/lddq/KwGck+lfLvj+eCLxS9laQoZS212z/rJSe/bNfTWvrdPpNyLF0jn2EhmGQK+bfFNsn2zT7x47i3vZZiShON3fdivdyRLmk2d2FsqcnfUzpdCurW6U/YdqTYLPtwEI4ya2j4cuPLtGFoIggOdzfe9xV6z1ppbaVJbS7v5LgNGJDwi+oIqGW9+ziGG988TQIG8vOEwe34V67qVJaWLvdHPCSJbpnuly+cMu35j7E96Uzw7FiiQOpAf52ICsDxisy8urmPVZ3uztbefJTHyj0we5q1dtJJtcIU+YNnGMHuK6OTbmNotJGzLhTMZWlfcgZCFwqseprGubof2jbHfIrKql5AfulT2rQgWZbWQI8k6qAjqVwADz171TkEl7bTF44tyxkKVOAB71NO17PYctVZHQ6hZLq+siRbxYYjCJVmwcHHUf/XrYltGvZ7d4FIskISV2bh65myvZbrwpBNBIDeWjbJDjt3HuMVrWN9b21rE1ytwySg8Bcqc1hNStZdNCYbBdaOqX8x0+6iKKdhkB3BB/dqeW3Sz0dLm4liunM4higRPvDuWqxbutskh08LF03QMMbh6g9M1W1exWZp7u22K6xh2YtwPXI9alSbai3oaJXKBmhsoZwLSFb+7fcI1GUVfXP9KmFw2j2u+5HJjKKkiDbz79RWfqN0upR2FpG6rLkSHaOcemauyadqGpXoggnjEcJ85xP0xjiteVK3O/UpEFrff2pBDvuEgkhGIyq4DgHoas38bNqIKDy96CQN15rG1c2bM+JPs8235EUZBI6ke1a+oHMK5fJS3Xc+cHjmm4pWcephWj5Gbq8DXEslwjnzIGw2FHPufWs6aItK+VbyVXzN2ev+FbaXIKxzxzv5ZA3MUzuJ9KzZ7Z0mk46kSb3OAR6EVpB9OwR2RWntA1vHMEi+9xGSckVHp141qkiXUYJQ/6uMYGKuzLLHGzbQ55IcEHYPesgyhZI5N2wr8zN1VlzyBVxSkrMu/c2QtzIJWsFVrfqBnOCeuas2JkuYZ9pTBbZsCfPF+NS2UqT3UiWu5bKUHkA4zjk5qjFCUuVFozNG7nc7HkY6YFZxu7od7anceCbVlu40hPneVL5kncnv0r3NTlQfUZryf4X2Uv9oQyzwwpLtYuejN6V6urbs4BGDjkV8zm0+atbseXWd5ClckHJGDnjvQSACScCloPSvLMgqOZmQKVQvkgED+dRpOzyIFjLROMiQH+YqxQAUyLftzLgMT0HOKfRQAUUUUAFFFFABRRRQAUUUhPzAYP1oAWkZQwIYAg9jS0UAY/ibw/ZeIdPa1vVIOCI5UOHjJ7g/0rxbxB8MvElo7NaWtjqEKj5pYpNkrAdBtPH1wa+gaK7cJmFbC6Qd12ZcKkobHyWdP1G0inkuvD2rjyxwVt2Cp78dajbS9Yv5hb6Tot9d3kuFMphZUUepJxivrigZ7816X9vS39mr+rNniptWPHvhh8JW0XUI9Z8TSxz6hH/qLaI5jh9yf4j+leieKWcQwKMbGYg/XtW7VXULRby2MTHB6qfQ15VXF1MRW9rWdzKE7TUmcYYkcqXydhyB2z60rkZ4Bz6Vfn025jcr5LMB3TnIqtqdvNpmlXGoXEYxEuQmcfQmnyKUkk9z03Xha9zg/iB4sXQ7cQR7jM/YDOM15PcX0nmG4lJEkrZEknPNdD4nZ7+8+03eHkZtrR5z75FZMdg1621lU20YyAexr6zB0KeHpr8TC7qu72LFvrqeUzzWCzGMgsUHDfh2rfgvVnu47mC2cK42+YfuY9x61zLW6WrRmFpGQ8bQOG+tdTpRhNhJsVoQV27S3BXvirqxjFXigdMsBIleZ2uM27L8uRjB74PpUVxDDHbJn5Lkf6to+AB3z9az75yswkt1EbIBu5zuHbirFnqcV1EVntjGyvgMuCJPoKmMbJMyqxaPe/AlxDdeE9NmthiNo+meQcnOa2JbuCG2a4llSOBRkyOcAD1zXKfDBWtvCOZ9scQldx2wvXn0rx7x38RX8U395Z2aPFpduxW3G3IuCp5Y+3oK+apZfPFYicYfCnqzmUXJ6Honin4pxWv7vw9bR3zk4ErSBV/Ad64qb4va3BNIzQNtj/AISgwD71wD2yw3tu4aPz5F3oAfljHc1BqWoXEkTFpI5EdihdYuDgda+ipZZhqa5VC/mzaNDue3eEfjBb6iqRa1YyW8h4aSP5l+uK9TsL22v7ZZ7KZJ4W6MhzXxjprK2NkpWROnqa7vwJ4wuvDepwyFl+yzDdPCi5MgHf/eFcOPyaDvLD6PsTOi1qj6ZkYKoy4TJABP8AKn1Wt5Yb+1imULJBIqyISM+4/Gor37b5w+yxwMmOS7EHP4V8zbWzMjC8J+LdG1ud7exu0a5A3eUxwSPb1rq6+SZJJtNv4dRs2/0mzPRF2uo/DrX0Z4C8V2/iTSo3yUu0QNIjDH416uY5f7BKrT1i/wADWvTcJanVUUUV5JiFFNQMM7m3ckjjGB6U6gDO1lXa2Ki4WCLB3vjnH9K+bLyObU9aRLm4l3QTsQOu7DcEexFe++OtSXTtO3SyxLDIDG6yPtznpivnXTIBDfXFyLnJLHydmfkH19q+iyWDUJT+47qcWqF+522tiOytJJLUS+Y7KPKXsuck1z8c9nNqb3t3LIskWSkY+ZSvvmml9T1TTZlF9E1qjZWTnLH0LUy20ae2u3jKBrm5A8tidyn1GK9CnFRi1J6mihaKRT1KSG7nhJdRZHe/mL97zPTHpVee01H7IJQ0uGUBUJ35I/8ArVYa0+zT3EF6MRbgiJIMFW6k1dureS3eymtr2VLVCEkhxhVftg+9bKXLZRNLGLPfSLp0EeyQ/IqShjtIAPeh1aFQ4u5TGwKxh4uo9D/jWjNEL26niupIbNlcqUcZH1I7g0zUdH1GziSEujW0nysEGeO2PSrUo7bC5u5J4NYx6nLpWzYsoLmRV+XjqPyrYMSrcmCSGbZ/DJHyrc8DHasCZpNEnjW2lAngdJirLnah6gk/yrvdOvRa3nneYQJdrAYzgHocVjWbT549fzJUrXMfVIrprJIrzdbykh1bbhdtQvZLbqsKXiyzHLtj7oBHQ16JqEqy4k86NotoDrKu4EGsbXNGiubMeXb+VcQj5SrfLLmuWniL2i1YqFQ423vdN0+WRLu1b7c+FiZB8uD3NVfEEs9pdKLfJknj2bcYI9Prmi9057OS2vJDdrMhaORXT5UX/PQ05Xt57KaJZrie6A+RrhQfL5yOfWu1RjzKS1N1NJipAkixQvbyfb5dsQBQALnGTkdq09X05odbubOSIb12qVzjK4ruvh/4cN1bWt7eO4kgbexVceY2On0qx8RtAiuo/wC1bViG4WQbeg9a4HjofWFT/q5yOspy5Tyu3jhgmNnJOYXjcFNxxhfp3qnqjy4WSfoTyvrzjNamopCxiEsSeYn33Dcr6VCsW6zntwpZnXCyOcsozXocyTuEXKO6IrfSZmi3tLHbWuA/7xvmbvg1Hq0kV/aQxR28TRgENJjaM+3tVDN+o8m4LLCRtEjDIOK0LS3u71HE0ZeNAED5xkeuO9Nx5XzSZpzoy7W9xCtpAXltUY/KXxtJ/nWzokd3PcxTNiOIPkNjlj0xj0q5Bp9pA6sgXzIxtXPAH+9W7oVh/al1bRfP5hk2ttG0YHpUVKsYpysZTqaHceBrK4eW6lYPGyALHOyAg56gCu8HTmqemWEOn23kwLhc5PuauV8fiavtqjmcMndhkUVE0W6RWLH5eQBSxxhGZgzHd6tkfhWBJIAAMAYFFFFABTXBI4bb74p1BoAgspknt1kimE8bE4cd+1T0wKETbGFUDoOgpJJlRC2GbnbhRznNDAkooooAKKKKACimxMzJl12NnpnNOoAKKZK5QA7Swzg47e9Km7B3468Y9KAHUUUZx1oAKKKKACiiigAriPizczJ4eS0tlJa5kw+OyDk129ZPiTTotQ09hIuWj+ZTXRhZxp1ozlsmJq6sfMWr3EkOqrb5SKEYCkcnGOtV4mlW4VLV2JzjdjGRWv8AETSP7O8Z+cqusMsSt8vQEcYrPsULeTJuzNkg4zj6AV9teMoKS2aPSw7vGxTcqZG+2nYY3B3LkZz0NakcYWSZXEnlZDKV6D61ZEJmUoI8uyly+McjsfYU11kjvoWAKo4CttXO5u2frUuSmatFO5Q3E/kK+xC/3wOcYqTUISi2q+W8sgQtg/KAOn/16WVJ7LUHnVVmjmwrDjcnt6VNfMr2M0FuzEh/L5OSWPUA96L8rXYlxuj0XxDrj6B8MNFsLNPNlvkEcrHjCHO4/wBK8xtLOGG8tlt1WO3QEsp5RfQZrqfG91FPrFgm0BdLtEheNjlQSB1Fce95PNcGKWSJIIwW/dkKGPvXLgqfJS0+1qzOnTUR+uxwy3f2m3cJbxRiNgE4ZjWfZo5iiYSDamcoSAKtROv2aWMMCshDFerAjtWTEUguBcMcJvKtHmuyKbjbsapJF14oyA0SIqlc4K/xeoPpUGnrPLMdqqvlH7x6IferVs8Ylhe3aXyySHRxkFfY1a0x0iN46W6zRThvkbIVMdz70+eyYNaWPVPhF4xgjnbQLicvCq7radzyzfxL/UV7CDkZr5h8MXGl2+u6VqEYDQLKA6R9F7YH419OIwZAYyCpHBFfK5vQjSrKUFuefWhyyPlVV+1y4vpMNkE7MKWzU+l6nc+FNaint7pjbKQdjDBx3+tVY5AkBuD5VwcAKWXG38anngFzChDxSnG5eeh7jNfR6fDL4WepOCnGzPonwj4ktfEemxXNqwJZckA9D3rfr5g8F65eaJrZSzR1t5MeblcBD617xpHjCxukxcyrFLkLjrXzeYZdLDzvT1izyakHCTR09ISRjAzQjK6hkYMpGQQcg0y4nit4WlnkWONBlmY4AryyDyb4zN5bxzX0wezyIgsY/wBTnuw6knt6V5kqx2umSBIyFnYxiPccop4LZ7V2nxCZ9b1HUJY9iWvyGAL/AMtmX+I1y1vbuLWJprlJZZVJYKMhsdj9K+uwUeTDxT3PSp3ajHsZUVgLm0NkLmVYg3lxR92K9zitXTzqMFyGuGEzW2Dhm2+UccH3rR0zTJbCO51cXCRLD8sizDlc9do9KjvLaa/nWAuZ4jht8eAzfjW7qqTcVsdDSS1LBmt3sj9udLh5AzXGMbi/VQvpWZp2i/aUgubppFtmQyCOTLAN2z6mnQf8Tb7ZZ2jfY3jb5jIgDMFp1u2oTwvcwO9vecBEYgpLjjp60knBNJk2H3tl/aOllrm0NzJJ8oMWUZT2PvSabBEk9nHcWlzMkeRcO7bVVv4Saivr/UoBb/6QiNGckle/cA1Wm1u9v/tK6i8e1SAzRp8r+gPvRGE2rdCJwsVdQezuL2WK40944hJtIjkDSY7HNeuaXZWc/hfTZLScG7jGwOy43Y/hPvivKooEVJ3BWeBULFXwjMfQGvWfho0k/hOOe8iRFmYmKIHOFB6n3rnzGXJSi09mZ21TRXVYDdJbpdqWJLyIg+6R2rXkfThvzIrzFQuCep9ak1nQrXUFDKnlSr8wMPylj7nvWQ/h835juY7ybT1QFHVkDMSO4rzlVp1EnKVhOCZTnKXE00UbrEHwPncEN+FW/DvheTVJA0sYhs1ODIsYUv8AT/Gr9h4V0mzYy+dPczFg5km5UeuBXexOhtg1qEZAPlAOBU4jHckeWj16mdWbjFJIfBCkEKRRDaqjAFJcpFJA6XG0xlTu3dMVn3mqQoxw42LwT2zWTe3Et2uHOYTx16ivLVNvVmdOhKWuxwHinwZLBFPfaDIlyWyTEerL7Zrh4dWIdortHhmVBiNxtPoa9wUiNdrDKngemKrzWFnPHGl1ZwTxocx5QEr+NexRzFxXLUVzv5HY8Xj1SxZ5DJIQQCCm8HH4U6K8a8CLpdvcSSBdo2qSPrXqz+H/AA8khYabZQyOcksg5PrW3DFb2VvnbFHEABuQYzW8sxgleEWQ4u1jhdB8G3N68UusP9nTG4pGOT9a7/wh/Y8M89hYsZb22P7ySRME/Q/4VBLFNcjKOIYSMgjlj71mHwskklzML2dZpynzodpG3n9a4Ktd4i6qSt27GU6Kcdz0WmIiozlc/Mcn61HZSmWBS2A44Ye9T15bVnY4WrOwUYx0pGyB8oHWmxyCTdgEbWK8jFIQ+ikGed2OvFLQAUUc55xiigAoo70UAFFFFABRRRQAUUVHcTLbwtK+7aoydoJP5CgCSimI6t0PIwSO4+tLvXONwoAdRVXT7s3kTyeRNCFkZAJVwWAONwHoe1WqNtGAUUUUAFFFFABSMAykHoRilooA8Q+N9hNDHBOqnyIWwWPfPTNed28ckMUdxAzspYNkY+Ud8V9B/FDSxqHha9wFZhGcKeM+lfPuhOLhnguX2ykHaDwCV/hPpX1+W1va4Vf3dDsw09eU3YneK1eR5WktTEScLyG7c1ElzEwggSXcsaByqjLMfQmnR2klxOkYk8u0WIvKEOfmBwAKeYhpmrIkChklA2P3OBkg1sktup3FaZvNmeGNIwMhnCDIA96ksbWO4ubeO2iWRI7gEEDsevHrUMDkxSKkCgSS/vCrYAJP3R7V6J4L0FLrUraP7OI4LXDsBkn15PuaWIqqhTcn2OLE1eXRHmXjoH/hJdRt5pnidQrkdtmOlc87HUAmIj5a8L/t/lXZ/GCBrX4g6iGV5Yp0jcrjAwR0FcbA729x5aybIg2QSOg9PrXTRlzUYTXVI2pu60K0geGTLow2ZOQOhx0oLQYtSu7YeXDDjOegPc96l83z5G8zKxMxLbmwTg9fxpL1oA5eKNykXKKDnHua2vc0sOuHltEnmtQ0cIfcrHnPtXRaZpc5sDdvLsgaPdsVvnfPoK5uO6UxGJmDQqOAR94+ntXTaJeStZmOFvImX/VZTfnPoaxq8yjoDKsDLAjm4jlVUbfEAm1W2nv719DaDq1xNpNtNFZTukqBw0YyDkCvEVmjh01VvLWS5YuflYYYH/CvbvhdkeCNOG1gNrYB7DJrxs4adOMrdTjxLT0PCtCtoTZLDePujbOAPX0qOyKKk0anake4KemQD6VCiyRWsjI8bBCSqMOcetTaHazXclvus55JJG+VkU4Pt9K9OUfik3odvMoLUtwxHUXhkZcRMf8AVnPOO5rftULvJNs8povlV243D196100wadaXYMT/ANosDHHIq4CAjtWakFxan7Ne3Mcu+HMDt8o9w3vXMqynscNd87ud/wDDrV3uYpLSecSY+aHjGB3H0rZ8Z6Vc6xoclpZPEshYMfMHBA7V5v4C1EP4ish5LoiDy5JOxOMflXsY3YOcdeK8LHQ+r4hTh6nO04M8eu/Bmqy6dKuoSZa3zIhiyuF67fxrG0zTo7+KO30r7PbmFfNkWbltwPP0r3Ge/toJhDOxViuclTtP49K8q8b+G4IrsappKyPFPIRN9nOWwevFduFx0qsnGej6djqw87PUxLPzm0KWOeWznJdgqSH5sZ65qXwrfx2ulX+6M7wOAV5BB4x7Uy9TFsps7R7ONpFUJMV+f6jrVZrEvqSyxQSWl6n7toy2Vf0wPSu6ycWpdTtbjNaFqSHz9MKugaTzRJ5qDBIPXmspb+eW6lsbfS5bwhN6Mjfcx6HpnvU2v6a9nq3lXE8zWSJvnXeQpJ7DFSteNYx2kdsyQKpBAVh8wHQ571aS5brW41Hl0I3tGuyEvbWZLkgbVfkkd+fWsu7sYzYXKSwywSLL80Q7r/e+tbpuL3Uory4t78RwrIGjfOGB7rzzV2aCewsYlhdNQnmO8SP2Pp70RqOL3CbSRy/g/QZdf1yGwRjLp6AtNLIN3yd+fXNe5Q2sUFvHb2sYSCJQiKOwrn/DNkljZJPpkb/apz+9XbhFHv6V0ywHdGzOQV5ODwTXj5jiHXqX6Iw5tbsREKnoMn3olhiZxLIoDKOGJqRzg8Co2XzAQ65UjkGvPuw31HqQyZXaVz+FWLFTDcqEYLFJnK5/i9qpqojQIgwo4AFSqrOuzGWBBU9Oap6oicbop67DiYBlOCcdOMVWCSqQItpjz35GPatTUr20jsTJqk0NtKv3kdh+nrXA+JvHNpZWMn9lo0hXhW24U/StqFGpXtGCLoyujq8MCwbap9jSBgCBkEn3rx698Sa3c6fBd+aVSc7Y06Fj/SqcOtapCzmeWUSdhzwfrXoLKajV3JG7ke5oqScSRpIh6gjNXZbUR2bKUAhdduB2HrXmugeMruwaGO78ucNGCQw+YV6Roepf8JBF58LRC1ACmM/eB7muLEUKlB3lsctWTTvbQhhQxoqFtwUYVu+KWaa3ht2kmlUR9yD/AJ5rXfS4JVCzKSoyNqsQCPelisLG38uJLeMY5UEZ6fWub2sL3M3iI9BuihXtROAymUBgG67e2R2NaJ6VGkaRksB8zYBbufSpK55Pmdzkk7u4VHOcQudrNxjCdfwpt3cxWdtLcXLhIY1LOx7AU+GRZokkjOUdQynGMg0hBCrJEqsxYjjJ6mn0UUAFIxIxgZ559qWigBFOQDgj60tFFABRRRQA122jpk1D5j55x9KbPy3BPpimemRk1aiaRjoSCVv4v0p7SplVLbdwJBqEe5zSSKkkRWRdyqd2MZpuKBxRJhQ0jgDL8EgdQOlQKCHBI4qJ5XguGIy8OPu91q4FAUHseafwl25SwnKg0tMi+7j0p9ZGDCiiigAooooAKKKKAKt/Yw31jLa3G4xyDBOeR75r5x8f+F7jwtrLJbkXVvM3nBtnI56kV7P8R/H2leBdMWfUC013NkW9rH9+U/0HvXzhr3xL1/XNTbUG+zWyAgC22hwqj3Pevocko4lXnFe4+/X0HCdpaF+x1Ey3nm+cyTDh8LsQj/GrazM89xMksrSryu84VexOapaZ4r0vVX2eI7MIH486A7D+Nez+CNJ8D6/aRyadGt5IihnSdyxGPUdCBXo4nFLDK9SDOx4qyOI8BeGLnVryMoJRbxNu3yj5Sff1Ne6aRplvpdr5NsoGeXbHLH1NWREkUBjgVYVAIXYAAv4V5hdfFbSfDayWGp3zapfQttMlqgYHnoccZrwq1avmcn7OOi6I5G3J3ZzP7QeksmuWWphwscsYh4PJcHjI9MV5lCxjhVZN7OrZHHGfevZNe17RfiJpssGmXf2fU4CGSGdcMw78GvF9TV9OvjH5JM8TnzMg/kQelfQZc5OhGjNWlHoehQfuouSRM9tLcyMixkkKSRgGmRxBtPZEDhjk8rjd/wDWqS3FtO0qyTrseLcYgOCaS+uAsaSQOR5aBSRwCT2rrXMnqbN3Rn6bHGgZbtDKjd+6n0rWsIIrm/RLdpIY40LSMr88dwO1Z0vmTFQGjy3LFjyo+lTxWzKS8SoDjacn73ufarkm3czlJWOhgmvtblggQeYiuI0Mn8fPf3r6S0W0bT9Mt7QRqBEgX5Tx0rxX4J6B/ausSau8E8VhatiLJ+SSQdceuK97FfLZzXUqiox2j+ZwVZXkfO/hfQWuzO1wzpbKCkeV/wBaeuc9q6m2Eltp6f2dcYnifairHkN6itq20jy706pYB5VuQFiiU7RGB61Q1ETCKOW/EVtdmTY3lg7D7+5rolX9tLfQ62+Zj7i5uZ9PufOt49qgCLzDkZ7k+1YGpZght4zH5ydnPKlj1rqr29jttPV2kURjaJQU3AD29zWTr1qhs8OxMNyN0bAY2D3FOhK0rWMG9dhfCVhLda9AtqY/ssY3yqOR9M/WvRGvLlgBJ5cZ5B2c9/WsXwTZNpuiSXU6+WHX5Mj5to7/AI1dwzjcHIBGQRXm42r7Wq+yHRgpNyZL5zBiCc1LbPGsm7ykz9MVXYce/SkVhHkucAdc1yrXQ6HBNDvEPhXSvEcCDULch15SSNtrKfXIrgdR+GmrWVncf2TqolbpGshKn8W57V6xbyK1vG2RggAVDdyhrd2VG3I20ZHU+v0rWjjK1H3YvTs9TkpzlGVkePR+BtYa3D6nq1taFV2FUUzFh6sT3pD8LluJfNuPEFzLu5KGMBfbGOlemKhOTgHPJzThEOOK6HmVdO6dvkdunVnkd94C8SWjpDpz2V/p6OCgY7HB7k13GjeHri109I7uCOa6674zhIvp711CIAe/FX4B59q0bAZHTHGaVXMatSKUvvMakmupk6fb/wBn2aqXBcnMjHuTV5jlQCB+NMWMEFHPPTBpxQlCpPTjOa5JPmd2DsN8sdetNjj8yTahOev1pLWB7ZNpcuD69qv2pC84ANDdloKcuVO2o4WyJFkrzjpWNreoQ6XY3F7Mp8q3QyPjrgVtXtwsUXBG5ugryr4r3rvbWWixHa12/mzHdj92vb8TxWmEpe2qKL2YqCb96Ryl14iuvEclzdTQKizkLAJCBtWlh0K3At0nxdBjhg75Cn6CmaLpNpqWorHb+VbzxgBxMxO8eoqwNOgsprueJprd1kKMGG7efQV9K5Rh7kNLHdBEVtM0uoy29vbk20JxiQfKf93/ABqO8vbbT5rmCe1la2cja7cqx74NSSXVlDdxwTzXAlRcSpyqhT/FULvHqFslpcGFZIyXg53Bx/jTtd3toVsZ+p+Uz/bbJpZI/lj8rGCn0rZ0u7vdMNrLZ3dzA8n3/m4I7D61DJbJ9lSVcgBSGRjgI3Yg1Yj091tbSW4eKKSUkmJnzv8ATHoacpRcFGWpM4pqxtf8JFqdxdpJNc3BKNhdp2gematXHii9ks0kWYpdwE7Vdu/qaxfPiuIGkiDu7fuzGxxkisIXMv2mUyoJg67QOnA9T7VgqFOW0VoYxpRejR6Tp3xBubdoo9RjjuQcKzx/KQa7zRdas9YhL2kmWXh4zwyn3FeARSQmxUR8TFi5xzuFXtJlvrWQXFgsyToQyhDkn6+tcuIy2lOPND3X+BFTCxa90+giAwwcEelKOKyPDGsJrWmJOBtmX5JU/utWvXz84OEnGW6PPas7MKKKKkQUUUUAFFFFACA5J4Ix+tLRRQBTlBDMO3UUigc/NU8+QCRGXABPBwfpWVcajBHatKFcleWj/iArWF5aI3heWiLjBlPA4Peno3fOKxfD2v2OtPex2zPFNaYE0c3BXIyD9PetQYwGGCpHBByKqUXF8slZlNa2YNGJVchdjseec5q5ER5YDemKqebggZwaZc3Dx7SgG3vUtcwnBy0LZlET46+nvVhWBx784rGdWuI1lIKMDkZNWY52j2HYX5CHaOQCetKUNNBTp2V0aNFFFZmAUUVFdzC2tZZmyRGhY4GegoAlqvqF5Bp9jPeXkixW8CGSRz0AHWpLdzJBG7Y3MoJxx2ry34tz32oaHrVjNm2sUjBRiceZz/KujC0Pb1VBuy6jUW9jwDx34km8XeKb/WroMkD4htISc7YVPH0J6msNltVhDKWyx+ZT/CKckaOQikuedrjoeKcIxbxxv5WJQcNu7ivvpKNO1OOy0SNqFOyHWtqnyncrL1x3rp/Auqz+G/Flle2/mGFZQsqqTyp6/h2rm2km+WaOJRH1DADrW74aWe917TojKWM0o3AL0A68VlVd6UlPVNGlSnGSPdvjB46XT/CpttIkZb2+QBpAP9TEfvH6kcCvmxbU74mVtiEZwp5xnqfeum8eXT3/AIxv4reUskZERA7Y9q5pleKR4yA4X5VxxvrDAYeOEocsN3qxxpRRq3V39mvLa6t7k+amNrr8rBh/OvYvCVppvxX8NSy6gFttZtX8qWaHjzOPlJFeEpLul8lSoZxgMR9z1Feyfs3Wiy/8JGkkq/ZWZFba+07lH3gR0rLM1yUPbRdpRtZiqPl+Ewdf+GPiDSpwkypdQNkRz26nIH+16cVjDwtq/nQiezYwn0Qn88d6+tLXZ9nTy5DKmOHJzuHrmmQu5ebzYBCiNhH3A7xjr7V5UeIK1rTim/uMHVkfOGneBtX1FVNnpMkdwML5sqbVI+prvvDnwljS4guteuPNaPnyIj8pPox7j2r1RJo5DhJFb6GlaaNY/MZ1CdN2ePSuWvnGIqLlj7q8tyXJvcit4LbTrRIbeKO3t4xhURcKv4CrI5FRSuoZUIJL8Yxnj39qbZ26WkAhjaRkBJG9ixGTnGa8p66sk5y/1q0sbeWPT4HklU7SiKQFz3NcxqaT3LSSRLceUwGSrK0eQOxrvYdFto2kLAvuyPm9D296gtPDlrbK8cbOICSwiGAFJ7iu+liKVPVbnXCtCOxyllp8V3AJbcSqpAwkkZ5kA4yK39M8Nh0STVmMz53mM/dB9OO3tXQ29tFbriJce/c1NWVXFylpHRGFSpzMjkjVoyhAweMVjMpRmVgAFPOa3evfiq9zbLOOeD0rmi7aMqlU5XZ7GGHkeQeWqmDHL55H4VbsNPjLb2XPuxzU8GnRwRqh+4PT+tXFhTgEsyghlGeBVymvsmlSurWiPdEdNrLlT2ps0e6LYvy5qQkDqaWsjmTtqYs8BAaN2K54yvUU9ECoFBJx3J5rUkjWT7wzUJtUHOT/AIVpzJ7m6rXWpSVWLnIAHYjrVy12htpZfMxnbnnFR3CiMokQJlfO1iPlB96dbWoR1nnWM3e3YzoMAj0obViZyuhZol3+Zj5u1NxkAHmrLkdMZqEg7x6UJijJ21IWQCo1cpwDxVv5e9UmGyUqqMwdslj0FUtTSLuQXI8xhuGcHivMvEsE1/4u1Eqw8qNUjXK5wQO3416dfziytpLmRd6RjOMgZrynU7uZ9SuJIY8jPnyqpwRn+denlsfecl0OmmnJabHOXVo1o0EstxFLG0vzjd86e+R0p4vz9vuSsxktIsPGJGyG9wfWtfS0ijW5BtUmmnJART8yjqN1ZH2oQvLaRW+yQZyrKAme1e2pc101c2ju7FhrjKRXE9tkv9/djdgnjn0rVTRtO1G1EkPm2LIMAg5DH2rE0q9iQjT7oySrKN+WAO1uwB9K7Cyu1t7Ah1iT5D9081lW5oaR3InN3VjlrOQC4ZURyBhZklHysB3HvTtRLPp5eXYyW7+ZbZHzsOuMVANSjvFuN7+TF52WPdiOgxTmuY7S+a6hCfZ5FCBHBO4n+VVZ82q1NU+pa0K5+03V0ZoyY12zsXG0ru/u1nytB9reKGZPJLFwzjj6Yq5Jc3Dzt9oSHKIEAjPOPQ1X1FvNtoSttHGFO8lRww7D8Ka0le25CdpXGW8qwxgrEo3sVPy9B2atCK7lt3hmWeSJ0yrFTkGs03MYieeUyBpDhVHUL700XLSW6qrly/ByOFo5OY0bPWfAWpQSanPbW77vNhEz5GDvBwf513gryz4Sw/aNUu7pVIEEQhZv7zHn+Qr1IZycjjtXzWYxUa7SPKr/AMRi0UUVxGIUUUUAFFFNkfZt+VjubHyjOPr7UAOoqK4uIrdN00ioOnNZ8usxIXPkTNGuPnAGCfSqjCUtkFizfSSwWtw0AEkwRnUSHC/QkV4td6hf65bQ3aXMf2O5kcXDqdu1VPAA9q9I8S6i99o2qWsMLxgWxfzi2MZHb3FeW6HYtcWOxUaUQRKvDYVD7j3r2cupKEJTlvdHoYRKKbZoKY5vD1wYJWLl9hnVfmlX0b1FP8DaxdeHvLh1l/8AR7t2VIi5LQqDhWA9/SubvdEbStbeeCSYCaNCVD5iQk9RT9Tgvo9+ovMht4RsgfszHivTlRpzjyN3UjrcFJWZ3d58TtGWV1sIrm8jjl8p5Qm1QR1wT1/Cp9J+JOhX94tuftCbuNzREqPrXBaJphks3KLHHFaskztI3JB7DtzWjHbapbzTX7JDE8UgxEAArRMO47kVzSwOGScFuvPqZOh0R7LZy2uo2UdzYSpLE3RlPBqxaRMrMzDGeBXGeD7yZJUjsbe3g0qDP2hgMb2IyGX39a7qRwiFq8KvTlSk4Hn1FKL5Su86i78sN82OlCXgNz5BR9+Mk44qssitPulwpzjFTyYDhhjNQ4rZjcEtGW1dSxAOSOopl1PHa20s8zbYo1LMcZwBUayBTnGM9cCrAww9QazatuYtWIY7mKSKGRG3RygFGAODnpUWrWEOpafc2lwisk0ZQ7hnqMVcAxRQm4u6EfFfi3w1e+FNWuLS/ieKFHPkS/wsvbntVQSGWznWYeY5G7djPHr9K+0NY0fT9ZtGttUs4bqBuqyqDXLP8L/CqQslrpkcAYBW2sfu9xX1NPiClOK9tF83dGtKpyHyPI6hEitjIwbggdDXuHgHwk2meGrvX7pRHdmBmVXGAgHQfWvRfD/w48PaXLMI9Oh3BsxyclgPTmn/ABjSYfDnVI7LYjlAoJ4A5qMRmscTUhQoKybV2xqTcrM+VLqe5N5PN/y2mYlivOfU1Vg+Vj54PA3Bscg1pAPGvnvgxKACw/vdwDVdXhmncFHeI/cH+0a+hnvojqSI4oFiZS8UhO3dhRnHua9u+COmGLwnM0d4kN1LI0rqyAebHjgZ7V534f0mW8vbeGYcTsElOfmVO+R9K9I1W5ttP0m5ttLe2WztSpEbZycDG7J/pXmY6bqxVCO7LjS5nod7Frdumg20NlqH2dopAkrSDOwf3fT6Vozzadq9natfaihUnBjhl2rIfQjuPavAbG+vobTyHe4mimB/eyAbUYcg+9X7VGEim9dYYLkhSjnDFh/EPSvOnlUVrzWKlhU1oe8XM1vdfubWNZIlDQCSBuYzj0HQVW8IaemnWf2HzQ9rGuIInHIUHLE56nca4zTo7XSLaAWd+YYUcylkkALN6H1/GukvNXa80uG5YpZ3qMSkjEEOv4evpXnVMNKC5I6pnNKm4rlRtX8NxcXiJNM9pEWOZYG5dR0Un+GvKPiJ8QdatvFNza+H5Y/sduBESW+84+8f1x+Fepwa3ai5j0+/KJNNCGjYkFZ+Odv0r57kkVb292S7wbhzkDPeuzKMPCdSTqxvZbdNepMIXdmtj6dlt1kuoJiX3RbsYcgc+o71P360UV4ByhRTZWKoSqlj6DvTh05oAAAOlFFFADXLhl2gEZ+bJxgUMCQMHHrTqKACiiigApGAZSD0PFLRQBh3sXmMImZ4RvCp82N309a2k5HUEdPxoaNGKllUlTkEjOPpSjA4H5Vcp8ySLlPmsQuT5hFMzU0iZII/GoiKExpjT1qCQkAcd6nTDDKNuHqKro8buTGGOflJ7cVSZpEzfEFjHqul3FlcSBI5Exu9D2NeNraXunXcsczJJOp8jzFJyccg8diK9xnQ8kDIrzPx1Y38fiPUniZoLSWyjk8xFHJBwwz64r1MurOLdPozsotfCYGpvIl1Fd2jvHIijzECHcxx6d6yozLeXEgvFc+cwdAMA57Crkl5Nc3XmxQyNGGCrJ3CgfxUln9og8pGWJiOXfpt565r2VeMfM3a00IfLhjv5NPFqfOHIlPVW9M+lPm00jSYn+2MG8whVU557gmrUcX2e4m824EytLuE2dxbP+FUtXijjma20/zi8sgbzgMIhHf8aFJtqzFbUzraJbWCfZGxuJG2tk5CCrX9o3c0ptHjihWRABIRxgHqD60+6jGmwPJeSI4ZSxYHGT9KypdSkguUUeVLFGAYW6gk/wCe9ax/ea2uKSsb0bxbNplEqgkP8o5HTJNRtcGOIw24VYm+VMnIyO4rHlv/ACBNJOq7ieq9zjp71f0lrnUlhFtAJVOcueD07VlJOCvLYzbtqVRO4eNVKhmODnnmtfRNGutf1GKwspY8kkTNj7q9zxVrR/AcktwJNTm22rNzHHkt9Sa7i91XTvDVvFDpC28WoGPYuVyQmeWPrXPVxifuYfV/kE5SkrJHY+HdJs/DOkxWccqhc5LyYUu1aD6jZowVriIMeg3ZrxW+1HUNW1FTfkyxKAAQeDn+IY6Vv6bLILZvMIUgFQ7csB9K82pl0vjqSu2ckqHVvU9SimjlGYnV/wDdOakrzDTEDLutZn3Hl2LEHHsa6XTtZuUuSs4eW3JAQ45A9Sa5KuCcPhdzOVFpXR1VIihFwM49zmore5juATGTx1BGDU1cTVtGYhVK8ujEzADChc7vU+gqrrUxljMEKM0gcEnkAfjWTe6jNcX0VukB8ocF3GFAHUg966KVBy1ZcYNhqLzSzyzSFVjCqu1hzuPQ1RtTK9+wLoFRASsQyAw7mp0smu4pZL8yRxw8gq33vQ1bktoJpoxDyroBMB8u5egrs5oxXKbRM/VVkj0DUJbl2VpInwjDnZ36dzXkVlquof2UwV3gLShdqrndH6H1OK9H8WPeX0H2SGdrCGBzG+48TIRjH4eteeaTbS6Xd3HkQtczKCI2kJKZ7V6mBgvZtytds66VraltrCS7gZBqEEgPz4Rsgr/d9sVJq1+l3pFrZlo5orfhljO0k9OTUml6JG+mebNbQ20s9wY7hI2xsPUFRVu00tJrC5luMx2kMm2FHA3S49frWznG929jeMino97fSWdza2tna28MgChJgWfA71MJIYLIW+nrJe3xYNNIyEj6AUWug60l073V4kVm6lgVA4+p/SrypKLK8ga+jkmXan7kAF0Pv7UpuF7xY+ZPYj1iK5i8P2en/Z7mN5LseeIWIxn7vTt0r2a3Ty7KCGZjuCKhLHkkD1rzSL/UW2l2krTvfj5XmJJYj+QFenwQ7baOJ/m2qFJ9SB1rxswndRXm2efitJIy5YQszBkbg5BNJCzmTDYxnvWrNCskWwk5HQ1nKDG+G5wa4oy5kKFTmROOcjOce9WbYt0PTr9KqK2c4FXoB8gJBBPY1E9EZVNESUUUd6zMQooqtPdxxbhuG4DPPSmk3sNJvRE7Ku4ORyvf0rjPGUFvPo1zaG5aYXUm8KX37D2x/s108F9FMo37RleSDkVj+K9GW606L7DHFEYmDblXHy+ldOFfJVjzaDacdz5uv9A1O1We1lhl+zk7kMKbt59vSrPhzwZfX9wjRWk9uVIZZJ+AT/u17LaaFqc1yNiAIV+aSQYH/wBetXWre18OaI00kymaU7BJI2ADjOAe3Svoqmau6pw+Jm0Kjm1E4230Cz0tI4dPka416VsS3EjYVM9Qe2Pauc1ELLGI32Xt5E7pK7EFcD+QpNQ1Y3NnJNJIyeXIWWKM/IT256k1mL50ETzTW8pjc7ZPKYYG7sB/WrpUpxd5u7PWpQ5FYsaXavLBbLbW8ItSrGXzJfmJ7n2Gaz7/AFC4llji8nCqN75Pzxgcfr1rd0uD+0reSZ0kEQAWAEBXOOpOPSsjVF8rVJUugk0agR7iCpJPQ/h0rWDvJ36DvfQo2EsUg23Tr9m3kxueuO+TW1qVvYTWK3+mXrTQo2yEK5GD3471lWd5Y22qJBcGIKoI27Mgeox71p+IDEGDWccEthNH8sUK7WRquTamrL/INDqvhzqV1qFzJZ3+6KfTl89HEYLOvcc9B9K4XxRFDba9eBSId7mQqV457j2rpPDniCTw/qdtexWklwvkeVLGGy4X1IrX1KW0167a/sZrdI5OqzABlbuK56UpUK8pW91o4KylGV0e1UUUV8geeFNZMkfOw5zxTqKACiiigAooooAKKKKACiiigApMDOcDPTNKaAMDGSfrQAVHJEkkbKw4YYOOKkpHGQOSMc8UAnYp6XYx6dZrbxElVJOT1NDhgCFH4CrfHpVNpGMrjOApxVptu7NYtttsi5P09azNb06PXNPfzpTaG3JaKUHAGBzuB6itMFnl2uxI9KrajYwXdnc206lopo2RxnqCK1g2pJp2ZutGu5454hOpwzmyhltFhKiR/s4BEh9QfpUMEMtzo+yPVIZl8za9uUAcDviufMQh8GC5jZhNaXDxI/cqrYAJ78V2XgjSbPX9Be71OFZbje2HHykY6dK+ony04K/R9jtlUta5z93q6rG2nvAtjauAhJb5nH17VkXM9raWwt4J5ZJAcogy2R713UXhHRwwM1u1woy22ZywzU93ommvcxwCziRTHuJQYJIHrVKtTi+VJmcqvK7WPMdTmubh0mQuI41CriPcM1m6hduzKjRbSSGkCDlj6Yr0C3t1md1lZmSNmVV4AwPpTDcrZiKSC1tRIWwWMeSa2WISXwmLrX0MLQfCOra20Us6taWOBhZPvOM/pXqum6fa6PZhIVwsa5LYrH07WLuRFDspB7YrpEO5MHuOa+dx2Kq1Xyy2N6SUlcgvbpINNmu8nYIywJ4zXkVpfy3+oSy3Ep2yH/WHkj/ZHtXo/jp2i8KagyHB2YryDw1KQUyqsNu/DcjNd+V070pT6lVXayR6daYknhtIGJmx948ZA5roo4XZREyzMGyxdQOPauN07Up2UyYQPtKgheRgdq2dMkkdIJ/NdZVTduU9c+taVYPoY20OmitVlaNbKRlcJtVByB9fxqwqSRIkM0u+4b7x6CPiqlrcyLIChCEYGQOuetXnuGntJWkVN0YGGA5P1rik5JpMiUiI3d3byRtaXohVBhoyA2/2z2rrBqu7RkvVjy7YUoDna2cGvMy7TeeXPVVPHHet/wANSONP1hNzbLclo1JyASOtRicNFxUjOpBNo27xpEvIiBI6SZzjoBVK6lS3h2Z3wsMrHuwVb61LbancHRY5TsLrbmUZH8WKxnYXVjZzSqu6YB3A6Ems6Ubu0uhny3sX3uom01AnniNJA0oJzu9s96faXUa3CJIJTMRkbh8qjPArN124awia0tVRIjEG6ZIJyMiuc029uY0Umd5DGmBvOc59a6KeH9pFtHTGnpodD4kjhvb2FrpA9qjMs53EP7ADuKxdfiSLTraFIAY4jvHH3+eB+FVpr6cwTNv+c3AAbHKgjoKr7na/uoTLIViAdSWyc/4V00qbjZX2NIKxJr+pxQQRC3Gy5vGWJZTyAoHLAevaq9nqVppyEasbq4jQbkaRcEMei4Hf/Grl4IrmOwknt4WeF9iHb046/Wr9lZQXXiHSUmXdHKHuXQ8hnA4JzWnNGMNUXJe6X4dJW6spW1iS6tvOQGKKNh+6X+p9aQfD26NnB9nvY5zE+YmkUxnafUr1q9rzvAi3KOxlLZyxzjiuz0SVptJtJHxuaME4GBXmVsTVoxUoPc4HWnHYz9P8M2ttqVrqE0ks15bReVGScKgIwcD39TW/RRXlSnKbvJmEpOTuwqOQAsoZVKdSSeh7VJQRng9KkQ1UVeQBzTsc0UUAFJnnGDS0UAU7q4ELug372XcCfu+nFYlwHkO3PXjcef0rZ1EBggPrSXkSLbqVUA4reD5UrdTqoyUEtNzMjw+drAIDjGMfhVu3m3I8Mw3xNwfpUUCglgelTCNVOQOTyabXNuazs9Gake0oNmNuMCuB+KMqNZW9jchZDIpbLAYzn0rtbIk7hXlHxoUjVVnDMHgtNyc8AlsV05bT5sVGLMaEP3qRyQ+ypYJdG3fzFm8rLnYuPXFKk1zdstw0EO1JPKMp+7sH3WUDryahsXe506KGZiyAsTnqfrWnotjG2jj95KIzOR5Yb5R06V9BNqKb6nsy0OggjtN3kXduTY2cQlnvZMxBmPOFHevMdblnv9euLm0kZbcyL5akZwn0+ldV8VLy6RY7WO4lSFFC4B6j0PrWS0Uf2ISKgWSKFXVl65pYVezj7R68xlHzMm6uNOvNciDQeam3y1kT5Qh9Sahv9KNsJ55LuURxNvZRzz2Ga2/D9jbXE91G0SrtgMoZeDuxnNVPEzldNhkAB8xQ7KehbHXFdUZ++oR2A0LKHTxp73M0wE7JmKdHJYkdsUnh+x+3Ws01ztEnmkZCk54HPFcnY39xMsFmzAQysM4UAr9K+l9E0yz03SraG0gRUKBzkZJJHJrhzGq8PG27b/IwqysrH//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Most of the cells are abnormal promyelocytes with folded, bi-lobed, dumbbell or reniform-shaped nuclei with abundant granular cytoplasm. Sometimes the granules can obscure the details of the nucleus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_6_21605=[""].join("\n");
var outline_f21_6_21605=null;
var title_f21_6_21606="Self-management education for the child with diabetes mellitus";
var content_f21_6_21606=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Self-management education for the child with diabetes mellitus",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/6/21606/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/6/21606/contributors\">",
"     Barbara Schreiner, PhD, RN, CDE, BC-ADM",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/6/21606/contributors\">",
"     Stephen Ponder, MD, FAAP, CDE",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/6/21606/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/6/21606/contributors\">",
"     Joseph I Wolfsdorf, MB, BCh",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/6/21606/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/6/21606/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/6/21606/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 28, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diabetes is an unrelenting chronic illness requiring management by skilled professionals, and daily attention and action by the child and parent. Diabetes Self-Management Education (DSME) provides the framework and information for preparing a family to take responsibility for the child's diabetes care, and facilitates the transition to self-care as the child matures. DSME is an integral component of care for all patients with diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21606/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The curriculum, educational principles, and outcomes of DSME are outlined in this topic review. DSME should be closely coordinated with diabetes medical care, which is described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/9/40090?source=see_link\">",
"     \"Management of type 1 diabetes mellitus in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     US NATIONAL STANDARDS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 1986, the National Diabetes Advisory Board, the American Diabetes Association (ADA), and other professional organizations articulated initial standards of practice for diabetes education programs in the United States. In 2007, revised national standards for diabetes self-management education (DSME) were published that more fully incorporated the needs of diverse patient care settings [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21606/abstract/2\">",
"     2",
"    </a>",
"    ]. In 2011, the American Diabetes Association included DSME in its revised version of Standards of Medical Care in Diabetes and recommended that all people with diabetes receive DSME at diagnosis, and as needed thereafter [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21606/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The national standards provide patients with information across nine content areas that represent the core body of knowledge needed by patients with diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21606/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Diabetes disease process and treatment options",
"     </li>",
"     <li>",
"      Nutritional management",
"     </li>",
"     <li>",
"      Physical activity",
"     </li>",
"     <li>",
"      Using medications safely and for maximal therapeutic effectiveness",
"     </li>",
"     <li>",
"      Monitoring blood glucose and other parameters, and interpreting the results for self-management decisions",
"     </li>",
"     <li>",
"      Preventing, detecting, and treating acute complications",
"     </li>",
"     <li>",
"      Preventing, detecting, and treating chronic complications",
"     </li>",
"     <li>",
"      Personal strategies to address psychosocial issues and concerns",
"     </li>",
"     <li>",
"      Personal strategies to promote health and behavior change (eg, goal-setting)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The content is presented in different ways depending on the patient's age, literacy level, learning preference, and cultural context. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Individualized curriculum'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H7\">",
"     'Cultural competence'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Several organizations are responsible for evaluating and awarding national recognition to DMSE programs that meet 10 defined standards. These standards address the organizational structure of the education program, the annual planning, the credentials of the instructors, the curriculum, and the methods for assessing outcomes. Program recognition is awarded to those education centers that successfully meet the national standards. Such recognition is a prerequisite for Medicare reimbursement.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ASSESSING LEARNER READINESS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many fine reference books, videotapes, and pamphlets produced by pharmaceutical companies are available for patients. However, the art and science of relaying health information to individuals with diabetes requires an individualized approach based on assessment of the individual patient's learning needs and readiness to learn. This is especially important for the pediatric patient and his or her parents.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Barriers to readiness",
"    </span>",
"    &nbsp;&mdash;&nbsp;Not every patient is ready for every piece of information about diabetes. Many variables make learning difficult or impossible. These barriers include the parents' and child's emotional response to the diagnosis. Was the child recently diagnosed? What are",
"    <span class=\"nowrap\">",
"     his/her",
"    </span>",
"    fears?",
"   </p>",
"   <p>",
"    Other barriers to learner readiness include the family's previous experience with chronic illness. Do other family members have diabetes? How many \"horror stories\" has the parent heard? Additional variables that can affect learning are the patient's ability to read, access to a strong support system, and trust in the medical provider.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Literacy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Health literacy, or the ability to read, understand, and implement medical directions, has been linked to glycemic control in adult patients with type 2 diabetes. In a study of 408 individuals, those with inadequate health literacy had worse glycemic control [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21606/abstract/4\">",
"     4",
"    </a>",
"    ]. Similarly, in a study of 200 families with a child who has type 1 diabetes, a lower level of literacy and numerical skills of the caregiver predicted worse glycemic control in the child [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21606/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Social support",
"    </span>",
"    &nbsp;&mdash;&nbsp;Including others in the education program provides needed support for the child or adolescent. Parents, relatives, other caregivers, school personnel, and even friends can be important advocates and helpers, and they should receive the same information as that provided to the child. School teachers and coaches, bus drivers, and the school nurse particularly need information about the child's diabetes. This can be accomplished through print materials and developing a diabetes plan for the school.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Cultural competence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Effective DSME is sensitive to the learner's cultural needs and the barriers to daily living. Kleinman's model for assessing cultural impact has been adapted for diabetes (",
"    <a class=\"graphic graphic_table graphicRef72192 \" href=\"UTD.htm?24/35/25148\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21606/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. This tool helps the physician or educator to identify health beliefs and cultural practices that may promote or interfere with diabetes self-care.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     PROVIDING DSME",
"    </span>",
"    &nbsp;&mdash;&nbsp;DSME requires a multidisciplinary team with expertise in the clinical care of diabetes, medical nutrition therapy, and teaching strategies, usually coordinated by the diabetes educator. With experience and maturity, the patient and family take an increasingly active role in contributing to their educational experience [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21606/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Effective DSME requires a series of contacts with the patient and family. Educators advocate building on survival information and progressing to more advanced content. Survival information includes the \"Five S's\": skills, supplies, simple pathophysiology, simple meal planning, and SOS (whom to call for help and when). Each of these categories includes several specific curriculum components (",
"    <a class=\"graphic graphic_table graphicRef52013 \" href=\"UTD.htm?29/12/29899\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Once the child and parents have mastered these concepts, more sophisticated information may be provided. This content includes hypoglycemia, sick day care, nutrition (such as carbohydrate counting, label reading), exercise, and diabetes self-care decisions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Teaching strategies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Effective teaching strategies encourage active collaboration between healthcare providers, patient, and family. The curriculum emphasizes practical skills, and explores and addresses developmental and psychosocial issues. Behavioral strategies, such as goal setting and problem-solving, are used to sustain self-management efforts [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21606/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Individualized curriculum",
"    </span>",
"    &nbsp;&mdash;&nbsp;Optimal education requires assessment of the patient and family's functional health literacy, needs, readiness, health beliefs and attitudes, and financial or physical limitations. The curriculum and educational process is then tailored to meet these needs and expectations. Reassessment and remodeling of the plan is essential, particularly when the patient is a child. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Follow-up'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Teachable moments",
"    </span>",
"    &nbsp;&mdash;&nbsp;DSME is an ongoing process. Children and families often exhibit an increased readiness to learn at key developmental or crisis times. The adolescent leaving for college or the young adult facing the onset of nephropathy are examples of people who may be ready and motivated to learn more. These teachable moments are ideal times to address further diabetes self-management issues.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Scare tactics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Generally, scare tactics do not work. Strategies such as showing pictures of amputations to a patient or walking them through the dialysis unit promote fear and anxiety. However, these strategies do not consistently prompt changes in behavior, particularly the long-term behavior changes that are required for optimal health [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21606/abstract/8\">",
"     8",
"    </a>",
"    ]. Furthermore, scare tactics often extinguish hope.",
"   </p>",
"   <p>",
"    Despite these considerations, families need to know the potential consequences of long-term hyperglycemia. Such information needs to be factual and should be delivered in a caring, nonthreatening manner. Diabetes education becomes an important component of motivation and adherence. Knowledgeable patients at least have the tools to make decisions about making behavior change.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Time and expertise",
"    </span>",
"    &nbsp;&mdash;&nbsp;Effective initial DSME may require as much as four to six hours or more of contact with the patient and family. Consequently, many clinicians providing medical diabetes care refer patients to qualified nurses and dietitians for DSME. Expert patient educators may be found among the ranks of certified diabetes educators (CDE), a nationally recognized credential in the field of diabetes education for patients. CDEs can be nurses, dietitians, pharmacists, or health educators. They have additional training and experience in teaching the patient with diabetes. Local diabetes educators may be found through the American Association of Diabetes Educators at 1-800-TEAM-UP4.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Reimbursement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Increasingly, third party payers and insurance companies are paying for DSME. As of 2009, 46 states had legislation mandating coverage for diabetes education [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21606/abstract/9\">",
"     9",
"    </a>",
"    ]. The investment in diabetes self-management education has important economic and personal returns. For every dollar invested in DSME, health care costs can be reduced by $8.76 [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21606/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Follow-up",
"    </span>",
"    &nbsp;&mdash;&nbsp;Long-term diabetes self-management support (DSMS) is important to optimize lifelong self-management skills [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21606/abstract/2,11\">",
"     2,11",
"    </a>",
"    ]. This phase is particularly important for the pediatric age group because of developmental and cognitive changes over time. DSMS may include case management (reminders about follow-up care and tests and access to psychosocial supports), as well as behavioral goal-setting, advanced educational curriculum, and education about any changes in diabetes management techniques (such as the use of an insulin pump and continuous glucose monitoring).",
"   </p>",
"   <p>",
"    Depending on the patient's needs and available resources, DSMS can be provided by a dedicated diabetes educator, or by the patient's diabetes medical provider, or by both in a sequence of alternating visits.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     OUTCOMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The importance of DSME to the medical management of diabetes is supported by clinical experience in a wide variety of patient groups with type 2 or type 1 diabetes mellitus. The efficacy of DSME is further supported by studies that demonstrate improvements in psychosocial and health outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21606/abstract/2,3,11,12\">",
"     2,3,11,12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Behavior change",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary outcome measure for effectiveness of DSME is behavior change. The American Association of Diabetes Educators has identified the following behaviors that are directly and positively affected by DSME [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21606/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Being active",
"     </li>",
"     <li>",
"      Healthy eating",
"     </li>",
"     <li>",
"      Taking medication",
"     </li>",
"     <li>",
"      Monitoring",
"     </li>",
"     <li>",
"      Problem-solving",
"     </li>",
"     <li>",
"      Reducing risks",
"     </li>",
"     <li>",
"      Healthy coping",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Positive behavior changes are associated with DSME in a variety of studies of adults with type 2 diabetes. As an example, a metanalysis of studies concerning the effectiveness of diabetes education demonstrated improvements in dietary behaviors, blood glucose monitoring behaviors, and other short-term behavior changes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21606/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A few studies in adolescents also demonstrate that diabetes education was positively associated with increased use of primary and preventive services, decreased use of inpatient hospital services, and an increased likelihood of following treatment plans [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21606/abstract/16-18\">",
"     16-18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Health outcomes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Health outcomes are important secondary goals for DSME; measures of hemoglobin A1c are the most commonly tracked health outcome. Most of the data for this outcome comes from studies of adults with type 2 diabetes. As an example, in a meta-analysis, diabetes education was found to decrease hemoglobin A1c by almost 1 percentage point [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21606/abstract/19\">",
"     19",
"    </a>",
"    ]. This represents a clinically important change, given that each 1 percent reduction in A1c over 10 years is associated with about 20 percent reduction in risk of diabetes complications, as shown in the United Kingdom Prospective Diabetes Study (UKPDS) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21606/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The cost-effectiveness of DSME was suggested in a large sample of patients with diabetes in a managed care setting. Those who received diabetes education cost the plan 5.7 percent less than members who did not participate in an education program [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21606/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A few studies describe health outcomes of DSME in patients with type 1 diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21606/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. As an example, a study of adolescents given DSME through a 20 day residential diabetes camp showed improvements in glycemic control as compared to worsening trends in a control group of adolescents who did not attend camp (decrease of 0.3 percent versus increase of 0.5 percent three months after the camp) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21606/abstract/22\">",
"     22",
"    </a>",
"    ]. When the subjects were reevaluated about seven months after camp attendance, some improvement was sustained for girls, but not for boys.",
"   </p>",
"   <p>",
"    Controlled outcome studies on the impact of education on children with type 1 diabetes are lacking. However, there is suggestive evidence that DSME for children with type 1 diabetes is associated with less health care utilization and perhaps better family functioning [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21606/abstract/17,18\">",
"     17,18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?17/48/18179?source=see_link\">",
"       \"Patient information: My child has diabetes: How will we manage? (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?35/25/36243?source=see_link\">",
"       \"Patient information: Keeping your child&rsquo;s blood sugar under control (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?36/52/37699?source=see_link\">",
"       \"Patient information: Carb counting and your child&rsquo;s diet (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?37/11/38066?source=see_link\">",
"       \"Patient information: Managing diabetes in school (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?5/33/5651?source=see_link\">",
"       \"Patient information: Giving your child insulin (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?38/26/39331?source=see_link\">",
"       \"Patient information: Checking your child&rsquo;s blood sugar level (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Diabetes self-management education (DSME) is an integral component of care for all patients with diabetes. Organized DSME improves diabetes-related self-care behaviors and health outcomes, such as hemoglobin A1C. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Outcomes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      DSME incorporates the following standard curricular elements: disease process and treatment options, nutritional management, physical activity, medication use, blood glucose monitoring, prevention and detection of acute and chronic complications, and strategies to address psychosocial issues and to promote healthy behaviors. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'US national standards'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The first step in DSME is to communicate \"survival information\": skills, supplies, simple pathophysiology, simple meal planning, and SOS (whom to call for help and when) (",
"      <a class=\"graphic graphic_table graphicRef52013 \" href=\"UTD.htm?29/12/29899\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Providing DSME'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The DSME curriculum then progresses to more advanced information. The approach and level at which these curricula are taught are individualized, based on the patient's age, functional health literacy, and cultural context. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Teaching strategies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Effective DSME requires training and experience in diabetes education, and a substantial number of contact hours with the patient and family. In many cases, DSME is initiated and coordinated by an expert certified diabetes educator (CDE). DSME is patient-focused; patients and families should have an active role in their educational experience. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Time and expertise'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Ongoing DSME, or diabetes self-management support (DSMS) is important to optimize lifelong self-management skills. This is particularly important for the pediatric age group because of developmental and cognitive changes over time. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Follow-up'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Schreiner B. Diabetes self-management education. In: Intensive diabetes management, 5 ed, Wolfsdorf J (Ed), American Diabetes Association, Arlington, VA 2012.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21606/abstract/2\">",
"      Funnell MM, Brown TL, Childs BP, et al. National standards for diabetes self-management education. Diabetes Care 2012; 35 Suppl 1:S101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21606/abstract/3\">",
"      American Diabetes Association. Standards of medical care in diabetes--2013. Diabetes Care 2013; 36 Suppl 1:S11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21606/abstract/4\">",
"      Schillinger D, Grumbach K, Piette J, et al. Association of health literacy with diabetes outcomes. JAMA 2002; 288:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21606/abstract/5\">",
"      Hassan K, Heptulla RA. Glycemic control in pediatric type 1 diabetes: role of caregiver literacy. Pediatrics 2010; 125:e1104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21606/abstract/6\">",
"      Kleinman A, Eisenberg L, Good B. Culture, illness, and care: clinical lessons from anthropologic and cross-cultural research. Ann Intern Med 1978; 88:251.",
"     </a>",
"    </li>",
"    <li>",
"     Nwankwo, R, Tang, T. Tailoring diabetes education and care to minority patients and families. In: Practical psychology for diabetes clinicians, 2nd ed, Anderson, B, Rubin, R (Eds), American Diabetes Association, Alexandria, VA, 2002. p.37.",
"    </li>",
"    <li>",
"     Anderson, R, Funnell, M, Burkhart, N, et al. 101 tips for behavior change in diabetes education. American Diabetes Association, Alexandria, VA 2003. p.37.",
"    </li>",
"    <li>",
"     Data from the American diabetes association, available at: www.diabetes.org/advocacy-and-legalresources/state-legislation/healthinsurance.jsp. (Accessed 9/29/09).",
"    </li>",
"    <li>",
"     CDC Fact Sheet: Preventing diabetes and its complications. Centers for Disease Control and Prevention, Washington DC, 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21606/abstract/11\">",
"      Glazier RH, Bajcar J, Kennie NR, Willson K. A systematic review of interventions to improve diabetes care in socially disadvantaged populations. Diabetes Care 2006; 29:1675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21606/abstract/12\">",
"      Brown SA. Interventions to promote diabetes self-management: state of the science. Diabetes Educ 1999; 25:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21606/abstract/13\">",
"      Peeples M, Mulcahy K, Tomky D, et al. The conceptual framework of the National Diabetes Education Outcomes System (NDEOS). Diabetes Educ 2001; 27:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21606/abstract/14\">",
"      Zgibor JC, Peyrot M, Ruppert K, et al. Using the American Association of Diabetes Educators Outcomes System to identify patient behavior change goals and diabetes educator responses. Diabetes Educ 2007; 33:839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21606/abstract/15\">",
"      Norris SL, Engelgau MM, Narayan KM. Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. Diabetes Care 2001; 24:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21606/abstract/16\">",
"      Duncan I, Birkmeyer C, Coughlin S, et al. Assessing the value of diabetes education. Diabetes Educ 2009; 35:752.",
"     </a>",
"    </li>",
"    <li>",
"     Diabetes Education for Children With Type 1 Diabetes Mellitus and Their Families, Structured Abstract. April 2008. Agency for Healthcare Research and Quality, Rockville, MD. Available at: www.ahrq.gov/clinic/tp/diabedtp.htm (Accessed 9/29/09).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21606/abstract/18\">",
"      Gage H, Hampson S, Skinner TC, et al. Educational and psychosocial programmes for adolescents with diabetes: approaches, outcomes and cost-effectiveness. Patient Educ Couns 2004; 53:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21606/abstract/19\">",
"      Norris SL, Lau J, Smith SJ, et al. Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care 2002; 25:1159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21606/abstract/20\">",
"      Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352:837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21606/abstract/21\">",
"      Santiprabhob J, Likitmaskul S, Kiattisakthavee P, et al. Glycemic control and the psychosocial benefits gained by patients with type 1 diabetes mellitus attending the diabetes camp. Patient Educ Couns 2008; 73:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21606/abstract/22\">",
"      Wang YC, Stewart S, Tuli E, White P. Improved glycemic control in adolescents with type 1 diabetes mellitus who attend diabetes camp. Pediatr Diabetes 2008; 9:29.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5831 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-61.234.146.186-5CB361C86E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_6_21606=[""].join("\n");
var outline_f21_6_21606=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      US NATIONAL STANDARDS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ASSESSING LEARNER READINESS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Barriers to readiness",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Literacy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Social support",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Cultural competence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      PROVIDING DSME",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Teaching strategies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Individualized curriculum",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Teachable moments",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Scare tactics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Time and expertise",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Reimbursement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Follow-up",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Behavior change",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Health outcomes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5831\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5831|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/35/25148\" title=\"table 1\">",
"      Cultural context DM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/12/29899\" title=\"table 2\">",
"      Survival info DM",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/9/40090?source=related_link\">",
"      Management of type 1 diabetes mellitus in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/52/37699?source=related_link\">",
"      Patient information: Carb counting and your child&rsquo;s diet (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?38/26/39331?source=related_link\">",
"      Patient information: Checking your child&rsquo;s blood sugar level (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?5/33/5651?source=related_link\">",
"      Patient information: Giving your child insulin (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?35/25/36243?source=related_link\">",
"      Patient information: Keeping your child&rsquo;s blood sugar under control (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?37/11/38066?source=related_link\">",
"      Patient information: Managing diabetes in school (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?17/48/18179?source=related_link\">",
"      Patient information: My child has diabetes: How will we manage? (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_6_21607="Pathogenesis of typhoid fever";
var content_f21_6_21607=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathogenesis of typhoid fever",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/6/21607/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/6/21607/contributors\">",
"     Elizabeth L Hohmann, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/6/21607/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/6/21607/contributors\">",
"     Stephen B Calderwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/6/21607/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/6/21607/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/6/21607/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 4, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H4748978\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Typhoid fever is characterized by severe systemic illness with fever and abdominal pain [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/1\">",
"     1",
"    </a>",
"    ]. The organism classically responsible for the enteric fever syndrome is S. enterica serotype Typhi (formerly S. typhi). Other salmonellae that may cause a similar clinical syndrome include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Salmonella paratyphi A",
"     </li>",
"     <li>",
"      Salmonella schottmuelleri (formerly Salmonella paratyphi B)",
"     </li>",
"     <li>",
"      Salmonella hirschfeldii (formerly Salmonella paratyphi C)",
"     </li>",
"     <li>",
"      Salmonella choleraesuis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The term &ldquo;enteric fever&rdquo; is a collective term that refers to both typhoid and paratyphoid fever.",
"   </p>",
"   <p>",
"    The pathogenesis of typhoid fever will be reviewed here. The epidemiology, microbiology, clinical manifestations, diagnosis, treatment, and prevention of typhoid fever are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/2/42024?source=see_link\">",
"     \"Epidemiology, microbiology, clinical manifestations, and diagnosis of typhoid fever\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/58/18345?source=see_link\">",
"     \"Treatment and prevention of typhoid fever\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/21/2394?source=see_link\">",
"     \"Immunizations for travel\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of enteric fever depends on a number of factors including the infecting species and infectious dose. Ingested organisms survive exposure to gastric acid before gaining access to the small bowel, where they penetrate the epithelium, enter the lymphoid tissue, and disseminate via the lymphatic or hematogenous route. A chronic carrier state is established in an estimated 1 to 5 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/2/42024?source=see_link&amp;anchor=H3746567#H3746567\">",
"     \"Epidemiology, microbiology, clinical manifestations, and diagnosis of typhoid fever\", section on 'Chronic carriers'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     The organisms",
"    </span>",
"    &nbsp;&mdash;&nbsp;The microbiology of organisms responsible for enteric fever is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/2/42024?source=see_link&amp;anchor=H4#H4\">",
"     \"Epidemiology, microbiology, clinical manifestations, and diagnosis of typhoid fever\", section on 'Microbiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It has been suggested that S. typhi represents a single clone with little intraspecies divergence [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. However, other studies have demonstrated that the S. typhi genome has undergone significant evolutionary rearrangement [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. Differences have been found among isolates of S. typhi in pulsed field gel electrophoretic (PFGE) patterns, outer membrane protein profiles [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/8\">",
"     8",
"    </a>",
"    ] and ribotypes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/9\">",
"     9",
"    </a>",
"    ]. Certain flagellar serotypes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/10\">",
"     10",
"    </a>",
"    ] and PFGE patterns [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/11\">",
"     11",
"    </a>",
"    ] have been associated with more severe clinical illness in endemic areas.",
"   </p>",
"   <p>",
"    In one series of 52 human isolates, for example, an identical characteristic PFGE pattern was observed in all 11 patients with fatal disease; the 41 isolates from patients with nonfatal disease had various PFGE patterns, suggesting an association for strains of S. typhi between genotype and the capability to cause fatal illness [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/11\">",
"     11",
"    </a>",
"    ]. Among 19 patients with positive stool and blood cultures identified, 15 pairs had identical PFGE patterns, but small differences were observed among four paired samples, suggesting that genetic alterations may occur in vivo during the course of infection [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/11\">",
"     11",
"    </a>",
"    ]. Such changes may occur in response to antimicrobial therapy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    host immune responses.",
"   </p>",
"   <p>",
"    Taken together, these studies suggest that S. typhi evolves in response to environmental pressures, that especially virulent clones may exist, and that further study is needed to understand the specific virulence properties of this pathogen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Infectious dose",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data on the numbers of Salmonella typhi organisms required to cause disease have been obtained from human volunteer studies and from epidemiologic investigations. In general, the greater the infectious dose, the higher the attack rate and the shorter the incubation period. In one report, 10",
"    <sup>",
"     5",
"    </sup>",
"    colony forming units of the Quailes strain of S. typhi was administered orally to 116 adults; 28 percent developed typhoid fever [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is difficult to generalize data obtained in experimental inoculations to actual ingestion of contaminated food and water; extrapolations from volunteer studies suggest that 10 to 20 percent of healthy individuals ingesting 10",
"    <sup>",
"     3",
"    </sup>",
"    S. typhi organisms will develop typhoid fever [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/13\">",
"     13",
"    </a>",
"    ]. Data compiled from 12 outbreaks related to food, water, or occupational laboratory exposures showed \"real life\" infectious doses are usually low (&lt;10",
"    <sup>",
"     3",
"    </sup>",
"    ) with relatively low attack rates (averaging 4 percent) and fairly long incubation periods (12 to 21 days) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/13\">",
"     13",
"    </a>",
"    ]. Smaller numbers of organisms are likely to induce disease in high-risk individuals such as those with achlorhydria or immunosuppressive illnesses such as AIDS [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Gastrointestinal infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;After ingestion, S. typhi organisms that survive exposure to gastric acid gain access to the small bowel, where they penetrate the epithelium, enter the lymphoid tissue, and disseminate via the lymphatic or hematogenous route.",
"   </p>",
"   <p>",
"    Diarrhea and constipation appear to occur with approximately equal frequency. The reasons for the variability in enteritis among Salmonella strains are not certain. In a cell culture model of gastroenteritis, nontyphoidal Salmonella strains associated with enteritis induced IL-8-mediated neutrophil transmigration across the epithelial cell; these observations were not seen with S. typhi or other strains not associated with enteritis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/15\">",
"     15",
"    </a>",
"    ]. The muted IL-8 response and relative absence of neutrophil infiltration seen with S. typhi may be mediated by Toll-like receptors and require the Vi capsular polysaccharide [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    S. typhi access the submucosal region of the bowel by two mechanisms: via the M-cell, a specialized epithelial cell that serves as a sampling and antigen presenting cell in the mucosa (or gut)-associated lymphoid system [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/17\">",
"     17",
"    </a>",
"    ]; and via direct penetration into or around the epithelial cell itself [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/18-20\">",
"     18-20",
"    </a>",
"    ]. The entry of S. typhi into the epithelial cell appears to be mediated by the cystic fibrosis transmembrane conductance regulator (CFTR), the protein that is abnormal in cystic fibrosis. In one study, mice that were heterozygous for the most common CFTR mutation seen in cystic fibrosis in humans (Delta F508) translocated 86 percent fewer S. typhi into the submucosa than wild-type mice; no translocation occurred in Delta 508 homozygous mice [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/21\">",
"     21",
"    </a>",
"    ]. Genetic analyses of an Indonesian case-control cohort showed that a specific CFTR polymorphism known to affect CFTR protein expression appeared to confer modest protection against acquisition of enteric fever [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/22\">",
"     22",
"    </a>",
"    ]. Thus, individuals who are heterozygous for CFTR may have a selective protection against typhoid fever.",
"   </p>",
"   <p>",
"    S. typhi proliferate in the submucosa, leading to hypertrophy of the Peyer's patches via recruitment of mononuclear cells and lymphocytes. Hypertrophy and subsequent necrosis of the submucosal tissues are probably responsible for abdominal pain and subsequent ileal perforation, a potentially fatal complication. Patients with typhoid fever may develop \"secondary\" bacteremia with other organisms due to microscopic or macroscopic breaches in the intestinal mucosal barrier [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Systemic spread and persistence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dissemination of S. typhi from the Peyer's patches to the reticuloendothelial system occurs via the lymphatic system and bloodstream. Replication within the reticuloendothelial system is a hallmark of enteric fever, and is responsible for the clinical findings of prostration, generalized sepsis, and hepatosplenomegaly. Some individuals contain the organism within the gastrointestinal system and do not become systemically ill but have persistent S. typhi carriage [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/12,24\">",
"     12,24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Quantitative studies using density gradient separation of blood cells or buffy coat cultures from patients with typhoid fever demonstrated that S. typhi isolated from blood cultures are frequently localized within the mononuclear cell-platelet layer [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. Dissemination of the organisms via the blood stream occurs early in the course of illness; bacteremias are more frequently detected and are of higher grade during the first week of clinical illness [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Eventually, organisms reside within monocyte-derived or tissue macrophages in the liver, spleen and bone marrow. The bone marrow is a clinical \"sanctuary\" for S. typhi and an important source of diagnostic culture material even after the initiation of antimicrobial therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. These intracellular organisms are likely sources for relapsing infection and late pyogenic complications such as pericarditis, visceral abscesses, or osteomyelitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/2/42024?source=see_link&amp;anchor=H7#H7\">",
"     \"Epidemiology, microbiology, clinical manifestations, and diagnosis of typhoid fever\", section on 'Other clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Replete hemophagocytic macrophages may provide a niche for Salmonella persistence [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/29\">",
"     29",
"    </a>",
"    ]. It has also been proposed that the hemochromatosis C282Y mutation (present in up to 12.5 percent of northern and central Europeans) may confer resistance to infection with S. typhi and mycobacteria, which require iron for growth in macrophages. Despite the total body iron overload, macrophages in C282Y homozygotes are low in iron. Hemochromatosis patients are not especially susceptible to salmonellosis or other intracellular infections, although they may be at increased risk for infection with other organisms such as Vibrios [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/30,31\">",
"     30,31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Persistence of intracellular S. typhi organisms within visceral and bone marrow macrophages has long been believed central to virulence. Molecular approaches to the study of the pathogenesis and persistence of S. typhi have been facilitated by experiments with murine models of typhoid fever and identified key genes and proteins [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/32-34\">",
"     32-34",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The",
"      <span class=\"nowrap\">",
"       phoP/phoQ",
"      </span>",
"      genes, which modulate transcriptional activation of bacterial proteins within macrophages, are important for full virulence; deletion of these genes markedly attenuated S. typhi in human volunteers [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Analysis of the S. typhi proteome under conditions mimicking the intracellular macrophage environment identified a subset of highly expressed proteins unique to S. typhi (versus nontyphoidal Salmonellae) that likely play a role in pathogenesis and perhaps in human host specificity [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/36\">",
"       36",
"      </a>",
"      ]. One protein identified was CdtB, part of a tripartite toxin that causes cell cycle arrest and DNA damage [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/37\">",
"       37",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Deletion of genes that facilitate colonization of deep tissues (cdt) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/38\">",
"       38",
"      </a>",
"      ], modulate adenylate cyclase levels",
"      <span class=\"nowrap\">",
"       (cya/crp)",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/39\">",
"       39",
"      </a>",
"      ], or encode the synthesis of essential nutrients such as purines (purA) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/40\">",
"       40",
"      </a>",
"      ] or aromatic amino acids",
"      <span class=\"nowrap\">",
"       (aroC/aroD)",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/39\">",
"       39",
"      </a>",
"      ] also results in strains that are significantly attenuated in humans.",
"     </li>",
"     <li>",
"      In contrast, deletion of the Vi capsular polysaccharide (a protective polysaccharide antigen that serves as a parenteral typhoid fever vaccine [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/41,42\">",
"       41,42",
"      </a>",
"      ]) did not result in significant attenuation of orally administered S. typhi in volunteers [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/43\">",
"       43",
"      </a>",
"      ]. In addition, strains that lack the Vi antigen-encoding genes were detected by PCR in 4 of 48 blood samples of typhoid patients in a study in Pakistan [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/44\">",
"       44",
"      </a>",
"      ]. Whether this rate will increase with increasing use of Vi vaccine is of interest, but presently unknown.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Several S. typhi mutants are currently being investigated as live vaccines for typhoid fever [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/35,38,40\">",
"     35,38,40",
"    </a>",
"    ] and as vector microorganisms for delivery of other antigens to the gastrointestinal mucosal immune system.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Host immunity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Host immunologic defects such as depressed cell-mediated immunity (eg, AIDS, glucocorticoid therapy) and altered phagocyte function (eg, sickle cell anemia, malaria) have not been associated with more severe or complicated typhoid infection. In contrast, a variety of host immunologic defects are known to predispose to more severe and complicated illness due to nontyphoidal salmonellosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/37/19033?source=see_link\">",
"     \"Pathogenesis of Salmonella gastroenteritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is some evidence that immunocompromised patients fare poorly with typhoidal infections, however. One study of four individuals with AIDS in Peru described atypically severe diarrhea or colitis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/14\">",
"     14",
"    </a>",
"    ]. Other case reports have documented unusual manifestations of S. typhi infection, such as arteritis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/45\">",
"     45",
"    </a>",
"    ] or chorioamnionitis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/46\">",
"     46",
"    </a>",
"    ] in HIV-infected patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Chronic carriage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic Salmonella carriage is defined as excretion of the organism in stool or urine &gt;12 months after acute infection. Chronic carriage occurs more frequently in women and in patients with cholelithiasis or other biliary tract abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/47,48\">",
"     47,48",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/2/42024?source=see_link&amp;anchor=H3746567#H3746567\">",
"     \"Epidemiology, microbiology, clinical manifestations, and diagnosis of typhoid fever\", section on 'Chronic carriers'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Gallstones may serve as a persistent nidus of infection [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/47,48\">",
"     47,48",
"    </a>",
"    ]. Gallstone biofilm has been observed in humans and mice, which appears to facilitate gallbladder colonization and shedding [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/49\">",
"     49",
"    </a>",
"    ]. In animal and in vitro models, S. typhi exposure to bile appears to induce formation of specific bacterial polysaccharide components that contribute to biofilm formation, and flagellar proteins may enhance bacterial adherence [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/50,51\">",
"     50,51",
"    </a>",
"    ]. In rare cases, chronic carriage has been observed to persist even after antibiotic therapy and cholecystectomy, suggesting that factors other than biliary abnormalities also may contribute to the carrier state [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In general, chronic carriers do not develop recurrent symptomatic disease. They appear to reach an immunologic equilibrium in which they are chronically colonized and may excrete large numbers of organisms, but have a high level of immunity and do not develop clinical disease [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/2,53-55\">",
"     2,53-55",
"    </a>",
"    ]. Chronic carriers frequently have high serum antibody titers against the Vi antigen, which is a clinically useful test for rapid identification of such patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/56,57\">",
"     56,57",
"    </a>",
"    ]. Susceptibility to colonization with S. typhi may also be related to blood group antigens [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The S. typhi carrier state may be an independent risk factor for carcinoma of the gallbladder as well as other cancers [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/58,59\">",
"     58,59",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/46/15082?source=see_link\">",
"     \"Gallbladder cancer: Epidemiology, risk factors, clinical features, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Chronic carriage may also result from infection with the S. paratyphi strains, but seems to occur much less frequently (up to 0.6 percent of cases in one study) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21607/abstract/60\">",
"     60",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/8/26761?source=see_link\">",
"     \"Approach to the patient with nontyphoidal Salmonella in a stool culture\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?37/26/38305?source=see_link\">",
"       \"Patient information: Typhoid fever (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4750796\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ingested S. typhi organisms survive exposure to gastric acid before gaining access to the small bowel, where they penetrate the epithelium, enter the lymphoid tissue, and disseminate via the lymphatic or hematogenous route. A chronic carrier state is established in a minority of cases. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In general, the greater the S. typhi infectious dose, the higher the attack rate and the shorter the incubation period. Infectious doses are usually low (&lt;10",
"      <sup>",
"       3",
"      </sup>",
"      ) with relatively low attack rates (averaging 4 percent) and fairly long incubation periods (12 to 21 days). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Infectious dose'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Dissemination of S. typhi from the Peyer's patches to the reticuloendothelial system occurs via the lymphatic system and bloodstream. Eventually, organisms reside within tissue macrophages in the liver, spleen, and bone marrow. These intracellular organisms are likely sources for relapsing infection and late pyogenic complications. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Systemic spread and persistence'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Host immunologic defects such as depressed cell-mediated immunity and altered phagocyte function have not generally been associated with more severe or complicated typhoid infection. However, there is some evidence that immunocompromised patients fare poorly with typhoidal infections. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Host immunity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Chronic carriage occurs more frequently in women and in patients with cholelithiasis or other biliary tract abnormalities. S. typhi exposure to bile appears to induce formation of specific bacterial polysaccharide components that contribute to biofilm formation, and flagellar proteins may enhance bacterial adherence. Chronic carriers frequently have high serum antibody titers against the Vi antigen, which is a clinically useful test for rapid identification of such patients. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Chronic carriage'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/1\">",
"      Parry CM, Hien TT, Dougan G, et al. Typhoid fever. N Engl J Med 2002; 347:1770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/2\">",
"      Dham SK, Thompson RA. Humoral and cell-mediated immune responses in chronic typhoid carriers. Clin Exp Immunol 1982; 50:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/3\">",
"      Levine MM, Black RE, Lanata C. Precise estimation of the numbers of chronic carriers of Salmonella typhi in Santiago, Chile, an endemic area. J Infect Dis 1982; 146:724.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/4\">",
"      Reeves, MW, Evins, GM, Heiba, AA, et al. Clonal nature of Salmonella typhi and its genetic relatedness to other salmonellae as shown by multilocus enzyme electrophoresis and proposal of Salmonella bongori comb. nov. J Clin Microbiol 1989; 27:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/5\">",
"      Selander RK, Beltran P, Smith NH, et al. Evolutionary genetic relationships of clones of Salmonella serovars that cause human typhoid and other enteric fevers. Infect Immun 1990; 58:2262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/6\">",
"      Liu SL, Sanderson KE. Rearrangements in the genome of the bacterium Salmonella typhi. Proc Natl Acad Sci U S A 1995; 92:1018.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/7\">",
"      Liu SL, Sanderson KE. Highly plastic chromosomal organization in Salmonella typhi. Proc Natl Acad Sci U S A 1996; 93:10303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/8\">",
"      Franco A, Gonzalez C, Levine OS, et al. Further consideration of the clonal nature of Salmonella typhi: evaluation of molecular and clinical characteristics of strains from Indonesia and Peru. J Clin Microbiol 1992; 30:2187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/9\">",
"      Altwegg, M, Hickman-Brenner, FW, Farmer, JJ. Ribosomal RNA gene restriction patterns provide increased sensitivity for typing Salmonella typhi strains. J Infect Dis 1989; 160:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/10\">",
"      Grossman DA, Witham ND, Burr DH, et al. Flagellar serotypes of Salmonella typhi in Indonesia: relationships among motility, invasiveness, and clinical illness. J Infect Dis 1995; 171:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/11\">",
"      Thong KL, Passey M, Clegg A, et al. Molecular analysis of isolates of Salmonella typhi obtained from patients with fatal and nonfatal typhoid fever. J Clin Microbiol 1996; 34:1029.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/12\">",
"      Hornick RB, Greisman SE, Woodward TE, et al. Typhoid fever: pathogenesis and immunologic control. N Engl J Med 1970; 283:686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/13\">",
"      Blaser MJ, Newman LS. A review of human salmonellosis: I. Infective dose. Rev Infect Dis 1982; 4:1096.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/14\">",
"      Gotuzzo E, Frisancho O, Sanchez J, et al. Association between the acquired immunodeficiency syndrome and infection with Salmonella typhi or Salmonella paratyphi in an endemic typhoid area. Arch Intern Med 1991; 151:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/15\">",
"      McCormick BA, Miller SI, Carnes D, Madara JL. Transepithelial signaling to neutrophils by salmonellae: a novel virulence mechanism for gastroenteritis. Infect Immun 1995; 63:2302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/16\">",
"      Raffatellu M, Chessa D, Wilson RP, et al. The Vi capsular antigen of Salmonella enterica serotype Typhi reduces Toll-like receptor-dependent interleukin-8 expression in the intestinal mucosa. Infect Immun 2005; 73:3367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/17\">",
"      Kohbata S, Yokoyama H, Yabuuchi E. Cytopathogenic effect of Salmonella typhi GIFU 10007 on M cells of murine ileal Peyer's patches in ligated ileal loops: an ultrastructural study. Microbiol Immunol 1986; 30:1225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/18\">",
"      Kops SK, Lowe DK, Bement WM, West AB. Migration of Salmonella typhi through intestinal epithelial monolayers: an in vitro study. Microbiol Immunol 1996; 40:799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/19\">",
"      Mills SD, Finlay BB. Comparison of Salmonella typhi and Salmonella typhimurium invasion, intracellular growth and localization in cultured human epithelial cells. Microb Pathog 1994; 17:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/20\">",
"      Tartera C, Metcalf ES. Osmolarity and growth phase overlap in regulation of Salmonella typhi adherence to and invasion of human intestinal cells. Infect Immun 1993; 61:3084.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/21\">",
"      Pier GB, Grout M, Zaidi T, et al. Salmonella typhi uses CFTR to enter intestinal epithelial cells. Nature 1998; 393:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/22\">",
"      van de Vosse E, de Visser AW, Al-Attar S, et al. Distribution of CFTR variations in an Indonesian enteric fever cohort. Clin Infect Dis 2010; 50:1231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/23\">",
"      Hoffman SL, Punjabi NH, Kumala S, et al. Reduction of mortality in chloramphenicol-treated severe typhoid fever by high-dose dexamethasone. N Engl J Med 1984; 310:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/24\">",
"      Meals RA. Paratyphoid fever: a report of 62 cases with several unusual findings and a review of the literature. Arch Intern Med 1976; 136:1422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/25\">",
"      Rubin FA, McWhirter PD, Burr D, et al. Rapid diagnosis of typhoid fever through identification of Salmonella typhi within 18 hours of specimen acquisition by culture of the mononuclear cell-platelet fraction of blood. J Clin Microbiol 1990; 28:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/26\">",
"      Wain J, Diep TS, Ho VA, et al. Quantitation of bacteria in blood of typhoid fever patients and relationship between counts and clinical features, transmissibility, and antibiotic resistance. J Clin Microbiol 1998; 36:1683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/27\">",
"      Gasem MH, Dolmans WM, Isbandrio BB, et al. Culture of Salmonella typhi and Salmonella paratyphi from blood and bone marrow in suspected typhoid fever. Trop Geogr Med 1995; 47:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/28\">",
"      Guerra-Caceres JG, Gotuzzo-Herencia E, Crosby-Dagnino E, et al. Diagnostic value of bone marrow culture in typhoid fever. Trans R Soc Trop Med Hyg 1979; 73:680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/29\">",
"      Nix RN, Altschuler SE, Henson PM, Detweiler CS. Hemophagocytic macrophages harbor Salmonella enterica during persistent infection. PLoS Pathog 2007; 3:e193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/30\">",
"      Weinberg ED. Survival advantage of the hemochromatosis C282Y mutation. Perspect Biol Med 2008; 51:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/31\">",
"      Moalem S, Weinberg ED, Percy ME. Hemochromatosis and the enigma of misplaced iron: implications for infectious disease and survival. Biometals 2004; 17:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/32\">",
"      Fields PI, Swanson RV, Haidaris CG, Heffron F. Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent. Proc Natl Acad Sci U S A 1986; 83:5189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/33\">",
"      Groisman EA, Chiao E, Lipps CJ, Heffron F. Salmonella typhimurium phoP virulence gene is a transcriptional regulator. Proc Natl Acad Sci U S A 1989; 86:7077.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/34\">",
"      Miller SI, Kukral AM, Mekalanos JJ. A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence. Proc Natl Acad Sci U S A 1989; 86:5054.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/35\">",
"      Hohmann EL, Oletta CA, Killeen KP, Miller SI. phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers. J Infect Dis 1996; 173:1408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/36\">",
"      Ansong C, Yoon H, Norbeck AD, et al. Proteomics analysis of the causative agent of typhoid fever. J Proteome Res 2008; 7:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/37\">",
"      Span&ograve; S, Ugalde JE, Gal&aacute;n JE. Delivery of a Salmonella Typhi exotoxin from a host intracellular compartment. Cell Host Microbe 2008; 3:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/38\">",
"      Nardelli-Haefliger D, Kraehenbuhl JP, Curtiss R 3rd, et al. Oral and rectal immunization of adult female volunteers with a recombinant attenuated Salmonella typhi vaccine strain. Infect Immun 1996; 64:5219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/39\">",
"      Tacket, CO, Hone, DM, Curtiss, R III, et al. Comparison of the safety and immunogenicity of DaroCDaroD and DcyaDcrp S. typhi strains in human volunteers. Infect Immun 1992; 60:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/40\">",
"      Levine MM, Herrington D, Murphy JR, et al. Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans. J Clin Invest 1987; 79:888.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/41\">",
"      Acharya IL, Lowe CU, Thapa R, et al. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report. N Engl J Med 1987; 317:1101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/42\">",
"      Plotkin SA, Bouveret-Le Cam N. A new typhoid vaccine composed of the Vi capsular polysaccharide. Arch Intern Med 1995; 155:2293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/43\">",
"      Hone DM, Attridge SR, Forrest B, et al. A galE via (Vi antigen-negative) mutant of Salmonella typhi Ty2 retains virulence in humans. Infect Immun 1988; 56:1326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/44\">",
"      Baker S, Sarwar Y, Aziz H, et al. Detection of Vi-negative Salmonella enterica serovar typhi in the peripheral blood of patients with typhoid fever in the Faisalabad region of Pakistan. J Clin Microbiol 2005; 43:4418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/45\">",
"      Houston S. Salmonella typhi bacteremia and HIV infection with common iliac artery occlusion. Cent Afr J Med 1994; 40:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/46\">",
"      Hedriana HL, Mitchell JL, Williams SB. Salmonella typhi chorioamnionitis in a human immunodeficiency virus-infected pregnant woman. A case report. J Reprod Med 1995; 40:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/47\">",
"      Lai CW, Chan RC, Cheng AF, et al. Common bile duct stones: a cause of chronic salmonellosis. Am J Gastroenterol 1992; 87:1198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/48\">",
"      Hofmann E, Chianale J, Roll&aacute;n A, et al. Blood group antigen secretion and gallstone disease in the Salmonella typhi chronic carrier state. J Infect Dis 1993; 167:993.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/49\">",
"      Crawford RW, Rosales-Reyes R, Ram&iacute;rez-Aguilar Mde L, et al. Gallstones play a significant role in Salmonella spp. gallbladder colonization and carriage. Proc Natl Acad Sci U S A 2010; 107:4353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/50\">",
"      Crawford RW, Gibson DL, Kay WW, Gunn JS. Identification of a bile-induced exopolysaccharide required for Salmonella biofilm formation on gallstone surfaces. Infect Immun 2008; 76:5341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/51\">",
"      Crawford RW, Reeve KE, Gunn JS. Flagellated but not hyperfimbriated Salmonella enterica serovar Typhimurium attaches to and forms biofilms on cholesterol-coated surfaces. J Bacteriol 2010; 192:2981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/52\">",
"      Ristori C, Rodr&iacute;guez H, Vicent P, et al. Persistence of the Salmonella typhi-paratyphi carrier state after gallbladder removal. Bull Pan Am Health Organ 1982; 16:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/53\">",
"      MERSELIS JG Jr, KAYE D, CONNOLLY CS, HOOK EW. QUANTITATIVE BACTERIOLOGY OF THE TYPHOID CARRIER STATE. Am J Trop Med Hyg 1964; 13:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/54\">",
"      Taylor DN, Pollard RA, Blake PA. Typhoid in the United States and the risk to the international traveler. J Infect Dis 1983; 148:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/55\">",
"      H&oslash;j L, Binder V, Espersen F, et al. Secretion rates of immunoglobulins, albumin, haptoglobin and complement factors C3 and C4 in the perfused jejunum and ileum of human Salmonella carriers. Acta Pathol Microbiol Immunol Scand C 1984; 92:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/56\">",
"      Lanata CF, Levine MM, Ristori C, et al. Vi serology in detection of chronic Salmonella typhi carriers in an endemic area. Lancet 1983; 2:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/57\">",
"      Lin FY, Becke JM, Groves C, et al. Restaurant-associated outbreak of typhoid fever in Maryland: identification of carrier facilitated by measurement of serum Vi antibodies. J Clin Microbiol 1988; 26:1194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/58\">",
"      Dutta U, Garg PK, Kumar R, Tandon RK. Typhoid carriers among patients with gallstones are at increased risk for carcinoma of the gallbladder. Am J Gastroenterol 2000; 95:784.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/59\">",
"      Caygill CP, Braddick M, Hill MJ, et al. The association between typhoid carriage, typhoid infection and subsequent cancer at a number of sites. Eur J Cancer Prev 1995; 4:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21607/abstract/60\">",
"      Musher DM, Rubenstein AD. Permanent carriers of nontyphosa salmonellae. Arch Intern Med 1973; 132:869.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2703 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-201.77.166.39-6D34BE7A96-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_6_21607=[""].join("\n");
var outline_f21_6_21607=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H4750796\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4748978\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      The organisms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Infectious dose",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Gastrointestinal infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Systemic spread and persistence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Host immunity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Chronic carriage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4750796\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/8/26761?source=related_link\">",
"      Approach to the patient with nontyphoidal Salmonella in a stool culture",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/2/42024?source=related_link\">",
"      Epidemiology, microbiology, clinical manifestations, and diagnosis of typhoid fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/46/15082?source=related_link\">",
"      Gallbladder cancer: Epidemiology, risk factors, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/21/2394?source=related_link\">",
"      Immunizations for travel",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/37/19033?source=related_link\">",
"      Pathogenesis of Salmonella gastroenteritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?37/26/38305?source=related_link\">",
"      Patient information: Typhoid fever (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/58/18345?source=related_link\">",
"      Treatment and prevention of typhoid fever",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_6_21608="Postherpetic neuralgia";
var content_f21_6_21608=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Postherpetic neuralgia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/6/21608/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/6/21608/contributors\">",
"     Zahid H Bajwa, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/6/21608/contributors\">",
"     Carol A Warfield, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/6/21608/contributors\">",
"     Dana G Crovo, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/6/21608/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/6/21608/contributors\">",
"     Jeremy M Shefner, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/6/21608/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/6/21608/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/6/21608/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 20, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Varicella-zoster virus (VZV) is the causative agent of varicella, or \"chickenpox,\" and herpes zoster, or \"shingles.\" Most cases of acute herpes zoster are self-limited, although the pain can cause significant suffering, particularly in the elderly. Symptoms may be severe enough to interfere with sleep, appetite, or sexual function. In addition, a variable percentage of patients may continue to experience pain for months to years after the resolution of the rash (postherpetic neuralgia or PHN). PHN can be quite difficult to treat.",
"   </p>",
"   <p>",
"    PHN traditionally has been defined as the persistence of pain for more than one month after the disappearance of the rash. We prefer a different classification system [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute herpetic neuralgia refers to pain preceding or accompanying the eruption of rash that persists up to 30 days from its onset.",
"     </li>",
"     <li>",
"      Subacute herpetic neuralgia refers to pain that persists beyond healing of the rash but which resolves within four months of onset.",
"     </li>",
"     <li>",
"      PHN refers to pain persisting beyond four months from the initial onset of the rash.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The epidemiology, pathogenesis, clinical features, and treatment of PHN are reviewed here. Other aspects of the varicella-zoster virus and the acute therapy of herpes zoster infection are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/8/23688?source=see_link\">",
"     \"Epidemiology and pathogenesis of varicella-zoster virus infection: Herpes zoster\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/20/33096?source=see_link\">",
"     \"Treatment of herpes zoster in the immunocompetent host\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY/RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of acute herpes zoster infection increases with impairment of the immune system due to age, disease, or chemotherapy. The annual incidence among healthy people under the age of 20 years is approximately 1 per 1000; the incidence is 5 to 10 times greater for those older than 80 years [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/2\">",
"     2",
"    </a>",
"    ]. Herpes zoster also is several times more common in patients with cancer or HIV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/8/23688?source=see_link&amp;anchor=H2#H2\">",
"     \"Epidemiology and pathogenesis of varicella-zoster virus infection: Herpes zoster\", section on 'Epidemiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Similarly, the probability of developing PHN increases with advanced age. Most studies agree that PHN is rare in children. In adults younger than 60 years of age with herpes zoster, the risk of PHN is estimated to be less than 2 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The best incidence data in older patients come from the placebo arm of a large randomized trial that evaluated vaccination against the varicella-zoster virus (VZV) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/5\">",
"     5",
"    </a>",
"    ]. In 334 patients 60 to 69 years of age who developed herpes zoster, PHN occurred in 6.9 percent. In contrast, among 308 patients age 70 years or older who developed herpes zoster, PHN occurred in 18.5 percent.",
"   </p>",
"   <p>",
"    The major risk factors for PHN are older age, greater acute pain, and greater rash severity [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/6-9\">",
"     6-9",
"    </a>",
"    ]. In patients who develop PHN, advanced age is associated with increasing severity and persistence of symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/10\">",
"     10",
"    </a>",
"    ]. The risk of PHN is not increased in immunocompromised individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute herpes zoster is caused by reactivation of the VZV. The virus persists for a period of years in the dorsal root ganglia of cranial or spinal nerves after resolution of the original infection. As cellular immunity wanes with age or immunocompromise, the virus is transported along peripheral nerves, producing an acute neuritis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/12,13\">",
"     12,13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    At the cellular level, infection with acute herpes zoster is characterized by hemorrhagic inflammation of the peripheral nerve, dorsal root, and dorsal root ganglion. Extension centrally into the spinal cord and leptomeninges also has been described [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/14\">",
"     14",
"    </a>",
"    ]. Fibrosis is noted in the dorsal root ganglion, nerve root, and peripheral nerve upon resolution of the acute process [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/15,16\">",
"     15,16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Autopsy data for cases of well-established PHN are limited. One study reported five cases, three with severe PHN and two with no persistent pain [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/17\">",
"     17",
"    </a>",
"    ]. The findings included dorsal horn atrophy as well as cellular, axonal, and myelin loss with fibrosis in the sensory ganglion in patients with persistent pain. However, marked axonal and myelin loss in the nerve",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    sensory root were found in cases with and without pain.",
"   </p>",
"   <p>",
"    A search for responsible neurotransmitters in PHN has been difficult. Substance P is a peptide implicated in the transmission of pain signals, while serotonin and norepinephrine are neurotransmitters thought to play a role in the inhibition of pain signals. Studies of the affected dorsal horn from one patient with PHN failed to demonstrate differences in the levels of these neurotransmitters when compared with the unaffected side [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/18\">",
"     18",
"    </a>",
"    ]. The same investigators were unable to demonstrate a deficiency of opiate receptors in the affected dorsal horn.",
"   </p>",
"   <p>",
"    The pain of acute herpetic neuralgia probably is produced both by the inflammation associated with the movement of viral particles from sensory nerves to skin and subcutaneous tissues, and by the damage to nerve structures detailed above. In addition, activity of primary afferent neurons that respond to tissue damage causes changes in the dorsal horn neurons, sensitizing them to further input and resulting in spontaneous activity capable of maintaining pain in the absence of ongoing tissue damage [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/18-22\">",
"     18-22",
"    </a>",
"    ]. The persistence of this response may explain the continuing pain of PHN [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some have speculated that ongoing VZV viral replication might be responsible for PHN. However, a randomized, double-blind, placebo-controlled trial of intravenous and oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/7/31856?source=see_link\">",
"     acyclovir",
"    </a>",
"    for 56 days in 10 patients with severe PHN of at least six months duration failed to influence the course of PHN [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both acute zoster and PHN can be severe conditions associated with profound psychosocial dysfunction, including impaired sleep, decreased appetite, and diminished libido [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. Thoracic (especially T4 to T6), cervical and trigeminal nerves are most commonly affected [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/27\">",
"     27",
"    </a>",
"    ]. The pain associated with acute zoster infection can be sharp or stabbing sensation, constant or intermittent, while \"burning\" is the quality of pain often cited by patients with PHN [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/1,26\">",
"     1,26",
"    </a>",
"    ]. More than 90 percent of patients with PHN also will have allodynia, defined as pain evoked by normally nonpainful stimuli such as light touch [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with PHN often demonstrate areas of anesthesia, as well as deficits of thermal, tactile, pinprick, and vibration sensation within the affected dermatomes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/28\">",
"     28",
"    </a>",
"    ]. The contralateral, uninvolved side tests normally. Sensory deficits may extend beyond dermatomal margins. It has been suggested that allodynia is most prominent in areas of relatively preserved sensation, while spontaneous pain is felt predominately within the area of lost or impaired sensation.",
"   </p>",
"   <p>",
"    PHN most often represents a continuum of pain that never resolved following an acute episode of herpes zoster. However, PHN rarely has been reported to occur in patients months to years after resolution of the initial event [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/29\">",
"     29",
"    </a>",
"    ]. These episodes occurred in the same distribution as the initial rash and were precipitated by a specific event (eg, a surgical procedure, tooth abscess).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prevention of PHN involves either treatment of acute zoster or the use of a vaccine to decrease the incidence of acute zoster and PHN. These issues are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/20/33096?source=see_link\">",
"     \"Treatment of herpes zoster in the immunocompetent host\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/22/36200?source=see_link\">",
"     \"Prevention of varicella-zoster virus infection: Herpes zoster\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/28/32200?source=see_link\">",
"     \"Prevention and control of varicella in hospitals\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of modalities have been investigated for the treatment of PHN:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Tricyclic antidepressants",
"     </li>",
"     <li>",
"      Anticonvulsants, particularly",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/19/19768?source=see_link\">",
"       gabapentin",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?16/31/16887?source=see_link\">",
"       pregabalin",
"      </a>",
"     </li>",
"     <li>",
"      Opioids",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?13/44/14022?source=see_link\">",
"       Capsaicin",
"      </a>",
"     </li>",
"     <li>",
"      Topical",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"       lidocaine",
"      </a>",
"     </li>",
"     <li>",
"      Intrathecal glucocorticoids",
"     </li>",
"     <li>",
"      NMDA receptor antagonists",
"     </li>",
"     <li>",
"      Cryotherapy",
"     </li>",
"     <li>",
"      Surgery",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Mild analgesics such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    and other nonsteroidal antiinflammatory drugs are of limited value in patients with either acute herpetic neuralgia or PHN.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Tricyclic antidepressants",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tricyclic antidepressant (TCA) medications are effective for PHN [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/30\">",
"     30",
"    </a>",
"    ], and they are often thought of as the mainstay of therapy. These drugs inhibit the reuptake of norepinephrine and serotonin in the central nervous system. They are thought to increase the inhibition of nociceptive signals from the periphery [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/31,32\">",
"     31,32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The efficacy of TCAs was originally demonstrated in a small study of 24 patients with PHN [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/33\">",
"     33",
"    </a>",
"    ]. In a subsequent prospective, randomized, double-blind, crossover comparison, 58 elderly patients with PHN were randomly assigned to six weeks of therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/30/27112?source=see_link\">",
"     amitriptyline",
"    </a>",
"    (12.5 to 150 mg per day),",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/8/8329?source=see_link\">",
"     lorazepam",
"    </a>",
"    (0.5 to 6 mg per day, an \"active\" placebo), or an inactive placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/34\">",
"     34",
"    </a>",
"    ]. A mean amitriptyline dose of 65 mg per day was achieved. Amitriptyline was significantly more effective than lorazepam or inactive placebo in providing moderate relief of pain (47, 15, and 16 percent, respectively). Equal numbers of patients withdrew from each group due to side effects. There was a significant correlation between the degree of symptom relief and serum amitriptyline levels. The authors concluded that serum levels of amitriptyline and active metabolites must be maintained at concentrations of 100",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    for at least three weeks before a patient is considered to have failed TCA therapy.",
"   </p>",
"   <p>",
"    Anticholinergic side effects (principally sedation and dry mouth) limit patient acceptance of TCAs (",
"    <a class=\"graphic graphic_table graphicRef62488 \" href=\"UTD.htm?37/46/38639\">",
"     table 1",
"    </a>",
"    ). A head-to-head trial concluded that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/21/30040?source=see_link\">",
"     nortriptyline",
"    </a>",
"    was better tolerated than",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/30/27112?source=see_link\">",
"     amitriptyline",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/35\">",
"     35",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/14/39144?source=see_link\">",
"     Desipramine",
"    </a>",
"    has the fewest side effects of the first generation TCAs [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/36\">",
"     36",
"    </a>",
"    ], and it was also found to be effective in relieving PHN in one small study (mean dose 165 mg per day) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/37\">",
"     37",
"    </a>",
"    ]. There may be a lag of up to three weeks before TCAs begin to reduce pain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Anticonvulsants",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anticonvulsant medications are useful in the treatment of neuropathic pain, most notably in reducing the lancinating component of painful syndromes such as PHN. Drugs that have been evaluated in randomized trials include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/19/19768?source=see_link\">",
"     gabapentin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/38,39\">",
"     38,39",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/31/16887?source=see_link\">",
"     pregabalin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/40\">",
"     40",
"    </a>",
"    ], and valproic acid [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/41\">",
"     41",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Immediate release",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/19/19768?source=see_link\">",
"       gabapentin",
"      </a>",
"      is probably effective for PHN, but there are inconsistent data regarding the efficacy of the once-daily (extended release) formulation of gabapentin.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      A 2011 systematic review [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/38\">",
"       38",
"      </a>",
"      ] identified four placebo controlled randomized trials, with two trials evaluating immediate release",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/19/19768?source=see_link\">",
"       gabapentin",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/42,43\">",
"       42,43",
"      </a>",
"      ] and two trials evaluating extended release gabapentin [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/44,45\">",
"       44,45",
"      </a>",
"      ]. In the pooled analysis, gabapentin at doses between 1800 and 3600 mg daily was beneficial for PHN compared with placebo for the outcome of &ldquo;much or very much improved&rdquo; (38 versus 20 percent, risk ratio 1.9, 95% CI 1.5-2.3, number needed to treat 5.5) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/38\">",
"       38",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The extended release formulation of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/19/19768?source=see_link\">",
"       gabapentin",
"      </a>",
"      was not significantly more effective than placebo for PHN when given once daily (1800 mg daily) in two published trials included in the systematic review, which together included 723 patients [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/44,45\">",
"       44,45",
"      </a>",
"      ], but was more effective than placebo at an alternative twice daily dosing schedule (600 mg AM and 1200 mg PM) in one of these trials [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/44\">",
"       44",
"      </a>",
"      ]. In a third unpublished trial of 452 patients with PHN, the group assigned to extended release gabapentin (1800 mg) taken once daily had a statistically significant reduction in mean pain scores compared with placebo, leading to regulatory approval of the drug in the United States as once-daily treatment for PHN [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/46\">",
"       46",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?16/31/16887?source=see_link\">",
"       Pregabalin",
"      </a>",
"      is a structural analog of GABA and is similar to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/19/19768?source=see_link\">",
"       gabapentin",
"      </a>",
"      . Randomized studies in patients with PHN have shown improvement in sleep and decrease in pain at doses of 150 to 600 mg daily [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/47,48\">",
"       47,48",
"      </a>",
"      ]. Common side effects are dizziness, somnolence, dry mouth, peripheral edema, and weight gain. It is designated as a schedule V controlled substance in the United States because it has been reported to cause euphoria. The recommended starting dose is 150 mg, divided into two or three doses daily, and increased to a total daily dose of 300 mg. When stopping the drug it should be tapered over a week, as withdrawal symptoms may occur [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/49\">",
"       49",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In an eight-week study of 48 patients with PHN, treatment with divalproex sodium (1000 mg per day) led to significantly greater pain relief than placebo [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/41\">",
"       41",
"      </a>",
"      ]. More patients treated with divalproex sodium had at least moderate improvement in pain (58 versus 15 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Opioids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Opioid analgesics may be more effective. This was illustrated in a randomized, double-blind, crossover study that compared",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/53/19289?source=see_link\">",
"     clonidine",
"    </a>",
"    (0.2 mg),",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/38/15978?source=see_link\">",
"     ibuprofen",
"    </a>",
"    (800 mg),",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/0/35848?source=see_link\">",
"     codeine",
"    </a>",
"    (120 mg), and placebo in 40 patients with PHN (median duration of pain 17 months) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/50\">",
"     50",
"    </a>",
"    ]. Clonidine and codeine decreased pain relative to placebo, while ibuprofen was ineffective. Clonidine provided more pain relief than codeine, although the degree of relief with either agent was modest. It was suggested that the side effects associated with these drugs contributed to their associated analgesic effect by suggesting to patients that they had received a potent drug.",
"   </p>",
"   <p>",
"    Other studies have confirmed the efficacy of opioids in patients with PHN [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/51,52\">",
"     51,52",
"    </a>",
"    ]. In one comparative study involving 76 patients, treatment with the opioids",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/31/19962?source=see_link\">",
"     morphine",
"    </a>",
"    (mean daily dose 91 mg) or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/57/36761?source=see_link\">",
"     methadone",
"    </a>",
"    (mean daily dose 15 mg) or the tricyclic antidepressants",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/21/30040?source=see_link\">",
"     nortriptyline",
"    </a>",
"    (mean daily dose 89 mg) or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/14/39144?source=see_link\">",
"     desipramine",
"    </a>",
"    (mean daily dose 63 mg) for eight weeks was significantly more effective than placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/52\">",
"     52",
"    </a>",
"    ]. There was a trend toward greater pain relief with opioids, but this was not statistically significant. More patients preferred opioids than tricyclic antidepressants. The analgesic",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/50/42792?source=see_link\">",
"     tramadol",
"    </a>",
"    also appears to have some benefit in patients with PHN [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Capsaicin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Limited data suggest that topical application of standard concentration",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/44/14022?source=see_link\">",
"     capsaicin",
"    </a>",
"    is effective for PHN [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/39\">",
"     39",
"    </a>",
"    ]. In one study, capsaicin cream appeared to produce moderate relief when applied four times per day: there was a 21 percent reduction in the pain score in those receiving capsaicin, versus a 6 percent reduction in those receiving placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/54\">",
"     54",
"    </a>",
"    ]. Capsaicin and placebo vehicle caused skin reactions in a similar proportion of patients.",
"   </p>",
"   <p>",
"    However,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/44/14022?source=see_link\">",
"     capsaicin",
"    </a>",
"    can cause burning, stinging, and erythema, making it difficult to achieve true blinding in clinical studies. In practice, application of capsaicin is intolerable in up to one-third of patients.",
"   </p>",
"   <p>",
"    Another approach is the use of a single 60-minute application of a high-concentration",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/44/14022?source=see_link\">",
"     capsaicin",
"    </a>",
"    patch (8 percent), rather than the multiple daily applications needed for standard concentration capsaicin cream (0.025 to 0.075 percent). A 2013 systematic review identified four randomized controlled trials that evaluated 1272 subjects with PHN treated with one application of either high-concentration capsaicin patch or standard concentration capsaicin. The only common endpoint reported by all four trials, a &ge;30 percent pain intensity reduction at eight weeks compared with baseline, was significantly greater for high-concentration capsaicin patch (43 versus 34 percent, relative benefit 1.3, 95% CI 1.1 to 1.5) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/55\">",
"     55",
"    </a>",
"    ]. High-concentration capsaicin must be administered by a healthcare professional and patients are monitored for up to two hours after treatment. To manage local pain from capsaicin application, the skin is pretreated with a local anesthetic such as topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    , and some studies used posttreatment oral analgesics such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/34/10792?source=see_link\">",
"     oxycodone",
"    </a>",
"    for up to five days [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/56\">",
"     56",
"    </a>",
"    ]. Further study is needed to confirm long-term effectiveness and tolerance of the high-concentration capsaicin patch.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Topical lidocaine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data from a few small relatively low-quality placebo-controlled trials and open label studies suggest that topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    (5 percent) is beneficial for pain relief in patients with PHN [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/57\">",
"     57",
"    </a>",
"    ]. However, given the paucity of evidence and shortcomings of the included trials, no firm conclusions can be made regarding the efficacy of topical lidocaine for the treatment of PHN.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Intrathecal glucocorticoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients who have PHN affecting nerves other than the trigeminal nerve, intrathecal glucocorticoids may be a reasonable option, particularly if there has been no response to the above measures.",
"   </p>",
"   <p>",
"    This was illustrated in a study of 277 patients with intractable PHN for at least one year who were randomly assigned to one of three groups: treatment with intrathecal",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/25/31129?source=see_link\">",
"     methylprednisolone",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    once per week for four weeks; treatment with intrathecal lidocaine alone once per week for four weeks; or no treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/58\">",
"     58",
"    </a>",
"    ]. More than 90 percent of patients in the methylprednisolone group reported excellent or good pain relief at four weeks and at one and two years compared with 6 and 4 percent in the lidocaine and no treatment groups, respectively. In addition, the areas of allodynia were reduced by more than 70 percent in the methylprednisolone group and only 25 percent in the lidocaine group. There were no serious adverse events associated with the injection. Another study that compared intrathecal with epidural methylprednisolone found significantly greater improvements with intrathecal administration [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     NMDA receptor antagonists",
"    </span>",
"    &nbsp;&mdash;&nbsp;Animal data suggest a role for excitatory amino acid neurotransmitters in the maintenance of chronic pain due to nerve injury [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/60,61\">",
"     60,61",
"    </a>",
"    ]. Antagonists of the N-methyl-D-aspartate (NMDA) receptor relieve neuropathic pain in humans [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most widely available NMDA receptor antagonists are",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/45/10967?source=see_link\">",
"     ketamine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"     dextromethorphan",
"    </a>",
"    . Intravenous ketamine induces modest pain relief in patients with PHN, but at doses that cause sedation, dysphoria, and dissociative episodes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/63\">",
"     63",
"    </a>",
"    ]. In a randomized, double-blind, crossover trial that compared six weeks of treatment with dextromethorphan versus placebo, no significant relief was demonstrated [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Cryotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cryotherapy involves freezing peripheral nerves. A small, unblinded study of cryotherapy for facial pain was unable to show a significant benefit in patients with PHN [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/65\">",
"     65",
"    </a>",
"    ]. The authors did not provide inclusion criteria, concomitant therapies, or information on how the response was assessed. In contrast, a second trial reported \"considerable\" relief in 11 of 14 patients with cryotherapy to the intercostal nerves for PHN [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/66\">",
"     66",
"    </a>",
"    ]. In most cases, however, the duration of relief was less than two weeks as assessed by questionnaire.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical interventions including electrical stimulation of the thalamus, anterolateral cordotomy, and electrocoagulation of the dorsal root carry substantial risks of permanent neurologic deficits. No consistent benefit has been demonstrated in patients with PHN.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17588021\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;The effectiveness of therapies such as TENS and acupuncture has not been proven. Intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    may provide benefit in patients who do not respond to other therapies [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/67\">",
"     67",
"    </a>",
"    ]; however, small controlled trials have not convincingly demonstrated that this therapy is superior to placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?8/42/8867?source=see_link\">",
"       \"Patient information: Neuropathic pain (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?13/12/13507?source=see_link\">",
"       \"Patient information: Shingles (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systematic reviews of the literature have concluded that the treatments shown to be more effective than placebo for PHN include tricyclic antidepressants,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/19/19768?source=see_link\">",
"     gabapentin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/31/16887?source=see_link\">",
"     pregabalin",
"    </a>",
"    , opioids, topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/44/14022?source=see_link\">",
"     capsaicin",
"    </a>",
"    , and topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/39,68,69\">",
"     39,68,69",
"    </a>",
"    ]. The long-term benefits of most therapies are uncertain, and side effects are common. Intrathecal",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/25/31129?source=see_link\">",
"     methylprednisolone",
"    </a>",
"    may be of benefit for patients refractory to the above measures [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/40,68\">",
"     40,68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A 2004 practice parameter from the American Academy of Neurology similarly recommends tricyclic antidepressants,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/19/19768?source=see_link\">",
"     gabapentin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/31/16887?source=see_link\">",
"     pregabalin",
"    </a>",
"    , opioids, and topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    patches as first-line therapies for PHN [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21608/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Based upon the available data and our own experience, we typically use the following approach:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Opioids and tricyclic antidepressants appear to provide the most benefit. Tricyclic antidepressants are generally the drugs of first choice because of their similar efficacy and lack of dependency. However, opioids can be used if tricyclic antidepressants are unsuccessful. These drugs can also be administered simultaneously, since tricyclics may not be immediately effective. Frequently, the improvement in sleep associated with these medications results in a significant decrease in overall suffering. In addition, aggressive titration of doses often produces a discernible analgesic effect with the first week of therapy.",
"     </li>",
"     <li>",
"      Anticonvulsant therapy with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/19/19768?source=see_link\">",
"       gabapentin",
"      </a>",
"      is a reasonable alternative to treatment with tricyclic antidepressants, or it may be added to tricyclic or opioid therapy. Other anticonvulsants also appear to be effective.",
"     </li>",
"     <li>",
"      Topical",
"      <a class=\"drug drug_general\" href=\"UTD.htm?13/44/14022?source=see_link\">",
"       capsaicin",
"      </a>",
"      may also provide relief, although it is often poorly tolerated. Topical",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"       lidocaine",
"      </a>",
"      may provide short-term relief.",
"     </li>",
"     <li>",
"      Intrathecal glucocorticoid injection can be considered for patients who continue to have intractable pain despite the above measures. These injections do not work for trigeminal nerve-related pain.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/1\">",
"      Dworkin RH, Portenoy RK. Pain and its persistence in herpes zoster. Pain 1996; 67:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/2\">",
"      Glynn C, Crockford G, Gavaghan D, et al. Epidemiology of shingles. J R Soc Med 1990; 83:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/3\">",
"      Rusthoven JJ, Ahlgren P, Elhakim T, et al. Varicella-zoster infection in adult cancer patients. A population study. Arch Intern Med 1988; 148:1561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/4\">",
"      Helgason S, Petursson G, Gudmundsson S, Sigurdsson JA. Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up. BMJ 2000; 321:794.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/5\">",
"      Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352:2271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/6\">",
"      Dworkin RH, Boon RJ, Griffin DR, Phung D. Postherpetic neuralgia: impact of famciclovir, age, rash severity, and acute pain in herpes zoster patients. J Infect Dis 1998; 178 Suppl 1:S76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/7\">",
"      Nagasako EM, Johnson RW, Griffin DR, Dworkin RH. Rash severity in herpes zoster: correlates and relationship to postherpetic neuralgia. J Am Acad Dermatol 2002; 46:834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/8\">",
"      Whitley RJ, Weiss HL, Soong SJ, Gnann JW. Herpes zoster: risk categories for persistent pain. J Infect Dis 1999; 179:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/9\">",
"      Jung BF, Johnson RW, Griffin DR, Dworkin RH. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology 2004; 62:1545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/10\">",
"      Ragozzino MW, Melton LJ 3d, Kurland LT, et al. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) 1982; 61:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/11\">",
"      Balfour HH Jr. Varicella zoster virus infections in immunocompromised hosts. A review of the natural history and management. Am J Med 1988; 85:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/12\">",
"      Burke BL, Steele RW, Beard OW, et al. Immune responses to varicella-zoster in the aged. Arch Intern Med 1982; 142:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/13\">",
"      Meier JL, Straus SE. Comparative biology of latent varicella-zoster virus and herpes simplex virus infections. J Infect Dis 1992; 166 Suppl 1:S13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/14\">",
"      Denny-Brown D, Adams RD, Fitzgerald PJ. Pathologic features of herpes zoster: A note on 'geniculate herpes'. Arch Neurol Psychiatr 1944; 51:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/15\">",
"      Head H, Campbell AW. The pathology of herpes zoster and its bearing on sensory localization. Brain 1900; 23:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/16\">",
"      ZACKS SI, ELLIOTT FA, LANGFITT TW. HERPETIC NEURITIS: A LIGHT AND ELECTRON MICROSCOPIC STUDY. Neurology 1964; 14:744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/17\">",
"      Watson CP, Deck JH, Morshead C, et al. Post-herpetic neuralgia: further post-mortem studies of cases with and without pain. Pain 1991; 44:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/18\">",
"      Watson CP, Morshead C, Van der Kooy D, et al. Post-herpetic neuralgia: post-mortem analysis of a case. Pain 1988; 34:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/19\">",
"      Woolf CJ. Recent advances in the pathophysiology of acute pain. Br J Anaesth 1989; 63:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/20\">",
"      LaMotte RH, Shain CN, Simone DA, Tsai EF. Neurogenic hyperalgesia: psychophysical studies of underlying mechanisms. J Neurophysiol 1991; 66:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/21\">",
"      Simone DA, Baumann TK, LaMotte RH. Dose-dependent pain and mechanical hyperalgesia in humans after intradermal injection of capsaicin. Pain 1989; 38:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/22\">",
"      Cline MA, Ochoa J, Torebj&ouml;rk HE. Chronic hyperalgesia and skin warming caused by sensitized C nociceptors. Brain 1989; 112 ( Pt 3):621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/23\">",
"      Bennett GJ. Hypotheses on the pathogenesis of herpes zoster-associated pain. Ann Neurol 1994; 35 Suppl:S38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/24\">",
"      Acosta EP, Balfour HH Jr. Acyclovir for treatment of postherpetic neuralgia: efficacy and pharmacokinetics. Antimicrob Agents Chemother 2001; 45:2771.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/25\">",
"      Drolet M, Brisson M, Schmader KE, et al. The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study. CMAJ 2010; 182:1731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/26\">",
"      Johnson RW, Bouhassira D, Kassianos G, et al. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med 2010; 8:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/27\">",
"      Watson CP, Evans RJ, Watt VR, Birkett N. Post-herpetic neuralgia: 208 cases. Pain 1988; 35:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/28\">",
"      Bowsher D. Pathophysiology of postherpetic neuralgia: towards a rational treatment. Neurology 1995; 45:S56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/29\">",
"      Schott GD. Triggering of delayed-onset postherpetic neuralgia. Lancet 1998; 351:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/30\">",
"      Argoff CE. Review of current guidelines on the care of postherpetic neuralgia. Postgrad Med 2011; 123:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/31\">",
"      Dubner R, Bennett GJ. Spinal and trigeminal mechanisms of nociception. Annu Rev Neurosci 1983; 6:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/32\">",
"      Basbaum AI, Fields HL. Endogenous pain control mechanisms: review and hypothesis. Ann Neurol 1978; 4:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/33\">",
"      Watson CP, Evans RJ, Reed K, et al. Amitriptyline versus placebo in postherpetic neuralgia. Neurology 1982; 32:671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/34\">",
"      Max MB, Schafer SC, Culnane M, et al. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology 1988; 38:1427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/35\">",
"      Watson CP, Vernich L, Chipman M, Reed K. Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology 1998; 51:1166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/36\">",
"      DasGupta K. Treatment of depression in elderly patients: recent advances. Arch Fam Med 1998; 7:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/37\">",
"      Kishore-Kumar R, Max MB, Schafer SC, et al. Desipramine relieves postherpetic neuralgia. Clin Pharmacol Ther 1990; 47:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/38\">",
"      Moore RA, Wiffen PJ, Derry S, McQuay HJ. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 2011; :CD007938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/39\">",
"      Edelsberg JS, Lord C, Oster G. Systematic review and meta-analysis of efficacy, safety, and tolerability data from randomized controlled trials of drugs used to treat postherpetic neuralgia. Ann Pharmacother 2011; 45:1483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/40\">",
"      Dubinsky RM, Kabbani H, El-Chami Z, et al. Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004; 63:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/41\">",
"      Kochar DK, Garg P, Bumb RA, et al. Divalproex sodium in the management of post-herpetic neuralgia: a randomized double-blind placebo-controlled study. QJM 2005; 98:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/42\">",
"      Rowbotham M, Harden N, Stacey B, et al. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 1998; 280:1837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/43\">",
"      Rice AS, Maton S, Postherpetic Neuralgia Study Group. Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain 2001; 94:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/44\">",
"      Irving G, Jensen M, Cramer M, et al. Efficacy and tolerability of gastric-retentive gabapentin for the treatment of postherpetic neuralgia: results of a double-blind, randomized, placebo-controlled clinical trial. Clin J Pain 2009; 25:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/45\">",
"      Wallace MS, Irving G, Cowles VE. Gabapentin extended-release tablets for the treatment of patients with postherpetic neuralgia: a randomized, double-blind, placebo-controlled, multicentre study. Clin Drug Investig 2010; 30:765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/46\">",
"      Medical Letter. Once-daily gabapentin (Gralise) for postherpetic neuralgia. Med Lett Drugs Ther 2011; 53:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/47\">",
"      Dworkin RH, Corbin AE, Young JP Jr, et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2003; 60:1274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/48\">",
"      Sabatowski R, G&aacute;lvez R, Cherry DA, et al. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain 2004; 109:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/49\">",
"      Pregabalin (lyrica) for neuropathic pain and epilepsy. Med Lett Drugs Ther 2005; 47:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/50\">",
"      Max MB, Schafer SC, Culnane M, et al. Association of pain relief with drug side effects in postherpetic neuralgia: a single-dose study of clonidine, codeine, ibuprofen, and placebo. Clin Pharmacol Ther 1988; 43:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/51\">",
"      Rowbotham MC, Reisner-Keller LA, Fields HL. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 1991; 41:1024.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/52\">",
"      Raja SN, Haythornthwaite JA, Pappagallo M, et al. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2002; 59:1015.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/53\">",
"      Boureau F, Legallicier P, Kabir-Ahmadi M. Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial. Pain 2003; 104:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/54\">",
"      Watson CP, Evans RJ, Watt VR. Post-herpetic neuralgia and topical capsaicin. Pain 1988; 33:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/55\">",
"      Derry S, Sven-Rice A, Cole P, et al. Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev 2013; 2:CD007393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/56\">",
"      Backonja M, Wallace MS, Blonsky ER, et al. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study. Lancet Neurol 2008; 7:1106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/57\">",
"      Wolff RF, Bala MM, Westwood M, et al. 5% lidocaine-medicated plaster vs other relevant interventions and placebo for post-herpetic neuralgia (PHN): a systematic review. Acta Neurol Scand 2011; 123:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/58\">",
"      Kotani N, Kushikata T, Hashimoto H, et al. Intrathecal methylprednisolone for intractable postherpetic neuralgia. N Engl J Med 2000; 343:1514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/59\">",
"      Kikuchi A, Kotani N, Sato T, et al. Comparative therapeutic evaluation of intrathecal versus epidural methylprednisolone for long-term analgesia in patients with intractable postherpetic neuralgia. Reg Anesth Pain Med 1999; 24:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/60\">",
"      Wu LJ, Zhuo M. Targeting the NMDA receptor subunit NR2B for the treatment of neuropathic pain. Neurotherapeutics 2009; 6:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/61\">",
"      Chizh BA, Headley PM. NMDA antagonists and neuropathic pain--multiple drug targets and multiple uses. Curr Pharm Des 2005; 11:2977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/62\">",
"      Kristensen JD, Svensson B, Gordh T Jr. The NMDA-receptor antagonist CPP abolishes neurogenic 'wind-up pain' after intrathecal administration in humans. Pain 1992; 51:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/63\">",
"      Eide PK, J&oslash;rum E, Stubhaug A, et al. Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo. Pain 1994; 58:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/64\">",
"      Nelson KA, Park KM, Robinovitz E, et al. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology 1997; 48:1212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/65\">",
"      Barnard D, Lloyd J, Evans J. Cryoanalgesia in the management of chronic facial pain. J Maxillofac Surg 1981; 9:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/66\">",
"      Jones MJ, Murrin KR. Intercostal block with cryotherapy. Ann R Coll Surg Engl 1987; 69:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/67\">",
"      Baranowski AP, De Courcey J, Bonello E. A trial of intravenous lidocaine on the pain and allodynia of postherpetic neuralgia. J Pain Symptom Manage 1999; 17:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/68\">",
"      Hempenstall K, Nurmikko TJ, Johnson RW, et al. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med 2005; 2:e164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21608/abstract/69\">",
"      Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010; 17:1113.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5289 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-61.234.146.186-481C146FAB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_6_21608=[""].join("\n");
var outline_f21_6_21608=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY/RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Tricyclic antidepressants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Anticonvulsants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Opioids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Capsaicin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Topical lidocaine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Intrathecal glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      NMDA receptor antagonists",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Cryotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17588021\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/5289\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/5289|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?37/46/38639\" title=\"table 1\">",
"      Side effects antidepressants",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/8/23688?source=related_link\">",
"      Epidemiology and pathogenesis of varicella-zoster virus infection: Herpes zoster",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?8/42/8867?source=related_link\">",
"      Patient information: Neuropathic pain (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?13/12/13507?source=related_link\">",
"      Patient information: Shingles (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/28/32200?source=related_link\">",
"      Prevention and control of varicella in hospitals",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/22/36200?source=related_link\">",
"      Prevention of varicella-zoster virus infection: Herpes zoster",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/20/33096?source=related_link\">",
"      Treatment of herpes zoster in the immunocompetent host",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_6_21609="NSIP lung biopsy";
var content_f21_6_21609=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F68775&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F68775&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Nonspecific interstitial pneumonitis (NSIP)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 392px; height: 518px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Representative fields of a lung biopsy specimen from a child with NSIP. A low-power view of the lung biopsy specimen (top) demonstrates a mixed pattern of inflammation and fibrosis, with moderately dilated and tortuous air spaces. The high-power view (bottom) demonstrates a mixed inflammatory infiltrate of lymphocytes, histiocytes, and plasma cells, as well as regions of brightly eosinophilic material within the alveolar septae. Patchy intraalveolar macrophages are visible within the air spaces. The alveolar walls are variably thickened by collagen bundles, fibroblasts, and epithelial hyperplasia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Cynthia Epstein, MD and Leland L Fan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_6_21609=[""].join("\n");
var outline_f21_6_21609=null;
var title_f21_6_21610="Epidemiology of human papillomavirus infections";
var content_f21_6_21610=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Epidemiology of human papillomavirus infections",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/6/21610/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/6/21610/contributors\">",
"     Joel M Palefsky, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/6/21610/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/6/21610/contributors\">",
"     Martin S Hirsch, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/6/21610/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/6/21610/contributors\">",
"     Allyson Bloom, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/6/21610/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 12, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Papillomaviruses are double-stranded DNA viruses that constitute the Papillomavirus genus of the Papillomaviridae family. These viruses are highly species specific; human papillomaviruses (HPV) infect only humans. There are more than 100 types of HPV, which can be subdivided into cutaneous or mucosal categories based upon their tissue tropism.",
"   </p>",
"   <p>",
"    The epidemiology and disease associations of HPV infections will be reviewed here. The clinical manifestations, diagnosis, treatment, and prevention of these infections and their association with malignancy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/53/26455?source=see_link\">",
"     \"Virology of human papillomavirus infections and the link to cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/17/19738?source=see_link\">",
"     \"Recommendations for the use of human papillomavirus vaccines\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H747443\">",
"    <span class=\"h1\">",
"     TISSUE TROPISM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Different human papillomavirus (HPV) types have a propensity to infect different body sites (",
"    <a class=\"graphic graphic_table graphicRef76908 \" href=\"UTD.htm?29/33/30236\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H747465\">",
"    <span class=\"h2\">",
"     Cutaneous",
"    </span>",
"    &nbsp;&mdash;&nbsp;Certain HPV types have a predilection for cutaneous epithelium and are found in plantar warts, common warts, flat warts, and butcher's warts [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/1\">",
"     1",
"    </a>",
"    ]. HPV types associated with plantar and common warts include type 1 and types 2 and 4, respectively. Flat warts are most often caused by HPV types 3 and 10, while butcher's warts (common warts that tend to occur in meat, poultry, and fish handlers) are most often associated with HPV types 7 and 2 [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Bowen's disease, a form of high-grade intraepithelial neoplasia, has both genital and extragenital forms [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/3\">",
"     3",
"    </a>",
"    ]. It can occur on the fingers, toes, palms, feet, and on the genital mucosa. Multiple HPV types have been isolated from these lesions; including HPV types 16, 18, 31, 32, 34, and others [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/1,3,4\">",
"     1,3,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Epidermodysplasia verruciformis is a rare, probably autosomal recessive condition, characterized by the appearance of HPV-induced wart-like lesions early in childhood, with malignant transformation in approximately half of patients during adulthood, often in skin surfaces with sun exposure. Multiple HPV types have been isolated from these lesions, but HPV types 5 and 8 appear to have the most malignant potential in these individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H747487\">",
"    <span class=\"h2\">",
"     Anogenital epithelium",
"    </span>",
"    &nbsp;&mdash;&nbsp;HPV types with a predilection for anogenital keratinized skin and mucous membrane infection also exist. Common sites for infection include: the penis, scrotum, perineum, anal canal, perianal region, vaginal introitus, vulva, and cervix. The major manifestations of anogenital HPV include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Genital warts (condyloma acuminatum) &ndash; Condylomata acuminata (also known as genital or venereal warts) are benign anogenital warts, caused most often by HPV types 6 and 11 [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/6,7\">",
"       6,7",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/38/23144?source=see_link\">",
"       \"Condylomata acuminata (anogenital warts)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Squamous intraepithelial lesions",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      carcinoma of the vagina, vulva, cervix, anus or penis &ndash; HPV infection has been clearly linked to all or nearly all squamous intraepithelial lesions and cancers of the cervix and anus. HPV is also linked to a subset of penile, vulvar, and vaginal cancers. Of the 14 most common oncogenic HPV types associated with these cancers, HPV 16 is the most common and associated with the highest risk of progression to cancer [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/2,4,6,8-10\">",
"       2,4,6,8-10",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The presence of a cervical transformation zone is not necessary for oncogenic HPV to infect the female genital tract. As a result, the prevalence of oncogenic HPV subtypes in the vagina is similar in women who have and have not undergone hysterectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/11\">",
"     11",
"    </a>",
"    ]. Similarly, HPV may infect not only the anal canal in the anal transformation zone, but also more distal sites, including the keratinized skin of the anal verge and perianal region [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/53/26455?source=see_link\">",
"     \"Virology of human papillomavirus infections and the link to cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/21/31065?source=see_link\">",
"     \"Cervical intraepithelial neoplasia: Definition, incidence, and pathogenesis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/33/1562?source=see_link\">",
"     \"Anal intraepithelial neoplasia: Diagnosis, screening, prevention, and treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/27/5560?source=see_link\">",
"     \"Vaginal intraepithelial neoplasia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/11/32952?source=see_link\">",
"     \"Vulvar intraepithelial neoplasia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/13/26840?source=see_link\">",
"     \"Carcinoma of the penis: Epidemiology, risk factors, staging, and prognosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H52654401\">",
"    <span class=\"h2\">",
"     Other mucosal surfaces",
"    </span>",
"    &nbsp;&mdash;&nbsp;An increasing body of evidence suggests a relationship between HPV infection, particularly with HPV type 16, and squamous cell carcinoma of the oral cavity, especially in those less than 50 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. Infection of the respiratory mucosa with HPV types 6 and 11 also occurs, particularly but not exclusively in young children and infants [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H746850\">",
"    <span class=\"h1\">",
"     DISEASE ASSOCIATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H746873\">",
"    <span class=\"h2\">",
"     Nongenital warts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cutaneous human papillomavirus (HPV) infections are widespread throughout the general population. Warts occur in 10 percent of children, with a peak incidence between the ages of 12 and 16 [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/16\">",
"     16",
"    </a>",
"    ]. Nongenital warts are not confined solely to the pediatric population; as many as 3.5 percent of adults have nongenital warts at any given time [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/6\">",
"     6",
"    </a>",
"    ]. Common warts represent up to 71 percent of all cutaneous warts followed in frequency by plantar warts and flat warts (34 and 4 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/2\">",
"     2",
"    </a>",
"    ]. Cutaneous warts can present in patients in ages ranging from 2 to 80 years. Only 16 percent of patients are over the age of 35, but in one report accounted for 11 referrals per 1000 patients annually [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H746880\">",
"    <span class=\"h2\">",
"     Genital warts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Population-based studies in sexually active individuals suggest that the burden of genital warts is high, with a prevalence ranging from 1 percent in the United States to approximately 10 percent in Scandinavian countries [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/16,18-20\">",
"     16,18-20",
"    </a>",
"    ]. The peak prevalence occurs in persons between the ages of 17 and 33 years of age, and the peak incidence is in those from ages 20 to 24 years.",
"   </p>",
"   <p>",
"    The incidence of HPV infection was evaluated in 8702 women who were enrolled in the placebo arms of two randomized trials of HPV quadrivalent vaccine [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/21\">",
"     21",
"    </a>",
"    ]. Approximately 3 percent developed genital warts over four years. In a multinational cohort of 2487 healthy men, 4.5 percent developed genital warts over a median of 18 months [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/22\">",
"     22",
"    </a>",
"    ]. Risk factors for genital warts in women and men included baseline and incident infection with HPV types 6 and 11, acquisition of new sexual partners, and a higher number of sexual partners.",
"   </p>",
"   <p>",
"    Men and women with anogenital warts frequently experience psychological distress and disruption of sexual relationships [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/38/23144?source=see_link\">",
"     \"Condylomata acuminata (anogenital warts)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H746887\">",
"    <span class=\"h2\">",
"     Cervical cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;Worldwide, an estimated 500,000 cases of invasive cervical carcinoma are diagnosed annually [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/25\">",
"     25",
"    </a>",
"    ]. Cervical carcinoma was the most frequent malignancy among women in developing countries until it was surpassed by breast cancer in the early 1990s [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/53/26455?source=see_link\">",
"     \"Virology of human papillomavirus infections and the link to cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/21/31065?source=see_link\">",
"     \"Cervical intraepithelial neoplasia: Definition, incidence, and pathogenesis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/55/28537?source=see_link\">",
"     \"Invasive cervical cancer: Epidemiology, risk factors, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Evidence linking HPV to cervical carcinoma is extensive [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/2,4,8,26\">",
"     2,4,8,26",
"    </a>",
"    ], with HPV 16 accounting for approximately 50 percent of cases and HPV 18 for 20 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/27\">",
"     27",
"    </a>",
"    ]. The epidemiology of high-risk types can be illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A study of paraffin-embedded samples representing 10,575 cases of invasive cervical cancer from 38 countries spanning five continents demonstrated that the most common HPV types were 16, 18, 31, 33, 35, 45, 52 and 58; HPV types 16 and 18 represented 71 percent of the cases overall.",
"     </li>",
"     <li>",
"      A pooled analysis of 11 case-control studies from nine countries involving 1918 women with histologically confirmed squamous-cell cervical cancer and 1928 controls was performed to better determine the risk associated with various HPV genotypes [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/28\">",
"       28",
"      </a>",
"      ]. HPV DNA was found in 90 percent of the women with cervical cancer and 13 percent of controls. Fifteen HPV types were classified as high risk (HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, and 82).",
"     </li>",
"     <li>",
"      The prevalence of antibodies against HPV 16, the most commonly identified high-risk type, was evaluated in almost 1600 men and women attending sexually transmitted diseases clinics in the United States [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/29\">",
"       29",
"      </a>",
"      ]. The seroprevalence of HPV 16 was 19 percent in men and 30 percent in women.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The high frequency of infection with high-risk types illustrates the potential significance of vaccination efforts against HPV. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/39/26229?source=see_link\">",
"     \"The life cycle, natural history, and immunology of human papillomaviruses\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A detailed discussion of other risk factors for cervical cancer is found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/55/28537?source=see_link&amp;anchor=H3#H3\">",
"     \"Invasive cervical cancer: Epidemiology, risk factors, clinical manifestations, and diagnosis\", section on 'Epidemiology and risk factors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3189670\">",
"    <span class=\"h2\">",
"     Anal cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although a relatively uncommon cancer, the incidence of anal cancer in the United States has increased substantially in the last three decades. Most of these cases are attributable to HPV infection, with similar high-risk types as found in cervical cancer, particularly 16 and 18 (see above). The epidemiological link of HPV infection to anal cancer is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/29/12761?source=see_link&amp;anchor=H10#H10\">",
"     \"Classification and epidemiology of anal cancer\", section on 'Human papillomavirus infection'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H52654214\">",
"    <span class=\"h2\">",
"     Cancer of the external genitalia",
"    </span>",
"    &nbsp;&mdash;&nbsp;HPV is also linked to penile, vulvar, and vaginal cancers. Unlike cervical and anal cancer, however, not all cancers of the external genitalia are associated with HPV infection. In contrast to HPV-negative cancers, which are often associated with chronic inflammation or lichen sclerosis, HPV-associated penile and vulvar cancers occur at a younger age, exhibit basaloid instead of keratinizing pathology, do not have p53 mutations, and are associated with sexual risk factors [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/30,31\">",
"     30,31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The epidemiological link of HPV infection to these cancers is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/13/26840?source=see_link&amp;anchor=H282027115#H282027115\">",
"     \"Carcinoma of the penis: Epidemiology, risk factors, staging, and prognosis\", section on 'Human papillomavirus infection'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/5/9303?source=see_link&amp;anchor=H2#H2\">",
"     \"Vulvar cancer: Clinical manifestations, diagnosis, and pathology\", section on 'Epidemiology and risk factors'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/30/31208?source=see_link&amp;anchor=H2#H2\">",
"     \"Vaginal cancer\", section on 'Incidence and risk factors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H746909\">",
"    <span class=\"h2\">",
"     Oropharyngeal cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;HPV infection may also play a role in the pathogenesis of squamous cell carcinomas of the head and neck. Like penile and vulvar cancer, oropharyngeal cancers consist of two broad categories of disease: HPV-associated and non-HPV-associated. HPV-associated oral cancers are primarily found in the oropharynx and base of the tongue and tonsil [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/32-34\">",
"     32-34",
"    </a>",
"    ]. HPV has also been linked to cancer of the larynx [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    HPV-related oropharyngeal cancers occur in a younger population than the non-HPV-associated cancers and are primarily associated with sexual risk factors [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. In contrast, the non-HPV-associated cancers are associated primarily with alcohol and tobacco use and often have p53 mutations. In the United States, the incidence of HPV-associated cancers has been rising and the incidence of non-HPV-associated cancers has been declining, such that the incidence of the former now exceeds that of the latter [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The prevalence of oral HPV infection was evaluated in a cross-sectional study of 5579 women and men who provided an oral sample for HPV DNA sampling [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/34\">",
"     34",
"    </a>",
"    ]. The overall prevalence of any HPV DNA was 6.9 percent, and the prevalence of HPV type 16 was 1 percent. HPV prevalence was approximately threefold more common in men compared with women (10.1 versus 3.6 percent), consistent with the observed sex distribution for HPV-associated oropharyngeal cancer.",
"   </p>",
"   <p>",
"    In an age and gender-matched case-control study of 130 patients with newly diagnosed squamous cell carcinoma of the head and neck, oropharyngeal malignancy was associated with high-risk sexual behaviors, oral HPV infection, and HPV 16 seropositivity [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/32\">",
"     32",
"    </a>",
"    ]. Oral HPV prevalence has been associated with a greater number of sexual (including oral sex) and open-mouthed kissing partners in both men and women [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/34,38\">",
"     34,38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The efficacy of HPV vaccine in preventing oral HPV 16 infection has not been studied. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/55/887?source=see_link\">",
"     \"Human papillomavirus associated head and neck cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15115461\">",
"    <span class=\"h2\">",
"     Recurrent respiratory papillomatosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recurrent respiratory papillomatosis (RRP) is the most common benign laryngeal tumor in children and is thought to be caused by HPV acquired during passage through the birth canal of an infected mother [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/39\">",
"     39",
"    </a>",
"    ]. HPV 6 and 11 are the types most commonly involved. The incidence is uncertain but has been estimated at 4.5 per 100,000 children and 1.8 per 100,000 adults in the United States. Although benign, substantial morbidity arises from obstruction of the larynx by the warts, and many affected children require multiple ablative procedures [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/39,40\">",
"     39,40",
"    </a>",
"    ]. In addition, the papillomatous lesions can rarely grow aggressively, spread into the lungs, and undergo malignant transformation.",
"   </p>",
"   <p>",
"    This condition is discussed in further detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/29/44505?source=see_link&amp;anchor=H36#H36\">",
"     \"Etiology and management of hoarseness in children\", section on 'Papillomatosis (HPV)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25826411\">",
"    <span class=\"h1\">",
"     RISK FACTORS FOR TRANSMISSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Human papillomavirus (HPV) is spread from skin surface to skin surface. Close personal contact is assumed to be of importance for the transmission of cutaneous warts [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/2\">",
"     2",
"    </a>",
"    ], while anogenital warts and HPV infection of the cervix are primarily transmitted by genital-genital, oral-genital, anal-genital, or oral-anal contact [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/2,26\">",
"     2,26",
"    </a>",
"    ]. However, HPV types typically isolated from common warts (types 1 and 2) have been isolated from anogenital warts in children, and infection of the respiratory tract mucosa (recurrent respiratory papillomatosis) is thought to occur during passage of the fetus through an infected birth canal. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/29/44505?source=see_link&amp;anchor=H36#H36\">",
"     \"Etiology and management of hoarseness in children\", section on 'Papillomatosis (HPV)'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The most consistent predictor of genital HPV infection has been sexual activity [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/41,42\">",
"     41,42",
"    </a>",
"    ]. Most studies have been performed in young women in whom the following findings have been noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The risk of HPV infection in women is directly related to the number of male sex partners [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/18,41,43-48\">",
"       18,41,43-48",
"      </a>",
"      ] and to the male partners' number of female sex partners [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/41\">",
"       41",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      As with other sexually transmitted infections, sex with a new partner is a stronger risk factor than sex with a steady partner [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/44,47\">",
"       44,47",
"      </a>",
"      ]. In a prospective cohort study of young women in San Francisco, for example, the relative hazard was 10.1 per new partner per month [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/47\">",
"       47",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Among heterosexual couples, type-specific concordance (ie, both partners infected with the same HPV type) is common, almost 25 percent in one series [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/49\">",
"       49",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Both vaginal and anal intercourse are major risk factors for HPV infection [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/41\">",
"       41",
"      </a>",
"      ]. Although penetrating vaginal intercourse is not required for transmission [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/44\">",
"       44",
"      </a>",
"      ], the prevalence of HPV infection is much lower among virgins (4 versus 22 percent in sexually active women in a report from Sweden) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/46\">",
"       46",
"      </a>",
"      ]. Anal intercourse is likely an efficient means of spread of HPV to the anal canal but it is similarly not required for transmission; other types of contact may also play a role in transmission, such as spread through fingers or toys, or from other genital organs infected with HPV [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/44,50,51\">",
"       44,50,51",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Male to female transmission is usually asymptomatic since most men are not aware that they are carriers of HPV [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/18\">",
"       18",
"      </a>",
"      ]. Likewise, most female to male transmission is asymptomatic [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/52\">",
"       52",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY IN FEMALES",
"    </span>",
"    &nbsp;&mdash;&nbsp;A meta-analysis in 157,879 women with normal cervical cytology demonstrated that the worldwide point-prevalence of human papillomavirus (HPV) is approximately 10 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/53\">",
"     53",
"    </a>",
"    ]. The highest regional prevalence was found to be in Africa, where 22 percent of women had evidence of HPV infection. The most common types worldwide were HPV 16 and 18, both of which are preventable by vaccination. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/39/26229?source=see_link\">",
"     \"The life cycle, natural history, and immunology of human papillomaviruses\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The prevalence of cervical HPV infection decreases sharply in women after the age of 30 [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/54\">",
"     54",
"    </a>",
"    ]. Those with persistent infection are at the highest risk for the development of high-grade squamous intraepithelial lesions or invasive cervical cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/54\">",
"     54",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H746887\">",
"     'Cervical cancer'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     United States",
"    </span>",
"    &nbsp;&mdash;&nbsp;The estimated prevalence of anogenital tract HPV infections in the United States is 20 million, with an annual incidence of 5.5 million. It has been estimated that 75 to 80 percent of sexually active adults will acquire a genital tract HPV infection before the age of 50 [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/55\">",
"     55",
"    </a>",
"    ]. Two longitudinal studies have also demonstrated that acquisition of cervical HPV infection also predicted acquisition of an anal HPV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/56,57\">",
"     56,57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Genital HPV infection is common in young sexually active women in the United States, as illustrated by the following observations among different age groups [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/41,43,44,58-60\">",
"     41,43,44,58-60",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The National Health and Nutrition Examination Survey (NHANES) assessed the prevalence of HPV infection in the United States by collecting vaginal swabs for HPV DNA in 1921 women [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/58\">",
"       58",
"      </a>",
"      ]. The overall prevalence was 27 percent and was highest among females aged 20 to 24 years (45 percent). The prevalence of the specific types contained within the quadrivalent HPV vaccine (ie, types 6, 11, 16, and 18) was 17, 7, 16, and 7 percent, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/61\">",
"       61",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/39/26229?source=see_link\">",
"       \"The life cycle, natural history, and immunology of human papillomaviruses\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In a series of 312 urban adolescent girls (mean age 16) with a median of two years of sexual activity and four lifetime sex partners, cervical HPV was detected in 64 percent using polymerase chain reaction (PCR)-based testing [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/43\">",
"       43",
"      </a>",
"      ]. Another study demonstrated that the one-year cumulative incidence of initial HPV infection in 244 female college students was 29 percent after their first male sexual partner [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/59\">",
"       59",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A prospective study evaluated 608 female college students at six-month intervals for three years; the evaluation included cervicovaginal lavage that was tested for HPV DNA [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/41\">",
"       41",
"      </a>",
"      ]. At entry, 26 percent were HPV-positive. Among those who were HPV-negative, 43 percent acquired HPV during the three-year follow-up. A similar rate of new disease acquisition (32 percent in two years) was noted in another report of 603 female university students [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/44\">",
"       44",
"      </a>",
"      ]. Long-term follow-up of a subset of these patients with HPV infection at baseline (n = 156) demonstrated persistence of the same HPV type in 4.8 percent (over an average of four years) in association with pathologic changes [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/62\">",
"       62",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a review of over 3800 women 18 to 40 years of age, the overall HPV prevalence was 39 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/45\">",
"       45",
"      </a>",
"      ]. Detection of high-risk and low-risk HPV genotypes declined with increasing age.",
"     </li>",
"     <li>",
"      In a seroepidemiologic study of injection and noninjection drug users (median age 24 years), HPV 16 seroprevalence was 38 percent and HPV 18 seroprevalence was 42 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/63\">",
"       63",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The above data reflect the overall prevalence of HPV infection. However, many sexually active young women have sequential infections with different oncogenic types of HPV. These infections are usually detected transiently, although they frequently produce reversible cytologic changes.",
"   </p>",
"   <p>",
"    There may be racial differences in the type and turnover of HPV infection in women [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/64,65\">",
"     64,65",
"    </a>",
"    ]. These differences are illustrated by the findings of a longitudinal study of 467 college-age women in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/64\">",
"     64",
"    </a>",
"    ]. The overall incidence of HPV infection was similar between black and white women, but black women had a slightly higher incidence of infection with high-risk HPV types. Two years after the incident high-risk HPV infection, more black women had persistent infection (56 versus 24 percent of white women). These findings might contribute to the higher incidence of cervical cancer in black women in the United States. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/55/28537?source=see_link&amp;anchor=H7674594#H7674594\">",
"     \"Invasive cervical cancer: Epidemiology, risk factors, clinical manifestations, and diagnosis\", section on 'Incidence and mortality'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Among older women, the prevalence of HPV detection may be related more to reactivation of infection acquired previously than to new, recent infections. In a cohort of over 800 women aged 35 to 60 years, the attributable risk for high-risk HPV detection associated with a history of more than five lifetime sexual partners was greater than that associated with a new sexual partner among women older than 50 years (87 versus 8 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/66\">",
"     66",
"    </a>",
"    ]. In contrast, among women 35 to 49 years, the attributable risks associated with lifetime and recent sexual partners were the same (28 percent). That this reflects reactivation of infection in older women is only one interpretation of the data, but raises important questions about the cause and importance of reactivation HPV [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/67,68\">",
"     67,68",
"    </a>",
"    ]. Reactivation has also been proposed as a major source of newly detected HPV infection among HIV-infected women. In a prospective study of 1848 HIV-infected women (the Women&rsquo;s Interagency HIV Study), more than half of the women with newly detected cervical HPV infection had reported no new sexual partners since the prior visit [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/69\">",
"     69",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Studies of anal HPV infection in women suggest that it is far more common than originally thought [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/70,71\">",
"     70,71",
"    </a>",
"    ]. In studies of high-risk women, including infected women and women with a history of commercial sex work or injection drug use, anal HPV infection is more common than cervical HPV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/72\">",
"     72",
"    </a>",
"    ]. In studies of lower-risk women, the prevalence and incidence of anal HPV infection is similar to that of cervical HPV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/56,71\">",
"     56,71",
"    </a>",
"    ]. Women with a history of vulvar or cervical high-grade squamous intraepithelial lesions or cancer are also at increased risk of anal HPV infection and HPV-related disease. In one study of women with cervical or vulvar high-grade squamous intraepithelial lesions, 12 percent had an anal squamous intraepithelial lesion and 9 percent had an anal high-grade squamous intraepithelial lesion [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/73\">",
"     73",
"    </a>",
"    ]. In these studies anal intercourse was not a consistent risk factor for either anal HPV infection or anal squamous intraepithelial lesions.",
"   </p>",
"   <p>",
"    Despite the frequency of anal HPV infections in women, they are often detected only transiently. In one study of 431 sexually active women, half of whom had incident anal HPV infections, more than 58 percent became HPV DNA test-negative over a 15-month period of follow-up [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/70\">",
"     70",
"    </a>",
"    ]. This observation may help explain why the incidence of anal cancer is much lower than that of cervical cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Worldwide",
"    </span>",
"    &nbsp;&mdash;&nbsp;There appears to be geographic variation in the distribution of HPV genotypes. For example, in an HPV prevalence study conducted in 13 areas from 11 countries (Nigeria, India, Vietnam, Thailand, Korea, Colombia, Argentina, Chile, the Netherlands, Italy and Spain), 15,613 sexually active women (15 to greater than 65 years of age) with normal cervical cytology were selected for HPV screening by polymerase chain reaction (PCR) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/75\">",
"     75",
"    </a>",
"    ]. HPV positive women in Europe were significantly more likely to be infected with HPV 16 than were those in sub-Saharan Africa (OR 2.6).",
"   </p>",
"   <p>",
"    A study of HPV prevalence was performed in Uganda in a cohort of 1275 sexually active women aged 12 to 24 years seeking health services at a local clinic [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/76\">",
"     76",
"    </a>",
"    ]. The prevalence of HPV and HIV infections was 75 and 9 percent, respectively. Among high-risk types, the most frequently detected were HPV 52 (13 percent), HPV 51 (12 percent), HPV 18 (11 percent) and HPV 16 (11 percent).",
"   </p>",
"   <p>",
"    In contrast, in a study of 2185 sexually active women recruited from universities in the United Kingdom, the prevalence of high-risk HPV infection, detected by testing of self-collected vaginal swabs, was 19 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/77\">",
"     77",
"    </a>",
"    ]. While HPV 16 was the single most common type detected, most of the women were infected with at least one nonvaccine HPV type.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY IN MALES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Factors associated with prevalent human papillomavirus (HPV) infection in men include HIV infection, current and past sexual behavior, number of sex partners, absence of condom use, prior sexually transmitted diseases, race, ethnicity, and circumcision status [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/78-84\">",
"     78-84",
"    </a>",
"    ]. Natural history studies demonstrate that uncircumcised men have slower rates of HPV clearance compared with circumcised men [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/85\">",
"     85",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a systematic review of articles published from 1990 to 2006, HPV prevalence in men ranged from 1 to 73 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/52\">",
"     52",
"    </a>",
"    ]. This wide range of prevalence was attributed to a combination of factors, including the anatomic sites sampled, number of specimens processed, and methods of detection used. A consistent finding among demographic groups is an association of increased sexual activity and high-risk HPV genotypes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Men who have sex with men",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a meta-analysis of 53 observational studies, the pooled prevalence for anal infection with any HPV type and any high-risk HPV type in HIV-uninfected men who have sex with men (MSM) was 64 and 37 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/84\">",
"     84",
"    </a>",
"    ]. The largest of these studies evaluated 1218 HIV-uninfected MSM between the ages of 18 and 89 years in four American cities [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/86\">",
"     86",
"    </a>",
"    ]. Demographic data and information on sexual practices were collected and specimens from the anal canal were tested for the presence of HPV infection by polymerase-chain reaction. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The overall prevalence of anal HPV infection was 57 percent.",
"     </li>",
"     <li>",
"      Prevalence did not vary across age groups.",
"     </li>",
"     <li>",
"      The most common HPV type was HPV 16, a high-risk type for anal cancer.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a multivariate analysis, anal HPV infection was independently associated with a history of receptive anal intercourse (odds ratio 2) and with more than five sex partners during the preceding six months (odds ratio 1.5). Another study that assessed the baseline prevalence of penile, scrotal, perineal and intra-anal HPV infections among 602 HIV-uninfected MSM found anal infections to be the most common site of involvement (42 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Among men with HIV infection, the prevalence of anal HPV infection appears to be even higher. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Effect of HIV infection on HPV'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Heterosexual men",
"    </span>",
"    &nbsp;&mdash;&nbsp;HPV genital infection is common among heterosexual men, as shown by the findings of the human papillomavirus in men (HIM) study, which follows a large prospective cohort of HIV-uninfected men from the United States, Mexico, and Brazil:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among 3326 heterosexual men, the prevalence of genital HPV of any type was 53 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/87\">",
"       87",
"      </a>",
"      ]. Almost one-third of study participants were infected with oncogenic HPV types. Factors associated with oncogenic HPV infection included smoking, heavy alcohol use, and a higher numbers of female sexual partners, whereas condom use was associated with a reduced likelihood of HPV infection.",
"     </li>",
"     <li>",
"      The 12-month incidence of genital HPV among 1159 men (about 90 percent of whom were heterosexual) was 39 and 27 percent for any type and oncogenic types, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/88\">",
"       88",
"      </a>",
"      ]. The overall median time to clearance of HPV infection was 7.5 months, although it was one year for HPV type 16.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other smaller studies of men in the United States have shown comparable HPV rates and associated factors [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/89-91\">",
"     89-91",
"    </a>",
"    ]. These rates may differ in various regions of the world. A study of 776 heterosexual HIV-uninfected men in rural Uganda reported a high incidence of oncogenic genital HPV infection (33 cases per 100 person years) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/92\">",
"     92",
"    </a>",
"    ]. The risk of infection decreased with age, married status, and circumcision; condom use had no association. In another study of 3463 heterosexual men from Latin America, North America, Africa, Europe, and Asia, the prevalence of genital HPV was 21 percent for any type, although fewer types were tested for in this study [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/81\">",
"     81",
"    </a>",
"    ]. Neither condom use nor circumcision was associated with HPV infection. The prevalence of HPV was lowest in Asia and highest in Africa.",
"   </p>",
"   <p>",
"    Few studies have evaluated the frequency of anal HPV infection in heterosexual men, but it appears to be less than that of genital HPV infection. In a study that included 1305 heterosexual men, anal infection with any HPV type was detected in 12 percent, over half of whom carried an oncogenic type [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/80\">",
"     80",
"    </a>",
"    ]. Approximately 50 percent of the heterosexual men with anal HPV infection had the same HPV type detected on genital sampling. Risk factors for anal HPV infection included increased lifetime number of female sex partners, shorter duration of relationship with the current sex partner, and past diagnosis of hepatitis B infection.",
"   </p>",
"   <p>",
"    The high rates of infection in these study populations suggest that strategies for the prevention of HPV infection also need to target men.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Effect of circumcision",
"    </span>",
"    &nbsp;&mdash;&nbsp;A meta-analysis of 23 studies was performed to assess the association between circumcision and HPV DNA [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/93\">",
"     93",
"    </a>",
"    ]. Circumcised men were less likely to have prevalent genital HPV infection than uncircumcised men (OR, 0.57, 95% CI 0.45-0.71). There was weak evidence that circumcision was associated with decreased HPV incidence or increased HPV clearance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H767353\">",
"    <span class=\"h2\">",
"     Effect of HPV sampling sites",
"    </span>",
"    &nbsp;&mdash;&nbsp;The epidemiology of HPV may also be affected by the specific genital sites that are sampled within studies; this issue is most controversial among males because of conflicting data on optimal HPV detection.",
"   </p>",
"   <p>",
"    A systematic analysis of optimal HPV sampling in the prevalence study cited above evaluated the site-specific prevalence of infection (eg, urethra, glans",
"    <span class=\"nowrap\">",
"     penis/coronal",
"    </span>",
"    sulcus, penile",
"    <span class=\"nowrap\">",
"     shaft/prepuce,",
"    </span>",
"    scrotum, perianal region, anal canal, semen, and urine) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/94\">",
"     94",
"    </a>",
"    ]. HPV detection was highest at the penile shaft (50 percent) and lowest in the urethra and in semen (10 and 5 percent, respectively). Another prevalence study of 379 males also demonstrated a wide range of infection rates depending on the site sampled (eg, 6 percent in semen to 52 percent on the penile shaft) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/95\">",
"     95",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The findings were different in the incidence study [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/90\">",
"     90",
"    </a>",
"    ]. Sampling of the glans, penile shaft, and scrotum demonstrated that genital infection in men is multifocal and that there is no clear preferential site for infection. HPV DNA was also detected under fingernails; however, it is unclear as to whether this observation has significant implications for transmission.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H767418\">",
"    <span class=\"h1\">",
"     EFFECT OF HPV VACCINE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bivalent and quadrivalent human papillomavirus (HPV) vaccines are available for the prevention of HPV genital infection in women and men; the bivalent vaccine is effective against HPV types 16 and 18 and the quadrivalent vaccine is effective against HPV types 6, 11, 16 and 18. Clinical trial data have demonstrated efficacy against acquisition of vaccine-associated HPV types with declines in incident and persistent cervical and vulvovaginal infection and abnormalities in women [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/96-98\">",
"     96-98",
"    </a>",
"    ]. The quadrivalent vaccine has also been shown to be effective in men at reducing persistent external genital and anal HPV infection as well as lesions that occur at these sites, including condyloma and squamous intraepithelial lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/99\">",
"     99",
"    </a>",
"    ]. No trials have directly evaluated the efficacy of the bivalent vaccine in men or for anal disease in women. However, in a post-hoc analysis of women who had participated in a trial of the bivalent vaccine, there were fewer persistent anal HPV infections in the vaccinated group compared with the placebo group [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/100\">",
"     100",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several studies have reported declining HPV prevalence and incidence of HPV-related disease in Australia following the 2007 implementation of a national program to administer the quadrivalent vaccine to women aged 12 to 26 years, which led to high rates of vaccine coverage, particularly among women under 18 years old [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/101-104\">",
"     101-104",
"    </a>",
"    ]. In one study of the cervical cytology registry in Victoria, Australia, there was a progressive decrease in the incidence of high-grade cervical squamous intraepithelial lesions among girls 18 years of age or younger in the two years after the vaccination program compared with the four years preceding it [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/101\">",
"     101",
"    </a>",
"    ]. Declines in the incidence of genital warts have also been temporally associated with vaccine availability in both young women and heterosexual men in Australia [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/103,104\">",
"     103,104",
"    </a>",
"    ] and in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/105\">",
"     105",
"    </a>",
"    ]. Although most of these studies did not formally link individual vaccination status or implicated HPV type with disease occurrence, they suggest an association between widespread vaccination and population decreases in HPV-related disease that is consistent with the efficacy observed in clinical trials of the HPV vaccines and that may reflect vaccine-associated herd immunity.",
"   </p>",
"   <p>",
"    Routine HPV immunization is recommended by multiple guideline committees for female adolescents and adults 9 to 26 years of age and male adolescents and adults 11 to 21 years of age; HPV vaccine is most effective when given before the onset of sexual debut. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/10/13480?source=see_link\">",
"     \"Clinical trials of human papillomavirus vaccines\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H767316\">",
"    <span class=\"h1\">",
"     VIRAL INTERACTIONS BETWEEN HIV AND HPV",
"    </span>",
"    &nbsp;&mdash;&nbsp;HIV and human papillomavirus (HPV) infections appear to affect the epidemiology of these two viruses bidirectionally.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Effect of HIV infection on HPV",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several studies have shown that HPV infection is more common among HIV-infected than uninfected men and women [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/84,106-108\">",
"     84,106-108",
"    </a>",
"    ]. In a study of 486 heterosexual South African couples followed for up to 24 months, new HPV infection was detected more frequently in HIV-infected women (57 versus 27 events per 1000 person-months) and men (80 versus 52 events per 1000 person-months) compared with HIV-uninfected individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/108\">",
"     108",
"    </a>",
"    ]. Furthermore, HIV infection was independently associated with a decreased likelihood of clearance of HPV infection over time.",
"   </p>",
"   <p>",
"    Another study evaluated the concordance of HPV infection among 254 heterosexually active couples and the impact of HIV coinfection on the prevalence of HPV [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/107\">",
"     107",
"    </a>",
"    ]. The following observations were made:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      HPV detection was significantly more common among HIV-infected women than among HIV-uninfected women (68 versus 31 percent, respectively).",
"     </li>",
"     <li>",
"      Similarly, HPV detection was significantly more common among HIV-infected men than among HIV-uninfected men (72 versus 43 percent, respectively).",
"     </li>",
"     <li>",
"      HIV coinfection in one partner had a significant impact on the prevalence of HPV infection in the other partner. For example, HIV-uninfected male partners of HIV-infected women had a greater prevalence of HPV than did HIV-uninfected male partners of HIV-uninfected women (58 percent versus 32 percent, respectively).",
"     </li>",
"     <li>",
"      Concordance of the same HPV genotypes was more commonly found among couples where one or both partners were HIV-infected, compared with HIV-uninfected couples.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Among men who have sex with men (MSM), HPV prevalence is similarly increased in the setting of HIV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/84,109\">",
"     84,109",
"    </a>",
"    ]. In a meta-analysis of 53 studies, the pooled prevalence of anal HPV infection was considerably higher in HIV-infected men (93 and 74 percent for any type and any high-risk type, respectively, compared with 64 and 37 percent in HIV-uninfected MSM) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/84\">",
"     84",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Effect of HPV on HIV acquisition",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first evidence for an association between HPV infection and increased risk of HIV acquisition came from studies of MSM. In a cohort of HIV-uninfected MSM, infection with more than one anal HPV type was significantly associated with HIV seroconversion (adjusted hazard ratio [HR] 3.5; 95% CI 1.2&ndash;10.6) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/110\">",
"     110",
"    </a>",
"    ]. Subsequent studies suggest that penile HPV infection is also a risk factor for subsequent HIV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/111\">",
"     111",
"    </a>",
"    ]. HIV-uninfected men in Kenya (n = 2168) who were participating in a randomized trial of male circumcision underwent HPV DNA sampling of their",
"    <span class=\"nowrap\">",
"     glans/coronal",
"    </span>",
"    sulcus and were followed up for 42 months for evidence of HIV acquisition [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/111\">",
"     111",
"    </a>",
"    ]. Approximately 50 percent of the men had evidence of HPV DNA at baseline. After controlling for subsequent circumcision status, baseline herpes simplex virus type 2 serostatus, and other sexual risk factors, those men who were infected with HPV at baseline had a significantly higher risk of HIV acquisition compared with men without HPV infection (HR 1.8; 95% CI 1.1-2.9).",
"   </p>",
"   <p>",
"    In contrast, in a case-control study of 44 men who acquired HIV infection and 787 HIV-uninfected men who had been followed in a circumcision trial, penile HPV acquisition was not associated with HIV acquisition after controlling for other HIV transmission risks [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/112\">",
"     112",
"    </a>",
"    ]. However, an association between clearance of HPV infection and subsequent HIV infection was observed in this study and postulated to be related to changes in local immune responses that might predispose to HIV infection.",
"   </p>",
"   <p>",
"    The presence of HPV infection also appears to be associated with an increased risk of HIV acquisition among women. In a meta-analysis of prospective studies of women who underwent HPV testing, HIV acquisition was associated with baseline HPV infection of any and high-risk type (HRs 2.06 [95% CI 1.44-2.94] and 1.99 [95% CI 1.54-2.56], respectively) when compared with no baseline HPV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/113\">",
"     113",
"    </a>",
"    ]. Of note, several included studies did not assess or adjust for sexual behavior or other coincident sexually transmitted infections, which are significant potential confounders in the association between HPV and HIV. In a separate study of women from Zimbabwe, clearance of cervical HPV infection was associated with risk of HIV acquisition [",
"    <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/114\">",
"     114",
"    </a>",
"    ], similar to the association with clearance of penile HPV infection described in the study above.",
"   </p>",
"   <p>",
"    Whether HPV infection itself predisposes to subsequent HIV infection or is simply a marker of increased HIV risk remains unknown. It is also unclear whether prevalent HPV infection or the immune response associated with clearing that HPV infection, or both, plays a role in potentiating HIV acquisition.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?5/22/5475?source=see_link\">",
"       \"Patient information: Human papillomavirus (HPV) vaccine (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?37/45/38610?source=see_link\">",
"       \"Patient information: Human papillomavirus (HPV) vaccine (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?3/60/4035?source=see_link\">",
"       \"Patient information: Genital warts in women (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?7/53/8019?source=see_link\">",
"       \"Patient information: Cervical cancer screening (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H746595\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Human papillomaviruses are double-stranded DNA viruses that only infect humans. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Different human papillomavirus (HPV) types have a propensity to infect different body sites. As examples, HPV types 1, 2, and 4 have a predilection for cutaneous epithelium while HPV types 6, 11, 16, and 18 have a predilection for mucous membrane infection. (See",
"      <a class=\"local\" href=\"#H747443\">",
"       'Tissue tropism'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cutaneous infection with HPV types 1 and 2 is frequently associated with plantar or common hand warts. Mucocutaneous infection with HPV types 6, 11, 16 and 18 is often associated with genital warts and precancerous and cancerous lesions of the cervix, vulva, vagina, penis, anus and oropharynx. Evidence linking HPV to cervical carcinoma is extensive [",
"      <a class=\"abstract\" href=\"UTD.htm?21/6/21610/abstract/2,4,8,26\">",
"       2,4,8,26",
"      </a>",
"      ], with HPV 16 accounting for approximately 60 percent of cases and HPV 18 for 10 percent. (See",
"      <a class=\"local\" href=\"#H746850\">",
"       'Disease associations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Close personal contact is assumed to be of importance for the transmission of cutaneous warts, while anogenital and cervical infection are primarily transmitted through sexual contact. Both of these represent transmission from one epithelial surface to another. As with other sexually transmitted infections, persons with multiple sex partners are at greater risk for HPV infection compared with those in a monogamous relationship, and individuals with a new sex partner are at greater risk than those with a long-term sex partner. (See",
"      <a class=\"local\" href=\"#H25826411\">",
"       'Risk factors for transmission'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The worldwide prevalence of HPV infection among females is approximately 10 percent. The highest regional prevalence is in Africa, where 22 percent of women have evidence of HPV infection. Worldwide, the most serious HPV infections are caused by high-risk types HPV 16 and 18, both of which are preventable by vaccination. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology in females'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Rates of anal cancer are rising among men and women in the United States. Studies in men who have sex with men (MSM) and heterosexual men demonstrate that HPV infection is highly prevalent among men, including high-risk type HPV 16. Some observational studies suggest that male circumcision is associated with lower rates of HPV infection than those observed in uncircumcised men. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Epidemiology in males'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Bivalent and quadrivalent HPV vaccines are available for the prevention of HPV genital infection in women and men; the bivalent vaccine is effective against HPV types 16 and 18 and the quadrivalent vaccine is effective against HPV types 6, 11, 16 and 18. Clinical trial data have demonstrated efficacy against acquisition of vaccine-associated HPV types with declines in incident and persistent HPV infections and decreasing rates of cervical and anal squamous intraepithelial lesions. (See",
"      <a class=\"local\" href=\"#H767418\">",
"       'Effect of HPV vaccine'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      HPV detection is more common among HIV-infected men and women than among men and women who are HIV-uninfected. Among HIV-uninfected men and women, HPV infection is associated with an increased risk of HIV acquisition compared with those without HPV infection. (See",
"      <a class=\"local\" href=\"#H767316\">",
"       'Viral interactions between HIV and HPV'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8049792\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The author and editors of UpToDate would like to acknowledge Richard Reichman, MD, who contributed to earlier versions of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/1\">",
"      Carr J, Gyorfi T. Human papillomavirus. Epidemiology, transmission, and pathogenesis. Clin Lab Med 2000; 20:235.",
"     </a>",
"    </li>",
"    <li>",
"     Bonnez W, Reichman RC. Papillomaviruses. In: Principles and Practice of Infectious Diseases, Fifth Edition, Mandell GL, Bennett JE, Dolin R (Eds), Churchill Livingston, Philadelphia 2000. p.1630.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/3\">",
"      Mackenzie-Wood A, Kossard S, de Launey J, et al. Imiquimod 5% cream in the treatment of Bowen's disease. J Am Acad Dermatol 2001; 44:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/4\">",
"      Franco EL, Duarte-Franco E, Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. CMAJ 2001; 164:1017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/5\">",
"      Karrer S, Szeimies RM, Abels C, et al. Epidermodysplasia verruciformis treated using topical 5-aminolaevulinic acid photodynamic therapy. Br J Dermatol 1999; 140:935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/6\">",
"      Beutner KR. Nongenital human papillomavirus infections. Clin Lab Med 2000; 20:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/7\">",
"      von Krogh G, Lacey CJ, Gross G, et al. European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts. Sex Transm Infect 2000; 76:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/8\">",
"      Sedlacek TV. Advances in the diagnosis and treatment of human papillomavirus infections. Clin Obstet Gynecol 1999; 42:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/9\">",
"      Thomas DB, Ray RM, Koetsawang A, et al. Human papillomaviruses and cervical cancer in Bangkok. I. Risk factors for invasive cervical carcinomas with human papillomavirus types 16 and 18 DNA. Am J Epidemiol 2001; 153:723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/10\">",
"      Tilston P. Anal human papillomavirus and anal cancer. J Clin Pathol 1997; 50:625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/11\">",
"      Castle PE, Schiffman M, Bratti MC, et al. A population-based study of vaginal human papillomavirus infection in hysterectomized women. J Infect Dis 2004; 190:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/12\">",
"      Chaturvedi AK, Madeleine MM, Biggar RJ, Engels EA. Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst 2009; 101:1120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/13\">",
"      Stier EA, Goldstone SE, Einstein MH, et al. Safety and efficacy of topical cidofovir to treat high-grade perianal and vulvar intraepithelial neoplasia in HIV-positive men and women. AIDS 2013; 27:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/14\">",
"      Llewellyn CD, Johnson NW, Warnakulasuriya KA. Risk factors for squamous cell carcinoma of the oral cavity in young people--a comprehensive literature review. Oral Oncol 2001; 37:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/15\">",
"      Uobe K, Masuno K, Fang YR, et al. Detection of HPV in Japanese and Chinese oral carcinomas by in situ PCR. Oral Oncol 2001; 37:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/16\">",
"      Allen AL, Siegfried EC. What's new in human papillomavirus infection. Curr Opin Pediatr 2000; 12:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/17\">",
"      Steele K, Irwin WG, Merrett JD. Warts in general practice. Ir Med J 1989; 82:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/18\">",
"      Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997; 102:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/19\">",
"      Kjaer SK, Tran TN, Sparen P, et al. The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries. J Infect Dis 2007; 196:1447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/20\">",
"      Leval A, Herweijer E, Arnheim-Dahlstr&ouml;m L, et al. Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability. J Infect Dis 2012; 206:860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/21\">",
"      FUTURE I/II Study Group, Dillner J, Kjaer SK, et al. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. BMJ 2010; 341:c3493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/22\">",
"      Anic GM, Lee JH, Villa LL, et al. Risk factors for incident condyloma in a multinational cohort of men: the HIM study. J Infect Dis 2012; 205:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/23\">",
"      Barr E, Tamms G. Quadrivalent human papillomavirus vaccine. Clin Infect Dis 2007; 45:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/24\">",
"      Insinga RP, Dasbach EJ, Myers ER. The health and economic burden of genital warts in a set of private health plans in the United States. Clin Infect Dis 2003; 36:1397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/25\">",
"      de Martel C, Ferlay J, Franceschi S, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012; 13:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/26\">",
"      Sonnex C. Human papillomavirus infection with particular reference to genital disease. J Clin Pathol 1998; 51:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/27\">",
"      de Sanjose S, Quint WG, Alemany L, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 2010; 11:1048.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/28\">",
"      Mu&ntilde;oz N, Bosch FX, de Sanjos&eacute; S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/29\">",
"      Thompson DL, Douglas JM Jr, Foster M, et al. Seroepidemiology of infection with human papillomavirus 16, in men and women attending sexually transmitted disease clinics in the United States. J Infect Dis 2004; 190:1563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/30\">",
"      Hoevenaars BM, van der Avoort IA, de Wilde PC, et al. A panel of p16(INK4A), MIB1 and p53 proteins can distinguish between the 2 pathways leading to vulvar squamous cell carcinoma. Int J Cancer 2008; 123:2767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/31\">",
"      Chaux A, Cubilla AL. The role of human papillomavirus infection in the pathogenesis of penile squamous cell carcinomas. Semin Diagn Pathol 2012; 29:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/32\">",
"      D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007; 356:1944.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/33\">",
"      Mork J, Lie AK, Glattre E, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001; 344:1125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/34\">",
"      Gillison ML, Broutian T, Pickard RK, et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA 2012; 307:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/35\">",
"      Li X, Gao L, Li H, et al. Human papillomavirus infection and laryngeal cancer risk: a systematic review and meta-analysis. J Infect Dis 2013; 207:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/36\">",
"      Gillison ML, D'Souza G, Westra W, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008; 100:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/37\">",
"      Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011; 29:4294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/38\">",
"      Pickard RK, Xiao W, Broutian TR, et al. The prevalence and incidence of oral human papillomavirus infection among young men and women, aged 18-30 years. Sex Transm Dis 2012; 39:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/39\">",
"      Derkay CS, Wiatrak B. Recurrent respiratory papillomatosis: a review. Laryngoscope 2008; 118:1236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/40\">",
"      Yuan H, Myers S, Wang J, et al. Use of reprogrammed cells to identify therapy for respiratory papillomatosis. N Engl J Med 2012; 367:1220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/41\">",
"      Ho GY, Bierman R, Beardsley L, et al. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/42\">",
"      American College of Obstetricians and Gynecologists. ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists. Number 61, April 2005. Human papillomavirus. Obstet Gynecol 2005; 105:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/43\">",
"      Tarkowski TA, Koumans EH, Sawyer M, et al. Epidemiology of human papillomavirus infection and abnormal cytologic test results in an urban adolescent population. J Infect Dis 2004; 189:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/44\">",
"      Winer RL, Lee SK, Hughes JP, et al. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003; 157:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/45\">",
"      Peyton CL, Gravitt PE, Hunt WC, et al. Determinants of genital human papillomavirus detection in a US population. J Infect Dis 2001; 183:1554.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/46\">",
"      Karlsson R, Jonsson M, Edlund K, et al. Lifetime number of partners as the only independent risk factor for human papillomavirus infection: a population-based study. Sex Transm Dis 1995; 22:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/47\">",
"      Moscicki AB, Hills N, Shiboski S, et al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA 2001; 285:2995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/48\">",
"      Ley C, Bauer HM, Reingold A, et al. Determinants of genital human papillomavirus infection in young women. J Natl Cancer Inst 1991; 83:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/49\">",
"      Nyitray AG, Menezes L, Lu B, et al. Genital human papillomavirus (HPV) concordance in heterosexual couples. J Infect Dis 2012; 206:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/50\">",
"      Shew ML, Weaver B, Tu W, et al. High frequency of human papillomavirus detection in the vagina before first vaginal intercourse among females enrolled in a longitudinal cohort study. J Infect Dis 2013; 207:1012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/51\">",
"      Widdice LE, Breland DJ, Jonte J, et al. Human papillomavirus concordance in heterosexual couples. J Adolesc Health 2010; 47:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/52\">",
"      Dunne EF, Nielson CM, Stone KM, et al. Prevalence of HPV infection among men: A systematic review of the literature. J Infect Dis 2006; 194:1044.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/53\">",
"      de Sanjos&eacute; S, Diaz M, Castellsagu&eacute; X, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007; 7:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/54\">",
"      Wright TC Jr, Schiffman M. Adding a test for human papillomavirus DNA to cervical-cancer screening. N Engl J Med 2003; 348:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/55\">",
"      Centers for Disease Control and Prevention, Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006; 55:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/56\">",
"      Goodman MT, Shvetsov YB, McDuffie K, et al. Acquisition of anal human papillomavirus (HPV) infection in women: the Hawaii HPV Cohort study. J Infect Dis 2008; 197:957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/57\">",
"      Goodman MT, Shvetsov YB, McDuffie K, et al. Sequential acquisition of human papillomavirus (HPV) infection of the anus and cervix: the Hawaii HPV Cohort Study. J Infect Dis 2010; 201:1331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/58\">",
"      Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. JAMA 2007; 297:813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/59\">",
"      Winer RL, Feng Q, Hughes JP, et al. Risk of female human papillomavirus acquisition associated with first male sex partner. J Infect Dis 2008; 197:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/60\">",
"      Widdice LE, Brown DR, Bernstein DI, et al. Prevalence of human papillomavirus infection in young women receiving the first quadrivalent vaccine dose. Arch Pediatr Adolesc Med 2012; 166:774.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/61\">",
"      Markowitz LE, Sternberg M, Dunne EF, et al. Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004. J Infect Dis 2009; 200:1059.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/62\">",
"      Sycuro LK, Xi LF, Hughes JP, et al. Persistence of genital human papillomavirus infection in a long-term follow-up study of female university students. J Infect Dis 2008; 198:971.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/63\">",
"      Plitt SS, Sherman SG, Viscidi RP, et al. Human papillomavirus seroprevalence among young male and female drug users. Sex Transm Dis 2007; 34:676.",
"     </a>",
"    </li>",
"    <li>",
"     Messersmith AR, Banister CE, Spiryda LB, et al. Increased risk of persistent human papillomavirus infection and abnormal Pap tests in African American compared to European American women in a college-age cohort. Presented at the American Association for Cancer Research Meeting, Chicago, IL, March 31- April 4, 2012. Abstract #550",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/65\">",
"      Hariri S, Unger ER, Powell SE, et al. Human papillomavirus genotypes in high-grade cervical lesions in the United States. J Infect Dis 2012; 206:1878.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/66\">",
"      Gravitt PE, Rositch AF, Silver MI, et al. A cohort effect of the sexual revolution may be masking an increase in human papillomavirus detection at menopause in the United States. J Infect Dis 2013; 207:272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/67\">",
"      Rositch AF, Burke AE, Viscidi RP, et al. Contributions of recent and past sexual partnerships on incident human papillomavirus detection: acquisition and reactivation in older women. Cancer Res 2012; 72:6183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/68\">",
"      Brown DR, Weaver B. Human papillomavirus in older women: new infection or reactivation? J Infect Dis 2013; 207:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/69\">",
"      Strickler HD, Burk RD, Fazzari M, et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst 2005; 97:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/70\">",
"      Shvetsov YB, Hernandez BY, McDuffie K, et al. Duration and clearance of anal human papillomavirus (HPV) infection among women: the Hawaii HPV cohort study. Clin Infect Dis 2009; 48:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/71\">",
"      Castro FA, Quint W, Gonzalez P, et al. Prevalence of and risk factors for anal human papillomavirus infection among young healthy women in Costa Rica. J Infect Dis 2012; 206:1103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/72\">",
"      Palefsky JM, Holly EA, Ralston ML, et al. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. J Infect Dis 2001; 183:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/73\">",
"      Santoso JT, Long M, Crigger M, et al. Anal intraepithelial neoplasia in women with genital intraepithelial neoplasia. Obstet Gynecol 2010; 116:578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/74\">",
"      Chiao EY. Duration of anal human papillomavirus infection among immunocompetent women: clues to anal cancer epidemiology and possible prevention strategies. Clin Infect Dis 2009; 48:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/75\">",
"      Clifford GM, Gallus S, Herrero R, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005; 366:991.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/76\">",
"      Banura C, Franceschi S, Doorn LJ, et al. Infection with human papillomavirus and HIV among young women in Kampala, Uganda. J Infect Dis 2008; 197:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/77\">",
"      Oakeshott P, Aghaizu A, Reid F, et al. Frequency and risk factors for prevalent, incident, and persistent genital carcinogenic human papillomavirus infection in sexually active women: community based cohort study. BMJ 2012; 344:e4168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/78\">",
"      Baldwin SB, Wallace DR, Papenfuss MR, et al. Condom use and other factors affecting penile human papillomavirus detection in men attending a sexually transmitted disease clinic. Sex Transm Dis 2004; 31:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/79\">",
"      Castellsagu&eacute; X, Bosch FX, Mu&ntilde;oz N, et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med 2002; 346:1105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/80\">",
"      Nyitray AG, Carvalho da Silva RJ, Baggio ML, et al. Age-specific prevalence of and risk factors for anal human papillomavirus (HPV) among men who have sex with women and men who have sex with men: the HPV in men (HIM) study. J Infect Dis 2011; 203:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/81\">",
"      Vardas E, Giuliano AR, Goldstone S, et al. External genital human papillomavirus prevalence and associated factors among heterosexual men on 5 continents. J Infect Dis 2011; 203:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/82\">",
"      Goldstone S, Palefsky JM, Giuliano AR, et al. Prevalence of and risk factors for human papillomavirus (HPV) infection among HIV-seronegative men who have sex with men. J Infect Dis 2011; 203:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/83\">",
"      Repp KK, Nielson CM, Fu R, et al. Male human papillomavirus prevalence and association with condom use in Brazil, Mexico, and the United States. J Infect Dis 2012; 205:1287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/84\">",
"      Machalek DA, Poynten M, Jin F, et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol 2012; 13:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/85\">",
"      Hernandez BY, Shvetsov YB, Goodman MT, et al. Reduced clearance of penile human papillomavirus infection in uncircumcised men. J Infect Dis 2010; 201:1340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/86\">",
"      Chin-Hong PV, Vittinghoff E, Cranston RD, et al. Age-Specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE study. J Infect Dis 2004; 190:2070.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/87\">",
"      Nyitray AG, da Silva RJ, Baggio ML, et al. The prevalence of genital HPV and factors associated with oncogenic HPV among men having sex with men and men having sex with women and men: the HIM study. Sex Transm Dis 2011; 38:932.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/88\">",
"      Giuliano AR, Lee JH, Fulp W, et al. Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study. Lancet 2011; 377:932.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/89\">",
"      Nielson CM, Harris RB, Dunne EF, et al. Risk factors for anogenital human papillomavirus infection in men. J Infect Dis 2007; 196:1137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/90\">",
"      Partridge JM, Hughes JP, Feng Q, et al. Genital human papillomavirus infection in men: incidence and risk factors in a cohort of university students. J Infect Dis 2007; 196:1128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/91\">",
"      Giuliano AR, Lu B, Nielson CM, et al. Age-specific prevalence, incidence, and duration of human papillomavirus infections in a cohort of 290 US men. J Infect Dis 2008; 198:827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/92\">",
"      Tobian AA, Kigozi G, Gravitt PE, et al. Human papillomavirus incidence and clearance among HIV-positive and HIV-negative men in sub-Saharan Africa. AIDS 2012; 26:1555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/93\">",
"      Larke N, Thomas SL, Dos Santos Silva I, Weiss HA. Male circumcision and human papillomavirus infection in men: a systematic review and meta-analysis. J Infect Dis 2011; 204:1375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/94\">",
"      Giuliano AR, Nielson CM, Flores R, et al. The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: the HPV detection in men study. J Infect Dis 2007; 196:1146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/95\">",
"      Hernandez BY, Wilkens LR, Zhu X, et al. Circumcision and human papillomavirus infection in men: a site-specific comparison. J Infect Dis 2008; 197:787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/96\">",
"      Garland SM, Hernandez-Avila M, Wheeler CM, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007; 356:1928.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/97\">",
"      FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007; 356:1915.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/98\">",
"      Paavonen J, Naud P, Salmer&oacute;n J, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009; 374:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/99\">",
"      Palefsky JM, Giuliano AR, Goldstone S, et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 2011; 365:1576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/100\">",
"      Kreimer AR, Gonz&aacute;lez P, Katki HA, et al. Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial. Lancet Oncol 2011; 12:862.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/101\">",
"      Brotherton JM, Fridman M, May CL, et al. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 2011; 377:2085.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/102\">",
"      Tabrizi SN, Brotherton JM, Kaldor JM, et al. Fall in human papillomavirus prevalence following a national vaccination program. J Infect Dis 2012; 206:1645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/103\">",
"      Donovan B, Franklin N, Guy R, et al. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis 2011; 11:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/104\">",
"      Read TR, Hocking JS, Chen MY, et al. The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme. Sex Transm Infect 2011; 87:544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/105\">",
"      Bauer HM, Wright G, Chow J. Evidence of human papillomavirus vaccine effectiveness in reducing genital warts: an analysis of California public family planning administrative claims data, 2007-2010. Am J Public Health 2012; 102:833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/106\">",
"      Singh DK, Anastos K, Hoover DR, et al. Human papillomavirus infection and cervical cytology in HIV-infected and HIV-uninfected Rwandan women. J Infect Dis 2009; 199:1851.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/107\">",
"      Mbulawa ZZ, Coetzee D, Marais DJ, et al. Genital human papillomavirus prevalence and human papillomavirus concordance in heterosexual couples are positively associated with human immunodeficiency virus coinfection. J Infect Dis 2009; 199:1514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/108\">",
"      Mbulawa ZZ, Marais DJ, Johnson LF, et al. Impact of human immunodeficiency virus on the natural history of human papillomavirus genital infection in South African men and women. J Infect Dis 2012; 206:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/109\">",
"      Sahasrabuddhe VV, Castle PE, Follansbee S, et al. Human papillomavirus genotype attribution and estimation of preventable fraction of anal intraepithelial neoplasia cases among HIV-infected men who have sex with men. J Infect Dis 2013; 207:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/110\">",
"      Chin-Hong PV, Husnik M, Cranston RD, et al. Anal human papillomavirus infection is associated with HIV acquisition in men who have sex with men. AIDS 2009; 23:1135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/111\">",
"      Smith JS, Moses S, Hudgens MG, et al. Increased risk of HIV acquisition among Kenyan men with human papillomavirus infection. J Infect Dis 2010; 201:1677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/112\">",
"      Tobian AA, Grabowski MK, Kigozi G, et al. Human Papillomavirus Clearance Among Males Is Associated With HIV Acquisition and Increased Dendritic Cell Density in the Foreskin. J Infect Dis 2013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/113\">",
"      Houlihan CF, Larke NL, Watson-Jones D, et al. Human papillomavirus infection and increased risk of HIV acquisition. A systematic review and meta-analysis. AIDS 2012; 26:2211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/6/21610/abstract/114\">",
"      Averbach SH, Gravitt PE, Nowak RG, et al. The association between cervical human papillomavirus infection and HIV acquisition among women in Zimbabwe. AIDS 2010; 24:1035.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8314 Version 14.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.247-05EE575892-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_6_21610=[""].join("\n");
var outline_f21_6_21610=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H746595\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H747443\">",
"      TISSUE TROPISM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H747465\">",
"      Cutaneous",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H747487\">",
"      Anogenital epithelium",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H52654401\">",
"      Other mucosal surfaces",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H746850\">",
"      DISEASE ASSOCIATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H746873\">",
"      Nongenital warts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H746880\">",
"      Genital warts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H746887\">",
"      Cervical cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3189670\">",
"      Anal cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H52654214\">",
"      Cancer of the external genitalia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H746909\">",
"      Oropharyngeal cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15115461\">",
"      Recurrent respiratory papillomatosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25826411\">",
"      RISK FACTORS FOR TRANSMISSION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY IN FEMALES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      United States",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Worldwide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      EPIDEMIOLOGY IN MALES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Men who have sex with men",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Heterosexual men",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Effect of circumcision",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H767353\">",
"      Effect of HPV sampling sites",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H767418\">",
"      EFFECT OF HPV VACCINE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H767316\">",
"      VIRAL INTERACTIONS BETWEEN HIV AND HPV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Effect of HIV infection on HPV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Effect of HPV on HIV acquisition",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H746595\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8049792\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/8314\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/8314|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/33/30236\" title=\"table 1\">",
"      HPV types disease associations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/33/1562?source=related_link\">",
"      Anal intraepithelial neoplasia: Diagnosis, screening, prevention, and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/13/26840?source=related_link\">",
"      Carcinoma of the penis: Epidemiology, risk factors, staging, and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/21/31065?source=related_link\">",
"      Cervical intraepithelial neoplasia: Definition, incidence, and pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/29/12761?source=related_link\">",
"      Classification and epidemiology of anal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/10/13480?source=related_link\">",
"      Clinical trials of human papillomavirus vaccines",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/38/23144?source=related_link\">",
"      Condylomata acuminata (anogenital warts)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/29/44505?source=related_link\">",
"      Etiology and management of hoarseness in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/55/887?source=related_link\">",
"      Human papillomavirus associated head and neck cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/55/28537?source=related_link\">",
"      Invasive cervical cancer: Epidemiology, risk factors, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?7/53/8019?source=related_link\">",
"      Patient information: Cervical cancer screening (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?3/60/4035?source=related_link\">",
"      Patient information: Genital warts in women (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?37/45/38610?source=related_link\">",
"      Patient information: Human papillomavirus (HPV) vaccine (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?5/22/5475?source=related_link\">",
"      Patient information: Human papillomavirus (HPV) vaccine (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/17/19738?source=related_link\">",
"      Recommendations for the use of human papillomavirus vaccines",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/39/26229?source=related_link\">",
"      The life cycle, natural history, and immunology of human papillomaviruses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/30/31208?source=related_link\">",
"      Vaginal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/27/5560?source=related_link\">",
"      Vaginal intraepithelial neoplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/53/26455?source=related_link\">",
"      Virology of human papillomavirus infections and the link to cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/5/9303?source=related_link\">",
"      Vulvar cancer: Clinical manifestations, diagnosis, and pathology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/11/32952?source=related_link\">",
"      Vulvar intraepithelial neoplasia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_6_21611="Noninvasive methods for arrhythmia risk stratification after MI";
var content_f21_6_21611=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F80458&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F80458&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Incidence of sustained ventricular arrythmias or sudden cardiac death in patients after myocardial infarction (MI)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"1\" rowspan=\"2\">",
"        Test",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\" rowspan=\"1\">",
"        Percent adverse outcome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        For normal test results",
"       </td>",
"       <td class=\"subtitle2\">",
"        For abnormal test results",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Holter monitor",
"       </td>",
"       <td>",
"        7-9",
"       </td>",
"       <td>",
"        14-23",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        LV ejection fraction",
"       </td>",
"       <td>",
"        5-6",
"       </td>",
"       <td>",
"        16-24",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Signal-averaged ECG",
"       </td>",
"       <td>",
"        1-3",
"       </td>",
"       <td>",
"        17-29",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Programmed stimulation",
"       </td>",
"       <td>",
"        0-4",
"       </td>",
"       <td>",
"        12-32",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Heart rate variability",
"       </td>",
"       <td>",
"        1-23",
"       </td>",
"       <td>",
"        16-17",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Cain ME, Anderson JL, Arnsdorf MF, et al. J Am Coll Cardiol 1996; 27:238.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_6_21611=[""].join("\n");
var outline_f21_6_21611=null;
var title_f21_6_21612="Heparin protocol II";
var content_f21_6_21612=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F72792&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F72792&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Example of a non-weight-based intravenous heparin protocol: Part II titration based upon the activated partial thromboplastin time",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"4\" width=\"25%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"4\">",
"        IV infusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        aPTT",
"       </td>",
"       <td class=\"subtitle2\">",
"        Rate change, mL/hour*",
"       </td>",
"       <td class=\"subtitle2\">",
"        Dose change, units/24-hour",
"       </td>",
"       <td class=\"subtitle2\">",
"        Additional action",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &le;45",
"       </td>",
"       <td>",
"        +6",
"       </td>",
"       <td>",
"        +5760",
"       </td>",
"       <td>",
"        Repeated aPTT",
"        <sup>",
"         &bull;",
"        </sup>",
"        in 4 to 6 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        46 to 54",
"       </td>",
"       <td>",
"        +3",
"       </td>",
"       <td>",
"        +2880",
"       </td>",
"       <td>",
"        Repeated aPTT in 4 to 6 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        55 to 85",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        None",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        86 to 110",
"       </td>",
"       <td>",
"        -3",
"       </td>",
"       <td>",
"        -2880",
"       </td>",
"       <td>",
"        Stop heparin sodium treatment for 1 hour; repeated aPTT 4 to 6 hours after restarting heparin treatment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &gt;110",
"       </td>",
"       <td>",
"        -6",
"       </td>",
"       <td>",
"        -5760",
"       </td>",
"       <td>",
"        Stop heparin treatment for 1 hour; repeated aPTT 4 to 6 hours after restarting heparin treatment",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    NOTE: This table reflects the original aPTT ranges, bolus sizes, and suggested changes in infusion rate that were present at the time this study was performed. The therapeutic ranges (ie, relationship between the aPTT and anti-factor Xa activity), initial and subsequent bolus sizes, and sizes of the infusion rate changes, as well as dosing differences depending on the disorder under treatment (eg, venous thromboembolism, stroke, acute coronary syndrome) should be established separately for each institution.",
"    <div class=\"footnotes\">",
"     aPTT: activated partial thromboplastin time; IV: intravenous.",
"     <br/>",
"     * Heparin sodium concentration, 20,000 units in 500 mL = 40 units/mL.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     With the use of Actin-FS thromboplastin reagent (Dade, Mississauga, Ontario).",
"     <br/>",
"     &Delta; During the first 24 hours, repeated aPTT in 4 to 6 hours. Thereafter, the aPTT will be determined once daily, unless subtherapeutic.",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn from: Hull RD, Raskob GE, Rosenbloom D, et al. Optimal therapeutic level of heparin therapy in patients with venous thrombosis. Arch Intern Med 1992; 152:1589.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_6_21612=[""].join("\n");
var outline_f21_6_21612=null;
var title_f21_6_21613="Mass rx for lymphatic filariasis_onchocerciasis and or loiasis";
var content_f21_6_21613=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F83529%7EID%2F83530&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=9\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F83529%7EID%2F83530&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=9\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Approach to mass treatment of lymphatic filariasis, onchocerciasis, and/or loiasis in settings of monoinfection or coinfection*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Lymphatic filariasis",
"       </td>",
"       <td class=\"subtitle1\">",
"        Onchocerciasis",
"       </td>",
"       <td class=\"subtitle1\">",
"        Loiasis",
"       </td>",
"       <td class=\"subtitle1\">",
"        Treatment regimen of choice",
"       </td>",
"       <td class=\"subtitle1\">",
"        Contraindicated agent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td>",
"        Diethylcarbamazine",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td>",
"        Ivermectin",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td>",
"        (Mass treatment not in place)",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td>",
"        Doxycycline plus ivermectin or albendazole",
"       </td>",
"       <td>",
"        Diethylcarbamazine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td>",
"        <span style=\"color: #ff0000;\">",
"         (Caution advised re mass treatment in such settings)",
"        </span>",
"       </td>",
"       <td>",
"        Diethylcarbamazine (contraindicated for L. loa microfilariae load &gt;2500/mL)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td>",
"        Doxycycline plus albendazole",
"       </td>",
"       <td>",
"        Ivermectin",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    * Dosing and duration are outlined in the text; see related topics.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Peter Weller, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Approach to treatment of a patient with lymphatic filariasis, onchocerciasis, and/or loiasis*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Lymphatic filariasis",
"       </td>",
"       <td class=\"subtitle1\">",
"        Onchocerciasis",
"       </td>",
"       <td class=\"subtitle1\">",
"        Loiasis",
"       </td>",
"       <td class=\"subtitle1\">",
"        Treatment regimen of choice",
"       </td>",
"       <td class=\"subtitle1\">",
"        Contraindicated agent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td>",
"        Diethylcarbamazine",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td>",
"        Ivermectin",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td>",
"        No treatment if asymptomatic. Diethylcarbamazine (for patients with microfilariae load &lt;2500/mL; see text for approach to management of patients with microfilariae load &gt;2500/mL).",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td>",
"        Doxycycline plus ivermectin or albendazole",
"       </td>",
"       <td>",
"        Diethylcarbamazine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td>",
"        No treatment if asymptomatic. Diethylcarbamazine (for patients with microfilariae load &lt;2500/mL; see text for approach to management of patients with microfilariae load &gt;2500/mL).",
"       </td>",
"       <td>",
"        Diethylcarbamazine (contraindicated for L. loa microfilariae load &gt;2500/mL)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td>",
"        Doxycycline plus albendazole",
"       </td>",
"       <td>",
"        Ivermectin",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Dosing and duration are outlined in the text; see related topics.",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Peter Weller, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_6_21613=[""].join("\n");
var outline_f21_6_21613=null;
var title_f21_6_21614="Contents: White cell disorders";
var content_f21_6_21614=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?39/57/40861\">",
"       Hematology",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       White cell disorders",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			White cell disorders",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         General",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/0/4106\">",
"           Biology and clinical features of radiation injury in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/53/21338\">",
"           Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/12/20680\">",
"           Erdheim-Chester disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/10/39080\">",
"           Evaluation of peripheral lymphadenopathy in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/5/41050\">",
"           Hemophagocytic lymphohistiocytosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/1/38934\">",
"           Histiocytic sarcoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/31/16890\">",
"           Introduction to recombinant hematopoietic growth factors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/50/32551\">",
"           Langerhans cell histiocytosis (eosinophilic granuloma) of bone in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/44/6858\">",
"           Regulation of myelopoiesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/17/38170\">",
"           Treatment of radiation injury in the adult",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Laboratory measurement",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/54/35690\">",
"           Automated hematology instrumentation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/26/38313\">",
"           Evaluation of the peripheral blood smear",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/2/24614\">",
"           Laboratory evaluation of neutropenia and neutrophil dysfunction",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Lymphocytosis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/12/3274\">",
"           Approach to the patient with lymphocytosis or lymphocytopenia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Neutropenia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/51/25402\">",
"           Approach to the immunocompromised patient with fever and pulmonary infiltrates",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/22/24937\">",
"           Congenital neutropenia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/61/42966\">",
"           Cyclic neutropenia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/21/21850\">",
"           Drug-induced neutropenia and agranulocytosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/0/44039\">",
"           Hematologic manifestations of HIV infection: Neutropenia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/33/42520\">",
"           Immune neutropenia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/14/10473\">",
"           Infectious causes of neutropenia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/31/16890\">",
"           Introduction to recombinant hematopoietic growth factors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/47/18170\">",
"           Overview of neutropenia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/59/3001\">",
"           Prophylaxis of infection during chemotherapy-induced neutropenia in high-risk adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/24/12680\">",
"           Recombinant hematopoietic growth factors in inherited bone marrow failure syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/52/40778\">",
"           Treatment of neutropenic fever syndromes in adults with hematologic malignancies and hematopoietic cell transplant recipients (high-risk patients)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/9/33945\">",
"           Use of granulocyte colony stimulating factors in patients with chemotherapy-induced neutropenia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Neutrophil function",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/41/17048\">",
"           Determinants of neutrophil movement",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/31/6650\">",
"           Neutrophil functions other than movement",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/2/6185\">",
"           Normal neutrophil development and kinetics",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/38/43620\">",
"           Primary disorders of phagocytic function: An overview",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Neutrophilia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/52/29511\">",
"           Approach to the patient with neutrophilia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/55/35705\">",
"           Causes of neutrophilia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/36/31303\">",
"           Definition and mechanisms of leukocytosis and neutrophilia",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-877A739508-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f21_6_21614=[""].join("\n");
var outline_f21_6_21614=null;
var title_f21_6_21615="Intrahepatic PSC ERCP";
var content_f21_6_21615=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F72605&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F72605&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Primary sclerosing cholangitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 291px; height: 360px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFoASMDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDzOS4JA8vgjjPrSRs5ly69RwPSpvJKPnGSexqNU2OFOCc4znrQBLd5ECoQCMcmsqeR8hTgc9PStnVUQLGgOGPUdB9KwZ5AG2g9O9AFe5ZkOUyexI7U0Y/iYF6YxbOPc89zVWTzGYjjI9Ov0oAszSiNgO/9KaXBXJPJH3TUbbWx0zjkGnSY2AIff1xQATTgAqMH+tQ7gw4GPcGoXckEkfkKWJlEmJD8uM0AWY4HuDgdcdulEswtflABZevelN6FTZAMf7VZ07b8Etk5xnPFACSTM77i2eetQk/PlsEZ/OmTSDy9qDOB3NRNISvPTuaAJS68Dkg96gORx70rbQOp6U1GVh79hQAmcDkDGO5pEAL7gRwOlOKnaWGOaarBcgcHnr9aAHtn347VVYkk89ac8jMTk0w0AFFFFABRSAg9DS0AFPjBPIGfamUoOOn0oAdIAG4Oc0yiigAooooAKdtwMt+VPSMggnGOtEjfOvTj9KAFViSQv6HpUlMG8jI28jrU6KMkP1oAETJGOmOae8gT5U+bA60xm2nCnjFMJ5oAVjk5opKKAPpIeHLF49zEhieOgrNutCs4JV6bgc7uuK5j/hJL2KEKj8DIz1IrPk8RXbybmdgMccdaANjxFYnkxPuUfLXJyWMyFiI+SMgVcGuyt9/Jz6HimPq0hX54wF6k0AYswmUHOQw4qKN9q7j6c1rSajA+4MNuRnnmoY4Yb1lWNwG69cUAUJE8tdwYEEevFNtzJk5UnIxu9K1vIiskK3Klt3AFUr3UhtdY1VVPTFAFR8Rt83L1SYn5s9T+gonnZwMEg/yqEvnq2SKAJWlIXC8frVSZyWOTwKcjtt59etRSqGck8kUAFObaPukmmDsOM+lG4AfdJ7f/AF6ABl3Ljt6ikCAf40oPJHpS0ANY9vX2qLdjcOcdMUjSMcjpmmDOeOtACnrx0pKD16YooAKKKKACiil7UAJ2ooooATnJ9KUUU9Iyc5FADQM/Spo0XAPU/SlZRwMewPpSlgq9sUAI2cdAR3GajVNxPQAenen7twH5kDmrMMecMTkDrQBAO+OOacG2nOcYpz43Er0zUUoyuR27UAPdyTxj3FR56FuPQetLGCB7e9BUkgk9DxQA4HIB9aKAc0UAdms5UnB+o7VSuiwY7uwzihHGGLnt39Khlk37hxgDqKAI97ISBwQastc5tkDct15FU8gsA+ceuOaaxVOAcjtmgB8hJI5BHbFavhiFX1FGk4Uc1jhfMB9B14ppvHikQRtgDpjvQB13itA6+dH36CuKkct14x2ru9FVdR03dcSfN24zmuQ1iFba6aJCSAT1oAzMk/KBt61EwKkqM++KsFQDgH1AqKXqdxOewoAjB4x+ZpQOM/04pAOfm4HY09gW7EY/QUANPJyTkn0qNh8wOeB708gLgYx9DSE7SoAHNABjjimO+FxnnoaeSAv9RVd23NmgBtKCQcjrSUUAFFFFABS9aSigBQCen0oJ+UUE8AZP0pKACinIhY8Dj1qVU2D1P5UANEYTBfGKejbkztxj070pCg88MTx70oBzgd6AGspbBGRTZAcYHNTDqCAeKaELHJH0oAZECPvAD+dWkf5TwxHbFHlnZjv/ADpiMEJDDNACBiDu6n1qPI3HoP50ucsfao8qJPcdzxQBIKSRtoH161Hgq+TnB4GKZvbP3jQBNwvG/FFVycnJooA6WWUMSPX161GGwG2/jxTGA8zIPXj1/KiTO04PPTFADd5zhQcn14qSKNppUAA9c+lVW427cHPUitWwbFqzAHgYyaAE1R44okhUAnHOB3rILo34c0t65eRmLZBPSjAYhO5oA6nwlcZhkiU9Mng1l60+2+k3AkdCar6PObWcckE8cCk1BjLeNt5LHI4oAozOFXg4xzk13nhj4SeJte8Jar4nNv8AY9KtLaS5h88EPd7Rk7F9MA/MeDjjNa3wg/4VzpV7DqXjy4vbm+jk3Q2X2Rnt48HhnIzvPfHQd819NW/xr+HFzCYj4itolI2+XNBInHTGCuKAPivwz4V17xID/YmkXl8g6yRxHYn1c4Ufia1v+EJtLAsfFPivR9LdBza2rG/uPptiygP1cVV8d+INW1PXL+2u9fudVsIZ3S3cTEQvGGO0ogwoBGOgFcmBtxgY4oA7eLU/A2kqTZ6BqWv3C8LNqtz9ngz6+TFyfoXrktTvhqOo3FyLS1sxI+77PaoUij46KCSQOPWqbsRwB70DjkjBPegBHBOA3A9aicfKvp9aUscc8cenWnR5bOe/U0ARUvAPPIqRtqNkdRUZ+ZuPwFAAfX1qQ4ZV+b8PemEHOMYIp6LgjP19hQA112jk5HamnGPeppOwUc+namuu9htAx60ARgbiAo5qVIcjLHHtTlQIvbd/OhQerYB9aAJUCqhJHH/6qBnpnjpmkUcbTnNCAE4oAG2lcfnQo464/qac+BgAfN+lKibwDjB6CgBGXbgZyx7CnIp8vBGT6VKVABxyc9aZ5gDEGgCMOTwWx74qPJJxnC5/OhxuYnJ9qZuJ6kKRxQBIT1OKrycjPOKmD8jbn1zUMmTyRjNAAHPAzx7009e34UlFABRRRQBuONqj29aZJJu+UH3qN5AD6ZOeabuCjLYz6UAODDAJxitOzffA6DGMcA1jglmG3O3FXdKLCcqDk9OlAFZ02yncM46VExYtjOCOgreuNMluJgIhknvRJ4duUXLDO0ZOeaAMWFyrRtyQDyav3b4fzos4NVrqwkt+WRgB3FSWjq6eVKT0yM0AVmmMjjd96hiu7oAcdTT7uEwy452+veq7A4GT15OKAEds8cdMZ60wnn0FKAcj3oIBOByP50AMA+XBP/16MnnOBinc7hjnmpGjOMDPpmgCvsU/LtIGM0smVOMgH1NEmI+FwSe/WrWgaPe+IdbtNK0uLzr26fagzgAYyWJPRQASSegFAGfgkkZzj3pFGSPrWz4rtNItNbubXw5dzXunwBYxdSgDz3Aw7qOyFs7QecYrLjXaeeuaABUB55B9+tIw2D9frUi7s4HPOOKlEAYguOnagCFI2djtyo646VMU8teO3Q4qU4RenHtTQC4JHC5zzQA2NO5HFK6gqecYqTaCwOcds01xyeMqR60ARoqtgfxGnuu3HJG6nDsM4xyRTQTjgHrxQBHtx/Dk+tWI8gDd196bGACdoOelICw9/wClACvIpJBx07d6guJADxg8884pXYhjk85qErubJPIoARSXdRn6AUx/lbHXHrU8EJ8zc2QF6e9R3BRm+UYNADE5z2PtTWYnqSaASFIHTvTnyeSoAoAZRRRQAUUUUAaJIbG5cYNKpDY7L15pzD+8BSIRjjp2oAe+wAbFxj9ajhmdJUbIH0pzsFqIL5mSOOaAO80u9VLZXYK3TGa6W1mhu42LDG4V5dZ3ZjhMOcY71cs9dltZcOSY89j0oA9C1LSLe5hKhTk9/WuA1XSlspFYNklu3NdRF4kgNqu9iCfzH/1q5fXtRS6uN0RPXOD2oAvt4da6szOjZJHXsPauWu4HhmMTLgjjGMV6J4T1y3SwMEhLPnhawPFFnvlaaPaMnOKAOTJ6A9utOiGASxPFTmMKFzycdD2qNE2+v40AChSwIAH1ok+VTjjJ7UkvUH6cYqFmzwc4HrQA2Qjqoweg7132pIPAfhl9JjAXxTq8QOoy/wAdjatgi29pH4Z+4XC9zUfg+ztfDukr401iFJ2VzFotnJgi4uVxmZwesUXB92wPWuPnuLi+vbi6vJnuLq4dpZZpTlncnJYn1JoAhii/djBpwj3Fgq85qeOP5fm4Hb6VKQIiRkdOMUAQLbrFgnHPPTpSyOevOc46ZpSc9fWmsMjjPTpQA1lLDhgQafgAZH5UuCEHGKXlhyegzQAzG7OemCOlC88KvGOtGM85I/GnRnaOBz/KgBuwbSzY9+aWPBGTnA7e3rT1jO1ieg75ojwG5I6d6AFVQrEk7VB44pkpx9zLe5pQplG3j5eRTPMCtgHOeMUAVpeSx4xToVLONwyo64qeO2NzkRggjk5q0LcRRFWwOKAM67uS3yp8oHaqiqW6CtN4YAPmI/nTTcwRjAGf8aAKkVtI7gAEH6VMNPlU9fY0/wC3Ko+VQffvSvqRK9OaAKEy7JCoGMcGhlAQMD9aJpPNcsQAT1xTc8AHkCgBKKUEdwfzooA2tu5Mkj64zmmLGSrNk/SrKgFSGx7VYW0YhApBJ44FAFIRK8fy7j6VLYafJO+xVbBONxFbSaf5O0uMM3RTXQWAgjtiSoXYMke9AHNDQPLfdIx29MEc1DeaJGQDnPtjvWzquqxx5IIJJ6A5rl7nVJpJSR8ifWgCZ9OMbqoYsgHXOcVNHp3moBkKTjc1Z8d1Lhl3Hn1p/wBsuI24bHHpQBt2ekPEQYpgffsa07q1lmtdowX6VzVnqs6kbyGHTFbI19Vj24+fHHHNAHOXcTQu6vy4OCDVU1uM8d+7E4Lkc81kTxGNyCCKAKo5JOcDjGa+nPCH7P2keKPhn4Zv7me507WJl+03MkY3CeJ23BCpOAdmMMPXkGvnjw5pL674i07S7dSZL24jgHPZiAfyGTX1b8R/jro3he3/ALE8FJBqd/DGIRMGzbW+OAMj75GOg49T2oA+cPimutL4vmtNe0ttK+yRrb2dgB+7t7ZSdioRww6ksPvEk1zEMQVcgYb1Irb8Sa3qniXVpNS1++nvLx+N7nAAzwqgcKvsBWZKTkKcDHoKAKxGxl3jGB2701ySBuHPTNTSDceeVHbvTMgqOPlz19KAIgvXoeakaM53Y3Z/CiRcMGPPPJNKh2kkfdz+FAERJb1J9zT41ZWyQD3znpT3UjGM7e5zzS+WqxlmA596AGyR5O4dfQ0xRsdcntSStkYT6ZqJwcDacEdBQBZ5SPLYPbGOtVi+G+Uc/WptoMCvgg55AqnLw/ufSgCaOXy2Zjk57kVIqbn3NhVznnvUVmpdiMfL3NSXk6tEFj+UL6H9aAHm8WHHlAZ6Z+tUri7d8gnp2qBuV+Y8npzxUQP60AKWJ6mkopBnv19qAFooooAKKKKACiiigDoNPiaeURpn5sY74rvND0tI0RZEy3rWPoccVoqSSqC3Xbmr11r6WwIQEnocGgDZ1eGzjTzNwLAYPNV9S8M6tfeA18T6Wn2rSklkguliB325XHzMO6kEHPbv61xt9rEtzkM3rjJr6R/ZA1EXmgeJdMmIdYrmObYw4IkTaeD/ALlAHyrM7uxy2RUQG7hhk19M/HD4EMklx4g8DW+UJMlzpkYxt7l4R/7J+XpXzcYwGcEEEcYPUfhQA+JAEGcDC8cc0GLcASRx27mhJAiHcOMcc/rUJdi4YnOBjPpQAjqVJAPfpQpAQgjmnFgW6A4HXGMmmE5bp+FAEkLtGSUPzAdRU0kouEXzD8+aq8YA9KsxQ8hnI55oAZbwvFKGUurdAQcEZ61de3VF/d9SOQOKnikjkiEbEEt/EPSppYHhC4A5ORzQBQZG45JbANRy5IIUDOep+tXZh1JOPTFQHIkIxuU9qAKo+bAfH0oAAQ7VB6/jTwhy2MH0xRISoIAHXt60ARqA2OBkdvSggRnCYJPrS8kfLwT2I6U4ZzyM9OKAI2yNvvwfr61HKWPB5xUzkFTwPf2qLaZW8tVGW44oAiUg8Z4pjrllOelSPGYzh85XvULOVHfPYUATmU+SVXovPWqnVjnrT0lIyNucnNT+UETeeuf0oAa7i2hAGQT69TVQlsFsZ56VKzb2Bbp044qvI+CMHsRxQAx2HOAAemAOKZTnOSO+O9NoAKKKKACiig0AFFFFABRRRQB2Vu0k92salvm4xjNbGuaI0NqrMO2TV3RZLBJkkkVN2enpV3xLqcKwFYsMXXjPQCgDztLXIbPrXvH7I90tj4v12Kd0ihl04SlmOAPLkGST7BzXiTEMxzIAG6A0plEKMFlcKw2MA2Mj0PqOnBoA+pviL+0Npmh3c9j4ZtYtYkWPi880iBZMkFcYywGByDg5xmvl7xHrF34h1y61bUDEbu6bfKYoljBPsB06fWqEsqFNwBJzgZNVzMMMCOtADJGBOVHU0h5PQClY9RgYz2pAM8daAGc5x1FTxxNJ0X8TT7a3UgE9Opq8IlUbQF2kZ4oAqxx4TtjPfvUksewqRznGR61YjRWTac8HnoBTHPynrigBkSES/Ln0q+hMiZ3HK+hqsMEbc57g+lIjlHCKQzMe/agC60JkU5XcOpNVngILAgjjjNX9KnMVwqzFSpPI9K9H0PRNM1Kxe4TbuHVSc0AeQ7NoC5OD1FMIG4ZYDHY+td34p8OCzDPbr8nGQK465BjB4578Y9qAKh+7xxxxz0pmDnjkYpwIBB3c+tNk/wBkHJPr0FAEEh5HZR2PrTEcxsGU4IpJGGSQTzx15oyCoHfHPvQB1ml6QmtwF0faV7GsG/037PeNC/QHqe/0qXQtQmspcRFvu461bu2+0XaXM2UVecUAZ11pZtV82Q/e+ZQe9Z00jyHHYV0t/fR38SqCoxx9awbqzKgkdevAoAqiInPI4pj2wzxig7kJHrUcoJI2nn0zQAv2cKATxz3pksLA5A4Pb0oZzjOSCOPxprSMTweO2e1AEZBBwaKkZlY4PX17USIByOlADACQcdqSpUGFIIBJ5xUVABSoMsB70saF2AFTzQmKVVz7daALaWfyDnt60VCJXwMgZ96KANxZ/KferAntip7i8N2mJMA46msrJSRiwOOlCuSDjC59TQBJJ8pbngelQeY2TnBp53NuJzwAQR0FQ4Pp2oAXOSuT3/Ko2f5tuOvtSsGHzAAknmnxRtIQAKAGKGLhU59qtxRMoDEDB4zmpVhCsFAIPtV4xIyAZOcYPNAFWI444O7I9alDfIpXGPWnR2gxkMDt6YOKI4upIIJPPuKABVY5GeB6UxUBcqBx3J9qsxj5grYDHhaYdqA9M4/OgCGYrG4UBSe/tTFUi4DHt1p0iASE9u2BR5mAMDAGQeOKAJ42BDbsZ5Oa6zwXqklrK8CNgPg5PauMXcBuJ4xkEDvVqzkeF1cKwcd6AO+1+e7Ub8l0PUEZFYOo2iXNj50sQTcfvDoa9I8Dx2ms6WVuwHlGAQ3euX+Jvl6fcR2USjywuRxxigDg59O2qCgJQe9Y81vLuIIPXPSuis7a5u1AjcgemeDWmmkSqu+ZgE6A0AcAykcFce5FAX5RgHGewrvrXw5HdZ+bjdlaJdCW3+UQgEHPNAHI6dbsrCVxgdgaZrOoF2MSKAAO1XdZuPs0ZRchiSAPSuYkYklyck9aAHrOUbO7OORWlbTLOVzwc85rGHLAEkg9OamRyrZXqKANuazjkVWAIPOcCse7tzGcjlMcVftb9Sqq7Z9Tnp7Cp2YT4OBtHegDnZMg7e2c80mDgbuBnGTW/NYJMq7ep/z+FZl3YtE/GSO/rQBSI5JHTNKh2nPvQ6lWPGBSKMgnjj1oAnBXAJGD6moXXaTyKXllUZ74x/WpEhYDe44HagBLd2RhtGD1zVqSRThmIZyMYPSqbMTJn7vpSc43bzkdPegCRi+flAIopvlE8k8/SigDpY2WZSCo+UcmoJodihyNwzxxT2YqmyJSTjJ4xTPMJZVb7vSgBqE47g9DUJUHc5+YY7dq14bZJVxFwTxiol014nLSZ96AKKwM5A42+1WIoiig49vp71ZEYj3Lnk+2KSPdj5QBjrg0AQldzISffApxYkcZGO9KMFVIwWJ7elSsiiIq+OlADYAVU85zxkdqsBiFAJOO3rUKDjAzjHWpVACgDA4oAuweR5Kh1AIHJNOEcDBtmCT69uaosxZMDgH0pA7LtAz7kUASGzDSEAgfSoTaMDhuR2INOa4cDCfMfpTopt5CnJJ644/CgCzp2kSTsq87Sa2Lnw+scBMcyeYvbNW9JlSC1LBNvGMg4NZV5ftFu8rGX/P60AXfB97cabq6or4BPrxmvRtS8Fy+LwLxeCBwF53GvIdNuGhnD3DAZG0DNfUPwq1bTLPwpH5kubhRv+bn0oA8C1Swn8NX0lvNE6YHQrWbe6/bzIiSBlx0zXoHxX1Ma1dXFygCgcggcn/9deFTXuDskAdcnr2oA62HxBFG+9CTGhALDoP8OhqW68YpMPL2oM5G411/7MGiaZ4q1HxZoms24uLG5sIyVIwVIk4ZT2YZyDXAfFrwFqfw68SNY3haaxmy9ldhcCdB6+jjPI/EcEUAYGtIkpM6NuDDP0rFdePmPT071PHdfIY2YYPOKa8YxuUg4oArqTgHgMKBk5bOewxTiPl75z0FIihe3Oe9ADSpDYU4GKntZ5QwUqSO+fSmlc5OMjP4VsaHpr3Xnsq5KDPFAEMV0N3zZGeozmtGwiF9OqY4bls1TOnSQOzOj7fcVUW6Nu7+S5BxgkcUAP1y3ht714ouVFZUoCrgAVJPcmRtzHc3rSJGZjgLz6jnmgCKMc55z7VaGWGM4A/SmNbNCAXyMj6VCCA/ynCjrk9aAJmwT6jt70wRlW7Ee46VGHYYxipNxzzwSM9OlADx09KKbhv8n/61FAG+mV+78wPfNKAZGxHn1ye9EasR15HbvVyJMfePbgDFABaoYHDkksK2rOdLkeXIo39ax1Hz5LMMHIxVmzU/alKsM+npQBYu9OKzHaQQvVc1nvEQxTbtyOmK19RRw8e1huzgkc4PpWeGI3KwBJ5BPNAECQgRg4wRweMcUsqqVBVc8cn1pWXbtJOQe9LKQVKZyPWgBiAJGgK8HpzS+WQM8YH930qdYgIQ5fpnGOaAxC8ruBOMEUAVoxkrluvGccUuwbWGcnpnFWRGkhIU4brTUt3JAI2hep7fjQBF5aJCCeSeB7VLZW/nTjHGPSopj+8Yk8Z6ir2gQl55CO3NAFuZngt3Ct0HXFYcExknyDjtuPPOa6PXItlrv38MD14ya5yS2e3szJtJL0AU3YyXe0Sdfau5i1yTS9LgVZNxxjAPJrzlNwJYjj6da0Lkyz6eMuTtwQKAO1vtYF7pzREYJGTj+VeZ3AzKwyc5IrU03UBGfKduB75zT7yzFwrSRqcnnGetAHr37GsmPiBrsZPXTc/lKn+NfTnj7wjpXjbw1c6PrcW6CQbklHDwOOjqexH+IPFfD3wv8bXnw11281Wzsor24ns2tUSVyqKS6tuOOTjb0469aq+OPiX4t8azv/berzLasMCztiYoAP8AdB5+rZNAGD4v0BvDHia+0l7yz1D7NLtW5tZQ6SKehyDwfUdjxVA7Vfr8pHIzmodoUbQAB0q8tm8lqpAOT0NAFd4wyb15GeR6VNaadcXjARIx5wcVt6Do7F91znYemf5V2dtaQW6EgRKB7YJoA4228POpXzTx/EAMV1nheCLTpyrLwxxzxVi6lVSCoXdjPtj39653U9aW1lBRhkHOBQB3fiJ9IuNPkVRGJSDkIefrXiGoW6pcSbW+UHANX73xBLOzBWKgmsaed5W+Y8elACxLGWwW4PHPFX0uIoFITGRzxWVRQBZurtrjgjAHvVcdfakooAevKnkZp+7sG3cd6iUlckHmnKxGQBle4oAeCwGBjH0NFPTO0Z60UAdWiBT8q5OOTU0eSu5cc9OKIQC2DwD05/nVqKNV+Tbkg8/SgCuyHOAuPXnOK0NIiQ3QVuvfPQVXgVlmwoB+bH1rZaNbKJmJXDDt1oAy9VkRrohCNq8HB7/Ss/I3A985NSXHMm/5cnt/WqzAryvJJxyelAEuWxjkgc89KeQNu7AwRUKE7efmPrT1bA69OaAHxuEj2gcN1FAOThTjP51EMlMk59Kl+VYsv9Cff0oAVPlJ29c4xnmpIpgN2DwOvHNQSSDIGMbe+eKjeQMpA4Xkjj0oAdMFkLbScMO3WpdJuWtrr5jwRgiqLyFQGbjtzRFdbJB3zyCOcUAdPrUxvLRVi+UjHXpj2qjrExGlRqozsGM1JpyG5jwpLHj5fSq3iJjaOInBXOTg8UAYVuLeWIgtsYVtaPZrNathsgnGPX8K5UnnjjvxWxpUrojfNxjrQAuqaWlo5JchjyB71XsL6S1P3t69Pm7UzUNQeSYh2yOgNZcrkchhg88Hr9aAOivFjuYS0eN/OcVzdxE6uQcgZzVi2nMZBY9T09a2vKiu4lIABH6UAc6igJuYd+K6PS5Ee2K8DbWbcWy+QqlgpXvRDKLNcLhi3b0oA661uI1hUHIwOPcU/wDtiIAxZBQcZrkP7UIRlP3u3fFZ0ty7uWJOevWgDY1fWpvNeKNtqZ/OueupjM+WO49zVqRxPFu53CqRXhvb2oAjoA96Xbx9egpKACiiigAoGM80cY96U/jj0oAUjp0qVE2g55qLG5hjGT+lTRo2/kk+lAD+OwwKKtpa5UHj86KAOuhjAiL8HPOOlTQYMZLHbjvinIgfaUG1gMg+pqZYSxAUZZiM4H5UAS6bbB3aSRcL2boDUF9MWlIU5Cjg59KuX8ptbdYlJ55PasKVsuRkg9qAIGfc3sKQncDuzk08p+7BGOvPNQs23JBX6GgBCFBOOvcYp0alozuHy+lMYM0p288BcVOcCMKDnA/KgBWAK5DZA6D0qF3II3ZYZzzRIwQAZzg1EsispL9c8CgA3b2zjgdu1NLc4wNvcY6/jSM21fQegpA4VsZBzxz2FADWYYKnp25qkAqkjdgnqannYI24g4zVZyh6Ek+/SgDo/CmovaX8R6wswBrrfHWifbrZbiBCGC568VwGkKJJ1KnGOOPWvY9FvYJfD7xTkGYL90jr70AeDOrI5RuCDirCXflxbWIyORUviCDydQkER+UnOBWTMcuc9BxQAsrb2LZqDJyxAJ56ZpxZjxkhQKRhnBy2Ce1AD1JIyVx6irVvdsh27iADyPaqRLIwyxAPtS5z3B9SO1AHS/ubuDKnhaz7iMlgoXkCqVpeSROBnEZ4x1zWwAtxDuj+8O2eaAMWeMq5JBGarNkkAk8HjArR1FyxAYYI6461QTODznBP40AT2rrwvJ96W4gLgso49zTbVC0pJ+X3Jq9ZMsodG2/40AZJQ5OT9KZt68jirN7GYpSCMA8ZxVZwcnJ/+vQA0/WgdeKUjBPQ49KM4oAUAbgCfyoYfNjqelPjwEJYcetKqgscZIPNACqnz5GauQxeWdwHzd6dbRKFBOPUYFTP3Uc9z780AOIX/a/75zRTMJ/Gx3d6KAO0gOR8pO7scd61NPjMBM8i/d6DtWXGFjQMRh84Getad06JYLh/mYYI7UAZWoXJmkkdz8uflHes+Ri2M5IBwfennOM5yvrTVJPzAkdjQAsgG3npVcKuCMc9j3qWTfkmRuen1pgAzkFtx5oAYRszuOB2GKi8wls5KqO/rUshDpkgHtg8VXdzsx90L8u6gBJGDA4XPJzzURIRwT1IyaEkPlcEY6VE55woznuaAJJXZnA2kA9ecfrUTSDrnJ6A5oLgKOcVBkODkgeg9KAHOQ6hstnPTGc1Gp5XaMH1oZi5GetaWkWDSXSvIpKKePegDZ0mzEduHbqeRmr9peyISEOFBxkHrUGo3sdrCE6HoAPpVCyaRoGkLrluuaAKPiTZPcDGN/cd652VNpK5P1Fal3MWuy4Y8HHNS3FmssJeNSDjoO9AGEoOCG5PY0KeABj+dPZQkjZGM1GxycdCffpQAN1ypx6mmjmPjjJ7dqU5XAwM9jTGwBjb+JGKAHIeQM4H1q5Y3hhLZPBHPtVLI2jGS2KQn+IdTzQBt3sIlAlU9c5NZDKyMxz781c0+5xIA5yrdQe1WLqAMwkVeAOgNAFBXCR5zyfbils5zDIcc44NMn/1m0cY465qLBU9cDqcnrQBtXFuLhFZMsSOmKx5ojHIVbhuprQ026ZXVCehx1p+pIkkh2nnv70AZDDG3s35U3t34qacEEAg59aaiF+MDINACxguCAvHtVu3i2Dpk46YpEj2lQuATkE9hViNOBkfnxQBJGpGd2eRipEUAdMULzhVOT70pHBHINADQi+gP1op1FAHV2yG4uFB5B5I6CrOrTLwg+6BnAHSpY5IbTKjDOckms6eWOV5DIMEZHWgCvGgMf3ue5z/ACqNWbcxQjb602SUr8q8IewpkrhVwp4/nQAS8HIOfSogxBG48jrSGVQwOPlPvmmO25lHG70zQAsjFlO0EN0znio9iHIbtycHrUfmkbEJ9cjpmpt4QszdM55oAa0AK5xjd2qGZVTLKRx6d6lmuBJ8wb5senFVsFlyWIbH40AV5HDDCLwPamiNnkCDnPrWpY6RPctuRCFPU1uW+hiBjI+cjoSKAMrT9LKtulGF7YFXry8htIg0RHmD35P1qPVtSSJPLiILL+prnJJnkJLkknigCzJe+dKWlBYnpx0rYVylrk9CMcVy+3aQTk5Pr0rbuTu04ew5oAx3I81gSckmtGwmZsIwATGMk1nKuVJ9PWlR2UgqcUAT6xbhMNHjaTk45rEIII3DJ610Ly/aoMHkqKzLm0fhtpweBigCjkk8nHp+dKyttByTntUkdsxb5uBU6yonyqoJ6ZzQBSDYznJJFN7VPcIANwOc1COSByR6UAKrFWBJ/GtvSpkZXWXGD2I61h5OcVNAxjYNnCj3oAu38HlyEoPlPIzVPbn73OO+K2reZLuMBsbscA/zrMuYvLkIA4NAECDaQWbp09BV6KVSpYctnv6VQOAmMZ3flVi0OxwMAr3oAmZA2Ny4Hrin/Z/LjyhBHWtiKCK7tm2gjjj2xWfKHtWKMeD7dqAKsQ+YA461MhA+6evTNOjMZQBj8394daliRChyRjt7UAOjIQMCASecnnFREc9eKeqnqcd+9O2EFSTyaAIiT6E0VKUHdgPaigDcjbBcEnAH86Y8mY2POT37GnxvCmC4PIzSyrC6AqSGz36CgCvLwpY9SOgqAtgHbz1J5qW5DIDu+b8agRGbJOQewFAFaUiNiHByfQdqZIwHyhQe+fSpJ8l9u3n1HQVXnIUFXB3EdR3oAfK5ZeOTjofWkmf9zls56/WoUcbORng0+CCW7cJGpAY857GgBsTGSTaqnJ5FdLomitOytP8AKuCcHv7VNpljBZoGZQ7Y71pSaikAEmQCOcAgfQUAaC+VaxFACDGcNnvXNeIdaMhKI2Xx2OKi1HW3uFxGPqOtc6C0k5MjAseeRQBXZi7EnqfX1pDuAwTx2qw4iG7sfY1AwwcfrQA3nI4zk1syzqlgEKjdjnjvWbbqRKrY5B6VPqDnzVGDnHzDPWgCrnaCFfj6dagkbA4OT0qRl29SPzqI5b5vwGO1AC20xifjv1OetajTKOQoZlHIxWMRjPB9q1NLKOrKxwTnvzQBQuLlpGYAYFUJQdxI6Vo6hb+ROcDg9DVNwSvQHPqaAGBxsIx0Heoz7YpSPU89aQc0AGTjFS5YjJxj261DTxlWyOeKAJ4GMb7lJH0rVnEU8GRgSAGshSFQcg844q5ZSFJFVuVJxxQBA8RL7SpK55qVQMYHrjpWteWgKbox8w5rMAI49OuaALlldC3HJOCPSpdRuEljQquDnknms/OV6k+g9amhXcp3EkY6ZoAbFHuORhsdqs4HQDb7etLaKPO6Zz29KldMNuyF5+tADIwAcZ5I6etLOQG2jJIzzTl243nkjpg5pGOSzHHI4oAAiuN2TzRUisdowSBj1ooAnEgVD82DTFmYqRjnPFQksXHbv/8AWqORiXJxhu5xQA53Kg5JJ6Cnx3rq2NvzdRVXeuWzgjpz3qIbtxIfBPAPtmgDTe/jT5imSTio3nt5VG/qPTtVGNC67QcnOeOtXrHTXaRXl+Xvz0NAE0elLM25nKIx7d61VMFjFgBeBwDVW4vYrWBQCGbGQuawLq6edyxJwexoA17rVduRE3ynoQKzJrlrh8k8k+vFVN3I5496epGSGOCRjIoAs27BZiF2ggY6U2RAWyMDnGRUSELkj5SODmrPysoAxQBBIu58YJIHamFSOAMjr71NGSQQDyOKD8rBlJJA/OgCS3RjOMsOlJeIXlYDGe2antwC5YE4Uc/lVe6bbMzdefzoArTBRhcksByPaoQO4GM9qm+ZiCud3J9KjxQBE65HB6etPiYxlSM8nsaGxtPX04qJ9ygA9DyPagCzeziUjIFVHwGwMmpUZduH6jikYBgFUAdDQBVdPl4GPaoatT/IO3PWqtABUqcBudw6VF2qUKWbgAn9DQA5EJbgEY9B1q5GmznvTIU2hf1NS98UAaul3IY+VLkk9D1pmp2ghbcp3Z74qpbMY33LnIxwO9bcTLdwYlPQYwe9AHOkZI/pVkDA+b5cjAFS3NmYJcPnA9KhT5wQ+No/DFAE0Ug2dT7VJHIWBGeT3qrGxJGPr7CpQeTu5NAF5lHlbkbB7ntVYqFAzkAdT60+M7kwBhfepmx5Z7FT09fegCAqpOWU5PoDRQzJk5Jz9TRQA0scgg8dz3+lR4BPAOMc1A7nHDDBOOOKUFwhOTn69qAFe3bd8vb17UqWzyXASMbsY9+KdEr3JCAEkdx0Fb2n7LN87QQeM0APs9PW1jBdecckVU1fUVhJit1XOeufSjWdVGfKgbGOprmp5Wkf5i3XmgCSSRmcs2SSetMwMkfxEd6YzELhsGnE5+YccZ9zQBKeQMZz0JNCDkcE9xx1pD93GeKcgyfXjigA5XdnryKliG5MADPtUbLk9eTzzUsZIXO3kcHHpQAqt1B5PH8qDkDJ556fypq856YB4zTyDkgjcPWgC3aKNjMRkjkVVuT5hG1fl4yTVppDDaZ5OTjiq8kyC3KqOT3xQBWBbZyBsHqKamMHPJ9DQSCoGflHQe9NJ+UAAH3oAaRkEHpTNvGCPmPGfUUkjEkEHgfnSlgy5HB9aABlC4xjrwDRMiJGMDk80N84weOetI8bFQWPPvQBVkYnkdM859aYwb659KfJgHk9+lPIyuUOD3oAhVCxHp9atRIFxt6nggUirtyDjPI4FTooCDI5+tAAqhckDHr70qphuMkkfWpAo2g8Z/u96niAZ9x6euKAGxphcYIZuDntWlaN5UnB79cd6hjj7hTuPQe1TR/KVT05GRzQBp3EK3MPmLjd6d+lYMsDK7M+MZxx3ras5wC4cfIeCD6Ut/ah4w3IJHC96AOfj4BOzDdMn+dSKM9T+Jp0keGxk7uhzQF4BbAHTjqKAJkcDDdQBjk015juPb+tAK4CkYH3c5psgAIAAwOPWgBcZ5G7n0NFR72HA4ooAqohkYBM9ev/ANap0tjtyykfhXU6VpkcVuGmUEd81T1ie3iR0IU5GAFoAZpscMFu0srAg9O3NVZ5hMzqhzjP3axHld8jee4xVjTJCk2GPytx6UAVJA28qw2nnryajbr82MkY6/rWrqkK53hecc//AFqzcAMc8kjpQAclSWXOD0xTQSQS3GDn6VICc5HfilPagAO5VGRk49adGGwCVwOpJpoznnnntT1Q7svux096AHK/zlsD8e1Oy2/PB445pOjLnOT6/pSsr7cDnJ5zQA3LOOp56k09BuZe5z0pVi5J3AtjpjvTyBDEC4G4jAFADrqTI2g4A4qGY/If0pHc45U8HPIqCSRsEnqT096AEV9wGevTFIxOzg/kKbkfJg4H0oPGecknI4zigAZTnhj6e9N+UEA8E9OtAYgZJ60m4lsjggYzQA5iOx+bqTT1ZngZAc1C5G7IyajMrKGXBwelAEYb5tvUYwBip40xweOM0xF2kHABHTFTj5lzkE+/agBCQ3XJH5YqUKAnAqHZk9gDwKnQ4UZ68c0AC/NyeM+tWLeTZJnPXn2FQLkqeD6/SpYwGJGCMf55oA041JAcDqM8nimNIRKQPmP90+lRRyY4Y8UTSZUMMFgRjA5xQBdViSADyDyM1pW0oYbJTgY7nFc/DM0a5P3j1Jq9HMQAVPzYzn3oAm1G12AMuQOTj9KyAecNx1xXTRSC5gKuOe5z1rGvLQxOxdflPIJoApBiGyMdKUDPJBUDjPWkDDGR/Oms2EyuDQBIzAk8A+5oqJASoO480UAbWp63tjKwn24/nXN3MrzvukIz2zTN284wCR796Yx6luGB44NADhknknOeRSoxUqQ3vSRgsPmzikfgtgYB4oA2VmjltugyB+P4VmKA85GflPb0qITEAKpIHTNO38nbgkcjFAEs0flMQOfpTCeQMUSOSoJPApkkmDwB+fSgCQHBOD1FPXk8P+QqMnJznPvTgDkYHI54oAsxMrSbeR3zVqUxxAlcN/eBqipKrvxz396aWLEnJyeMUATmcqQIwCeoOe9VyTKSWOD2BPWkJK5XpxQ7HgDGPT0oAawYAru6VHKOAOcewzUhJYdc5waaeOlAERIzkgY6YzRv+XHGMUsnDZHP9KiJPyjrk0AB78YxQSeOlI2TnmmqctuHT/PFACuTjjA9zSKpAy2CfanHGeQPbipUXJIY8UAMGO5x+FOCgMBkEetBBJxxgmpdg4GOBQAjEMQFwBjt3p+c4zxQoIH0/lSqnDNz+VADjjgHt15p8IycDgg88f596aFYKS2QPTpUkQBYu/fgUASL7jjpUhYkZI68VXjJ3/N0HODUruTgqOP9mgCIYXB+Yc/5zViF1BPUFT36VXLEpk4459qBJywXcc+lAG3bz7CdpCj6VelVbq1PPJHGfpXO28w9+D+Qq5b3flOA+SM5zQBQvU8pwo454qqWIOAQO5wa2r9FuIxKnYZzisQqQ2COaAJ97D+Hd7jvRUQVccv+lFAFROSQuRnjpmkbOTz1oBxyBjtS5+X2+lAArkdTkH3p6YJYjAGKaSD93A4we1LEoLYPAz2oAkjhaTIA3YGOKYVCnBPIxjjvWq4iso0Ksrk/pWUSGcHpk9u1ACKVV+eT6inAhcjjI6UmCGBHbqByaQ4MmTwD74oAkVTj5sZ9qep/WmjO488UckdSOMe9AEpLMxX17elJHgHLY29DTC20d/wpoPKgZP4UAOPLZ7e1ITge496d/nmm4ycjINADVbcSPbkjpQVAB28H2pVHOccmlPr/ACoAY/OcnHFQkevXrVhuY/XjNVnyGIxx7dqABjxg59MihBgAH8fegZIyRz6CkUk4/PigBxGATzmnsdq42kHNJng/J+PoKciktyQD/L8KAHbecYGM8/8A1qkLZxxjioVYdcEkc04AjbnPJ70ATADBJPTt606LZlmA7dCc5qNc55xSx4JPbGetAEyA7SuCpJ5OP0pAVDgqMjtgd6QNkLtz2Bp2PmbB+bP6UALFy5LdRxgUrttRgeRnAxTWb5yBwOpxwaikZQCeRnnGeKAHB8IVIzmlOWXGcZ5571F1A9KeHIHJJPT6UAKjbWHYAfnTjISwK8qO3vVZ352r1pYmUngn6elAGvY3BKhGHB49c1Bf2vlneowh45qNCEG7f0Par8Ti4iKs2T2yaAMaip5YGWRhkcGigDO6DPrxRj14oooAd0BA6Dr70sfJwByelFFACyNuBHTFJyACTkZ5waKKAHEhQNoyx704Mu0E9z3oooAAcpwNxp2SQMDrRRQAcFTzxSK24GiigBcZ68Y9KVflAH4UUUARnKgZI5OcGpB/CSTj6UUUANY4BPQ0xo8AY5NFFAEPIbHQGjG4hep7DNFFADjnp6VPkLkn0/OiigCMnDZ525/OnlnBxgc9KKKAHZ+XG3J9z0peo5/SiigBysB1yfb1p3mEknOD2FFFADWIycZA/nTSxz35oooAY2QeoVfrQW/dkg/jRRQBATzk5NPiJByO3PFFFAFuBs8HBB96ljm8iQNuyM8j0oooAsG53HKoSD70UUUAf//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Image obtained during endoscopic retrograde cholangiopancreatography in a patient with primary sclerosing cholangitis demonstrates stenotic intrahepatic bile ducts (arrows) with several intraductal stones (arrowheads).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jonathan Kruskal, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_6_21615=[""].join("\n");
var outline_f21_6_21615=null;
